data_2rrb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rrb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-O 119.055 -0.858 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 151.19 59.68 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.565 3.51 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -157.96 117.66 3.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.761 1.224 . . . . 0.0 110.517 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.41 -18.73 12.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.601 1.096 . . . . 0.0 114.472 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.3 m -78.3 -14.13 59.55 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -99.26 117.03 32.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.605 1.162 . . . . 0.0 110.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.09 158.49 19.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.781 1.632 . . . . 0.0 111.217 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -128.36 84.39 63.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.427 1.091 . . . . 0.0 110.352 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.82 71.79 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.983 3.122 . . . . 0.0 111.413 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -159.53 94.61 1.7 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.759 1.624 . . . . 0.0 109.991 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -59.31 141.85 98.31 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.023 3.149 . . . . 0.0 114.751 -173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -162.54 159.57 24.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.13 1.772 . . . . 0.0 110.917 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p -66.63 -15.39 63.43 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -69.17 150.95 46.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 55.9 m -142.86 170.36 15.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.072 1.349 . . . . 0.0 111.503 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 pt -140.71 155.59 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.171 1.389 . . . . 0.0 111.438 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.6 p -83.44 163.07 20.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 111.159 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -135.34 160.51 38.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.548 1.539 . . . . 0.0 111.905 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -157.6 137.11 8.41 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.572 1.549 . . . . 0.0 110.609 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -57.66 150.19 63.14 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.729 2.953 . . . . 0.0 112.991 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -159.97 142.96 13.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.011 1.324 . . . . 0.0 110.914 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.139 1.776 . . . . 0.0 112.253 -174.394 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.65 159.91 47.64 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 111.904 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.0 mt -139.45 142.12 37.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.599 1.56 . . . . 0.0 110.626 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.03 173.7 41.52 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.823 1.201 . . . . 0.0 113.44 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 m -64.98 142.84 58.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.35 1.06 . . . . 0.0 112.515 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -156.27 -47.26 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.566 1.146 . . . . 0.0 112.296 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 63.17 -163.2 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.347 1.859 . . . . 0.0 113.4 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.99 132.69 6.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.913 1.285 . . . . 0.0 110.203 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.28 157.18 62.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.627 . . . . 0.0 111.711 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.7 t0 49.06 53.38 14.48 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 126.251 1.82 . . . . 0.0 114.848 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.09 169.35 17.76 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.624 2.882 . . . . 0.0 112.097 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -157.54 158.13 35.07 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.385 1.474 . . . . 0.0 111.329 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.09 -21.21 65.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.08 148.43 41.89 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.4 m -136.48 150.36 48.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.895 1.278 . . . . 0.0 110.832 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.1 mt -139.96 129.58 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.716 1.207 . . . . 0.0 109.161 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.3 m -73.15 130.57 40.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.242 1.417 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -140.39 153.89 46.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.7 1.6 . . . . 0.0 111.619 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -158.63 131.41 4.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.499 1.519 . . . . 0.0 110.803 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.23 151.73 38.85 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.549 2.833 . . . . 0.0 111.308 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.87 145.09 49.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.671 1.588 . . . . 0.0 110.635 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.17 1.788 . . . . 0.0 111.79 -177.385 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 CA-C-O 118.118 -1.379 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.39 -28.3 22.39 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.532 2.154 . . . . 0.0 111.164 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -143.68 176.57 9.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.766 3.226 . . . . 0.0 108.08 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.04 -143.45 6.54 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.162 1.363 . . . . 0.0 112.63 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.2 m -141.05 143.74 34.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.242 1.417 . . . . 0.0 110.491 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -98.68 28.46 4.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.322 1.449 . . . . 0.0 112.885 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.93 -28.32 69.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.741 1.216 . . . . 0.0 113.303 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -86.51 119.81 71.65 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.333 1.053 . . . . 0.0 109.116 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.34 5.59 6.09 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.498 2.798 . . . . 0.0 114.637 -171.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -133.91 96.19 16.49 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.653 1.181 . . . . 0.0 111.767 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.34 150.53 52.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.298 2.665 . . . . 0.0 110.777 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -156.9 141.02 16.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.593 1.157 . . . . 0.0 110.837 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.67 -19.03 61.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -62.09 119.67 9.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.7 m -169.12 157.51 7.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.063 0.945 . . . . 0.0 113.222 -169.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.0 pt -138.85 161.7 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.627 1.971 . . . . 0.0 111.236 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.0 p -78.45 -17.68 55.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.431 1.493 . . . . 0.0 114.039 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -77.03 127.13 32.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.175 0.99 . . . . 0.0 112.245 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -76.21 136.52 68.94 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.502 1.121 . . . . 0.0 111.188 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.27 165.89 30.99 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.228 2.619 . . . . 0.0 111.473 170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -162.6 168.92 21.02 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 111.837 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.481 1.512 . . . . 0.0 113.439 173.012 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.65 155.84 54.05 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.071 3.181 . . . . 0.0 111.713 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.98 125.95 39.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.607 1.163 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.5 -151.8 40.34 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.561 1.077 . . . . 0.0 113.678 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.1 p -160.49 -160.1 0.74 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.94 1.696 . . . . 0.0 110.924 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -55.19 136.61 48.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.461 1.104 . . . . 0.0 111.799 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 13.08 0.52 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.91 119.26 15.68 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 111.866 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.29 -0.04 6.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.703 2.935 . . . . 0.0 114.59 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -96.08 114.79 64.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.966 1.306 . . . . 0.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -65.39 134.83 40.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.152 2.568 . . . . 0.0 113.216 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -157.87 96.95 1.52 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.332 1.453 . . . . 0.0 109.736 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m -85.73 11.05 11.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.08 136.35 57.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 66.8 p -100.26 174.19 6.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.202 1.001 . . . . 0.0 112.814 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.8 mt 71.74 -35.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.934 2.493 . . . . 0.0 113.589 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -63.36 146.58 53.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 111.935 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -73.05 153.31 40.91 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.674 1.19 . . . . 0.0 114.143 -172.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -71.24 150.85 94.46 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.818 1.247 . . . . 0.0 111.751 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.41 141.2 60.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.237 2.624 . . . . 0.0 110.382 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -155.31 9.45 0.29 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.323 1.849 . . . . 0.0 111.687 -173.341 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 CA-C-O 119.429 -0.65 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 -16.84 30.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.663 2.909 . . . . 0.0 114.472 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -65.24 -8.12 16.14 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.75 -3.83 89.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.253 1.406 . . . . 0.0 114.173 170.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.7 p -145.28 -51.58 0.26 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.991 1.396 . . . . 0.0 113.526 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -167.62 121.64 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.868 1.667 . . . . 0.0 111.211 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.38 152.56 22.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.875 1.67 . . . . 0.0 111.486 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.05 147.8 10.47 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.859 1.664 . . . . 0.0 111.222 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.32 137.19 11.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.681 . . . . 0.0 111.683 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -157.18 64.97 3.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.429 1.491 . . . . 0.0 110.469 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.29 140.7 27.92 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.5 2.8 . . . . 0.0 112.984 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -160.64 175.15 12.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.451 1.501 . . . . 0.0 111.713 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p -65.4 -17.71 64.75 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.37 141.69 58.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 154.42 35.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.487 1.115 . . . . 0.0 113.001 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.41 22.18 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.452 1.501 . . . . 0.0 112.365 -173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.1 m -77.08 70.0 3.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.753 2.021 . . . . 0.0 110.143 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.39 2.32 5.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.611 1.565 . . . . 0.0 113.857 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 71.35 149.57 0.13 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 129.217 3.007 . . . . 0.0 113.655 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -79.64 -153.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.342 3.361 . . . . 0.0 109.338 169.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -76.47 33.8 0.13 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.897 1.279 . . . . 0.0 112.908 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.909 2.483 . . . . 0.0 110.164 -178.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.06 157.95 46.17 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.131 3.221 . . . . 0.0 111.904 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.9 tp -144.38 -21.83 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.785 1.234 . . . . 0.0 113.72 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.34 73.42 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 119.175 0.898 . . . . 0.0 113.804 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.3 m -70.32 -8.31 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.728 1.211 . . . . 0.0 114.023 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -129.06 4.76 5.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.376 1.87 . . . . 0.0 112.841 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.62 154.78 40.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 112.928 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.38 132.42 4.23 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.771 1.628 . . . . 0.0 110.659 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 127.69 10.51 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.101 2.534 . . . . 0.0 110.989 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -165.99 131.12 1.85 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.181 1.792 . . . . 0.0 109.56 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 113.01 3.68 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.768 2.312 . . . . 0.0 111.046 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -158.08 31.23 0.25 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.702 1.201 . . . . 0.0 112.336 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -74.76 -4.26 36.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.75 141.79 58.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.2 t -75.71 167.39 21.97 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.7 pt -146.81 174.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.806 2.042 . . . . 0.0 111.66 -169.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.4 t -143.69 148.48 35.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.666 1.586 . . . . 0.0 110.728 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -99.8 1.1 42.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.14 1.376 . . . . 0.0 113.342 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 133.89 91.17 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.562 1.145 . . . . 0.0 111.721 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 157.99 41.4 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.65 2.9 . . . . 0.0 111.647 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -160.51 145.03 14.24 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.267 1.427 . . . . 0.0 110.896 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.021 1.729 . . . . 0.0 112.122 -175.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 CA-C-O 119.065 -0.853 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.54 159.31 24.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.566 3.511 . . . . 0.0 113.511 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.79 -10.14 59.22 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.83 79.27 Favored Glycine 0 N--CA 1.475 1.29 0 C-N-CA 124.912 1.244 . . . . 0.0 115.298 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.4 p -166.39 167.99 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.763 1.625 . . . . 0.0 111.595 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.42 132.43 11.67 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.29 1.036 . . . . 0.0 111.96 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -165.01 155.56 14.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.006 2.122 . . . . 0.0 110.493 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.89 121.54 85.3 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.796 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.5 155.61 45.39 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.386 2.724 . . . . 0.0 111.25 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.02 127.73 78.66 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.247 1.019 . . . . 0.0 110.81 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.34 95.15 0.76 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.06 2.507 . . . . 0.0 109.819 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -163.44 123.62 2.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.292 1.437 . . . . 0.0 110.404 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p -79.63 -7.94 58.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -65.87 140.41 58.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.8 t -109.05 179.78 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.266 1.027 . . . . 0.0 113.437 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.6 tt -161.19 145.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.419 2.288 . . . . 0.0 110.037 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.8 t -161.14 156.61 24.64 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.073 1.749 . . . . 0.0 110.486 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -160.98 149.3 16.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.754 1.621 . . . . 0.0 112.552 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -84.97 149.53 53.43 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 111.683 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.53 153.7 65.19 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.424 2.749 . . . . 0.0 111.027 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -151.59 22.67 0.7 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.172 0.989 . . . . 0.0 112.49 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.525 1.93 . . . . 0.0 112.301 -171.333 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 119.531 -0.594 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.2 -11.3 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.11 3.206 . . . . 0.0 114.638 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.5 tp 70.23 -29.84 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.733 2.813 . . . . 0.0 114.784 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.98 11.54 84.66 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.956 1.265 . . . . 0.0 114.211 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.1 t -164.82 162.37 20.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.248 1.819 . . . . 0.0 110.832 -174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -164.72 156.2 15.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.036 1.735 . . . . 0.0 112.104 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.5 154.77 25.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.238 1.815 . . . . 0.0 111.019 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -69.92 120.64 79.06 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.96 0.904 . . . . 0.0 111.868 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.2 161.32 26.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.334 2.69 . . . . 0.0 111.745 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -158.19 130.82 4.37 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.406 1.482 . . . . 0.0 110.214 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.57 98.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.556 3.504 . . . . 0.0 114.182 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -160.42 29.37 0.16 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.279 1.831 . . . . 0.0 110.513 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m -80.73 6.62 12.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.305 1.842 . . . . 0.0 114.094 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -70.27 150.91 45.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.8 m -132.98 134.46 44.51 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.594 1.558 . . . . 0.0 110.202 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.63 123.4 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.357 -0.839 . . . . 0.0 109.581 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.2 m -67.92 131.7 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.175 0.99 . . . . 0.0 108.376 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.19 140.31 44.83 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -163.53 147.59 8.57 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.049 2.139 . . . . 0.0 111.042 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 160.65 38.73 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.697 2.931 . . . . 0.0 112.044 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -160.27 144.28 14.16 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.589 1.556 . . . . 0.0 110.634 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.064 2.146 . . . . 0.0 110.274 -178.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 155.3 49.21 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.09 3.193 . . . . 0.0 112.022 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 pp -93.36 10.72 30.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.02 1.328 . . . . 0.0 114.386 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.37 126.6 40.33 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.313 0.959 . . . . 0.0 111.56 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.5 m 59.84 12.83 3.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.548 1.539 . . . . 0.0 113.764 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.25 -34.29 0.27 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.902 2.881 . . . . 0.0 114.413 -173.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -178.47 178.18 0.87 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.059 3.343 . . . . 0.0 109.02 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.57 160.22 36.36 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.429 -0.795 . . . . 0.0 112.947 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.75 157.65 36.73 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.725 2.95 . . . . 0.0 112.255 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.51 137.39 10.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.292 1.437 . . . . 0.0 109.953 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.46 91.05 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.142 2.562 . . . . 0.0 110.644 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -158.61 126.42 5.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.874 1.669 . . . . 0.0 110.577 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p -79.59 -9.21 59.59 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -67.68 150.68 48.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.7 p -141.2 154.69 45.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.418 1.087 . . . . 0.0 111.914 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt -154.63 145.28 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.976 1.31 . . . . 0.0 110.578 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.2 p -96.81 3.25 52.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 113.948 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.87 137.94 18.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.202 1.401 . . . . 0.0 111.801 -172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -66.16 131.21 94.38 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.85 158.11 53.62 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.332 2.688 . . . . 0.0 111.439 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -76.91 -16.46 59.37 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.634 1.974 . . . . 0.0 112.937 -178.255 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.66 -8.71 12.38 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.134 3.223 . . . . 0.0 114.386 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -142.2 155.72 45.29 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.269 1.828 . . . . 0.0 110.745 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.76 28.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.561 1.077 . . . . 0.0 112.89 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.0 m -140.82 18.4 2.32 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.347 1.059 . . . . 0.0 113.366 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.02 150.79 28.62 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.776 1.23 . . . . 0.0 112.436 -173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.66 173.61 16.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.09 2.156 . . . . 0.0 110.64 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -154.34 128.72 4.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.392 1.077 . . . . 0.0 111.935 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.32 158.01 45.13 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.536 2.824 . . . . 0.0 111.455 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.24 58.91 9.1 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.92 1.688 . . . . 0.0 113.834 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.74 173.82 13.3 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.168 3.245 . . . . 0.0 111.613 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -154.54 156.57 36.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.52 1.128 . . . . 0.0 112.405 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -56.55 -27.71 58.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.006 1.722 . . . . 0.0 114.073 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -68.17 143.26 55.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.0 m -134.37 151.97 51.53 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.165 1.386 . . . . 0.0 111.207 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.7 mt -140.38 129.57 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.176 1.39 . . . . 0.0 108.145 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.1 m -149.39 140.17 22.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.436 1.494 . . . . 0.0 109.661 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.88 147.15 53.85 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.984 0.913 . . . . 0.0 112.552 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -158.3 128.34 3.39 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.477 1.511 . . . . 0.0 110.625 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.97 151.0 34.81 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.497 2.798 . . . . 0.0 111.38 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -147.87 150.43 34.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.333 1.453 . . . . 0.0 110.885 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.078 1.751 . . . . 0.0 112.285 -175.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 119.501 -0.611 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.04 156.38 51.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.096 3.198 . . . . 0.0 111.93 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.24 162.94 31.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.009 1.723 . . . . 0.0 111.621 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.59 77.67 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.134 0.873 . . . . 0.0 114.235 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.8 m -58.36 143.54 44.7 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.695 1.598 . . . . 0.0 113.59 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -119.11 141.77 48.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.971 1.308 . . . . 0.0 111.375 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.49 173.09 14.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.613 1.965 . . . . 0.0 110.967 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.11 72.25 12.14 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.199 1.0 . . . . 0.0 112.06 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.78 160.47 46.13 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.624 2.883 . . . . 0.0 110.607 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.33 116.41 25.2 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.984 0.914 . . . . 0.0 111.733 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.73 161.03 12.28 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.282 2.655 . . . . 0.0 112.085 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -159.39 161.86 35.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.128 1.371 . . . . 0.0 111.736 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.86 -13.5 25.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.536 1.534 . . . . 0.0 115.088 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -61.55 146.63 48.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.1 p -131.13 172.74 11.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.216 1.406 . . . . 0.0 111.528 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.5 pt -144.18 161.35 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.161 1.384 . . . . 0.0 111.838 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -113.92 138.9 49.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.957 1.703 . . . . 0.0 108.692 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.84 156.8 43.05 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.08 1.352 . . . . 0.0 112.071 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -157.94 137.46 8.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.739 1.616 . . . . 0.0 110.519 -174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.19 154.4 46.66 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.388 2.725 . . . . 0.0 111.259 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -145.59 151.05 37.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.029 1.332 . . . . 0.0 111.25 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.148 1.779 . . . . 0.0 112.26 -175.567 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 119.447 -0.64 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.57 -8.2 12.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 124.157 3.238 . . . . 0.0 114.568 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -156.11 124.35 5.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 109.508 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.33 133.63 11.88 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.806 1.193 . . . . 0.0 112.078 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -165.46 168.72 16.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.675 1.59 . . . . 0.0 111.065 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -140.63 132.02 26.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.764 1.626 . . . . 0.0 110.873 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.89 175.76 9.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.205 2.202 . . . . 0.0 110.608 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -158.85 123.97 2.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.142 0.977 . . . . 0.0 112.584 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -80.25 170.73 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.746 2.964 . . . . 0.0 111.843 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -155.44 138.33 10.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.206 1.803 . . . . 0.0 109.545 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.04 97.01 0.97 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.757 2.305 . . . . 0.0 111.596 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -163.04 126.5 2.82 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 110.923 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.21 -13.93 60.49 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -74.99 155.21 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.0 t -144.96 166.6 24.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.635 1.174 . . . . 0.0 112.121 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.2 pt -146.32 155.33 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.48 1.512 . . . . 0.0 111.999 -173.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.1 m -69.65 137.57 52.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.231 1.413 . . . . 0.0 110.075 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -78.75 37.75 0.3 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.348 1.459 . . . . 0.0 113.228 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.59 132.55 88.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.856 1.663 . . . . 0.0 111.532 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.21 147.39 29.52 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.423 2.749 . . . . 0.0 111.304 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -138.28 14.05 2.81 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.668 1.187 . . . . 0.0 113.289 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 127.317 2.247 . . . . 0.0 110.173 -179.23 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.42 -19.73 65.53 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.029 3.152 . . . . 0.0 116.988 -172.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.88 0.51 54.85 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.154 1.382 . . . . 0.0 113.094 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.8 135.79 9.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.103 1.811 . . . . 0.0 110.861 -169.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 m -81.4 -0.29 40.77 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -157.58 143.28 17.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.078 1.751 . . . . 0.0 110.525 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.99 157.33 37.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.256 1.822 . . . . 0.0 111.042 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -157.48 72.28 4.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.376 1.47 . . . . 0.0 111.022 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.57 153.63 60.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.63 2.887 . . . . 0.0 111.464 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -148.87 136.54 11.15 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.388 1.475 . . . . 0.0 110.357 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.19 102.35 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.794 2.33 . . . . 0.0 112.464 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -164.07 121.18 1.71 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.674 1.589 . . . . 0.0 110.749 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.79 -18.86 65.59 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.703 1.201 . . . . 0.0 114.004 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.02 141.43 54.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 m -76.09 81.36 2.92 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.776 0.798 . . . . 0.0 111.25 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.7 pt -84.45 4.51 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.307 1.443 . . . . 0.0 112.92 173.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 p -82.94 1.77 37.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.249 2.62 . . . . 0.0 113.931 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.22 139.89 46.35 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.274 1.429 . . . . 0.0 112.173 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -62.3 151.09 83.05 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.034 0.934 . . . . 0.0 112.903 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.18 156.34 55.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.241 2.627 . . . . 0.0 110.698 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -139.79 143.96 37.13 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.801 1.241 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.126 1.77 . . . . 0.0 112.336 -174.608 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.74 -8.32 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.186 3.258 . . . . 0.0 114.469 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.0 tp -159.59 144.71 15.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.652 1.581 . . . . 0.0 110.187 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.59 51.9 3.43 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.529 1.538 . . . . 0.0 114.007 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.2 m 68.77 12.88 8.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 114.711 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -73.04 123.31 23.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.255 1.022 . . . . 0.0 111.052 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.98 45.81 0.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.329 2.252 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.59 160.24 25.71 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.681 1.192 . . . . 0.0 113.641 -165.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.24 -179.89 4.82 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.01 3.14 . . . . 0.0 111.329 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.98 120.88 37.01 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.394 1.478 . . . . 0.0 112.785 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.64 161.51 33.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.021 3.147 . . . . 0.0 112.634 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -156.43 58.64 0.56 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m 73.5 5.82 5.0 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.825 2.05 . . . . 0.0 116.261 167.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.14 125.25 23.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 24.4 p -89.33 58.96 4.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.484 1.114 . . . . 0.0 110.788 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -14.97 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -169.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -81.01 139.12 35.95 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.351 1.861 . . . . 0.0 110.979 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -135.41 168.26 19.53 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.961 1.704 . . . . 0.0 111.201 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.91 140.94 68.14 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.957 1.303 . . . . 0.0 112.749 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.66 150.48 56.8 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.42 2.747 . . . . 0.0 111.29 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -134.36 15.23 3.77 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.139 1.376 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.733 2.013 . . . . 0.0 112.287 -173.112 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.08 156.74 51.56 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.104 3.202 . . . . 0.0 111.95 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.98 161.09 31.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.967 1.707 . . . . 0.0 111.679 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.38 14.64 78.19 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.232 0.92 . . . . 0.0 114.235 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -75.7 -1.33 24.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -138.51 155.4 48.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.217 1.807 . . . . 0.0 111.297 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.81 35.0 0.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.68 1.592 . . . . 0.0 111.541 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -160.09 153.16 18.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.708 1.603 . . . . 0.0 112.131 -169.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.67 163.11 36.53 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.481 2.787 . . . . 0.0 111.012 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -159.63 122.4 1.93 Allowed Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.562 1.545 . . . . 0.0 109.61 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.43 126.54 9.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.951 2.434 . . . . 0.0 111.583 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -152.53 90.39 1.49 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.722 1.609 . . . . 0.0 110.7 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m -79.41 -14.57 58.85 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.89 155.34 38.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.1 t -146.78 143.16 28.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.896 1.678 . . . . 0.0 111.181 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.2 pt -134.86 -9.41 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -168.32 148.35 4.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.849 . . . . 0.0 110.827 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -104.33 4.05 33.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.695 1.598 . . . . 0.0 111.943 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -154.32 111.94 2.44 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.884 1.674 . . . . 0.0 110.972 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.31 158.02 52.38 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.0 2.467 . . . . 0.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -148.89 25.17 0.93 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.496 1.118 . . . . 0.0 111.905 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.253 1.259 0 C-N-CA 127.044 2.138 . . . . 0.0 112.997 -171.218 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 CA-C-O 119.519 -0.601 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.25 156.16 51.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.047 3.165 . . . . 0.0 111.707 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -84.27 -11.15 56.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.962 0.905 . . . . 0.0 113.296 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.71 150.7 21.29 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.351 1.453 . . . . 0.0 112.144 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.9 p -165.19 166.32 19.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.892 1.277 . . . . 0.0 112.182 -175.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -67.33 141.52 57.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.365 1.066 . . . . 0.0 111.656 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.65 174.96 9.98 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.926 1.69 . . . . 0.0 111.954 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 57.69 62.0 5.59 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 126.111 1.764 . . . . 0.0 112.875 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 179.81 5.81 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.03 3.153 . . . . 0.0 112.133 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.57 76.59 71.4 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.694 1.598 . . . . 0.0 109.672 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.83 149.54 78.24 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.881 3.054 . . . . 0.0 115.939 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -169.57 170.09 8.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.756 2.422 . . . . 0.0 111.319 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m -64.72 -16.89 63.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -60.1 140.48 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.8 t -75.55 153.15 37.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -169.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.5 pt -85.61 3.83 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.264 1.826 . . . . 0.0 113.197 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.6 t -64.92 -12.49 49.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.971 1.708 . . . . 0.0 114.006 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -49.61 132.45 21.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.763 1.625 . . . . 0.0 113.057 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -163.89 150.87 10.25 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.52 162.29 40.31 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.529 2.819 . . . . 0.0 111.463 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -69.76 -33.76 72.87 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.586 0.754 . . . . 0.0 112.982 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.399 1.88 . . . . 0.0 110.772 -171.254 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.31 147.65 95.0 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.102 3.201 . . . . 0.0 112.669 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -153.92 108.31 3.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.265 1.026 . . . . 0.0 110.06 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.15 85.16 1.03 Allowed Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 111.62 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.3 p -78.49 5.82 9.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.342 1.857 . . . . 0.0 115.754 -170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -49.57 124.83 10.17 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 0.0 112.015 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.18 131.88 31.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 110.378 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -174.76 170.78 1.45 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 127.317 2.247 . . . . 0.0 109.771 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -56.11 123.95 15.08 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.121 2.547 . . . . 0.0 111.362 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -167.43 162.84 10.1 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.91 2.084 . . . . 0.0 110.081 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.51 155.47 3.51 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.891 3.727 . . . . 0.0 116.174 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -108.85 140.27 42.53 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.678 1.991 . . . . 0.0 111.327 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m 71.45 -36.23 0.35 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.34 2.656 . . . . 0.0 115.377 171.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.01 139.43 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 t -157.79 -173.72 4.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.0 pt -145.05 156.86 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 111.045 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 t -116.28 -15.73 10.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.138 1.375 . . . . 0.0 113.536 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -158.54 148.23 19.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.854 1.661 . . . . 0.0 111.08 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -156.02 109.11 2.11 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 125.232 1.413 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.03 140.23 86.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.463 2.775 . . . . 0.0 111.171 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -95.98 1.26 52.66 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.898 . . . . 0.0 113.307 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.873 2.069 . . . . 0.0 112.139 -177.751 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.83 153.02 58.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.105 3.203 . . . . 0.0 111.76 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.1 mt -144.39 158.37 43.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.049 1.739 . . . . 0.0 110.748 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.41 -10.38 85.63 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.28 0.943 . . . . 0.0 114.305 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.0 t -165.9 160.03 16.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.213 1.805 . . . . 0.0 111.424 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -90.11 0.57 57.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.138 1.375 . . . . 0.0 112.676 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.0 -166.47 2.56 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.468 1.907 . . . . 0.0 111.088 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -139.87 69.99 36.33 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.305 1.042 . . . . 0.0 112.236 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.8 160.45 46.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.676 2.917 . . . . 0.0 110.787 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.68 116.77 34.96 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.984 0.914 . . . . 0.0 112.084 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.06 128.99 15.54 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.891 2.394 . . . . 0.0 110.315 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -161.17 172.1 17.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.984 1.314 . . . . 0.0 111.43 -173.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -69.06 -14.19 62.88 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -64.05 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.1 t -152.16 -152.9 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 111.108 -171.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.52 169.62 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.87 2.068 . . . . 0.0 110.893 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.7 t -68.01 141.54 56.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.479 0.711 . . . . 0.0 110.999 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -72.75 -13.38 61.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.251 1.02 . . . . 0.0 112.633 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -62.57 138.1 96.55 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.704 1.202 . . . . 0.0 111.557 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 171.13 2.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.064 3.176 . . . . 0.0 113.162 168.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -83.3 2.39 36.31 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.897 2.079 . . . . 0.0 113.505 -174.028 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.42 -7.65 12.76 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.057 3.171 . . . . 0.0 114.613 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.4 mt -137.82 129.6 28.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.589 1.556 . . . . 0.0 110.363 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.81 -11.83 39.24 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.796 1.189 . . . . 0.0 114.523 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.4 p -101.56 -8.99 21.39 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -165.32 147.17 7.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.571 1.548 . . . . 0.0 112.271 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.29 15.34 0.46 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.355 1.462 . . . . 0.0 113.798 -176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -63.74 121.43 70.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.185 0.994 . . . . 0.0 112.064 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.53 156.31 32.15 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.303 2.669 . . . . 0.0 111.864 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -156.41 127.26 3.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.39 1.476 . . . . 0.0 110.19 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.48 117.86 3.47 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.938 2.426 . . . . 0.0 111.004 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -160.41 121.81 3.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.076 1.35 . . . . 0.0 111.133 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.5 -0.03 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.456 1.502 . . . . 0.0 114.83 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -60.79 150.54 32.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.9 p -142.42 -175.51 4.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.991 0.916 . . . . 0.0 113.136 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -144.19 170.48 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.306 1.843 . . . . 0.0 111.082 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 t -147.38 179.66 7.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.96 1.704 . . . . 0.0 110.76 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -141.66 172.16 13.06 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.703 1.601 . . . . 0.0 113.577 -169.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -152.99 136.51 10.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.852 1.661 . . . . 0.0 110.597 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -62.88 141.87 86.2 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.652 2.901 . . . . 0.0 112.602 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -139.98 19.05 2.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.972 1.309 . . . . 0.0 112.747 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.34 1.856 . . . . 0.0 110.907 -173.295 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.07 156.76 51.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.092 3.195 . . . . 0.0 111.812 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -157.67 128.99 6.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.044 1.338 . . . . 0.0 110.538 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.4 172.67 36.45 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.26 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -161.75 151.98 17.18 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.142 1.377 . . . . 0.0 111.282 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -77.06 135.61 38.63 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.337 1.055 . . . . 0.0 111.417 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.46 132.92 15.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.446 1.498 . . . . 0.0 110.949 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -165.79 139.24 3.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.991 1.716 . . . . 0.0 110.151 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.08 82.49 2.34 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.464 2.776 . . . . 0.0 110.968 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -161.41 126.08 2.1 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.856 1.663 . . . . 0.0 110.34 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.29 135.35 18.44 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.029 2.486 . . . . 0.0 111.364 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -156.58 39.19 0.33 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.34 1.456 . . . . 0.0 110.509 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m -77.75 -8.66 58.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.891 1.677 . . . . 0.0 115.273 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -63.82 151.24 42.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.4 t -153.27 -168.14 2.92 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.428 1.491 . . . . 0.0 111.469 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.7 pt -144.72 168.27 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.886 2.075 . . . . 0.0 111.257 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.6 t -61.96 144.87 54.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.411 1.084 . . . . 0.0 110.618 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -80.63 -3.76 51.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -156.89 95.32 2.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.053 1.741 . . . . 0.0 110.153 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -61.8 156.67 47.09 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.921 3.081 . . . . 0.0 112.298 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -145.86 152.04 38.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.432 1.493 . . . . 0.0 110.808 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.866 2.066 . . . . 0.0 110.25 179.364 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 162' ' ' ALA . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 162' ' ' ALA . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' HB3' ' HE ' ' A' ' 135' ' ' ARG . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 131' ' ' GLU . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-O 119.055 -0.858 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 151.19 59.68 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.565 3.51 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -157.96 117.66 3.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.761 1.224 . . . . 0.0 110.517 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.41 -18.73 12.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.601 1.096 . . . . 0.0 114.472 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.3 m -78.3 -14.13 59.55 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -99.26 117.03 32.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.605 1.162 . . . . 0.0 110.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.09 158.49 19.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.781 1.632 . . . . 0.0 111.217 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -128.36 84.39 63.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.427 1.091 . . . . 0.0 110.352 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.82 71.79 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.983 3.122 . . . . 0.0 111.413 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -159.53 94.61 1.7 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.759 1.624 . . . . 0.0 109.991 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -59.31 141.85 98.31 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.023 3.149 . . . . 0.0 114.751 -173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -162.54 159.57 24.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.13 1.772 . . . . 0.0 110.917 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p -66.63 -15.39 63.43 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -69.17 150.95 46.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 55.9 m -142.86 170.36 15.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.072 1.349 . . . . 0.0 111.503 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 pt -140.71 155.59 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.171 1.389 . . . . 0.0 111.438 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.6 p -83.44 163.07 20.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 111.159 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -135.34 160.51 38.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.548 1.539 . . . . 0.0 111.905 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -157.6 137.11 8.41 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.572 1.549 . . . . 0.0 110.609 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -57.66 150.19 63.14 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.729 2.953 . . . . 0.0 112.991 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -159.97 142.96 13.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.011 1.324 . . . . 0.0 110.914 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.139 1.776 . . . . 0.0 112.253 -174.394 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.65 159.91 47.64 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 111.904 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.0 mt -139.45 142.12 37.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.599 1.56 . . . . 0.0 110.626 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.03 173.7 41.52 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.823 1.201 . . . . 0.0 113.44 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 m -64.98 142.84 58.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.35 1.06 . . . . 0.0 112.515 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -156.27 -47.26 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.566 1.146 . . . . 0.0 112.296 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 63.17 -163.2 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.347 1.859 . . . . 0.0 113.4 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.99 132.69 6.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.913 1.285 . . . . 0.0 110.203 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.28 157.18 62.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.627 . . . . 0.0 111.711 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.7 t0 49.06 53.38 14.48 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 126.251 1.82 . . . . 0.0 114.848 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.09 169.35 17.76 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.624 2.882 . . . . 0.0 112.097 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -157.54 158.13 35.07 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.385 1.474 . . . . 0.0 111.329 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.09 -21.21 65.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.08 148.43 41.89 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.4 m -136.48 150.36 48.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.895 1.278 . . . . 0.0 110.832 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.1 mt -139.96 129.58 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.716 1.207 . . . . 0.0 109.161 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.3 m -73.15 130.57 40.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.242 1.417 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -140.39 153.89 46.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.7 1.6 . . . . 0.0 111.619 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -158.63 131.41 4.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.499 1.519 . . . . 0.0 110.803 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.23 151.73 38.85 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.549 2.833 . . . . 0.0 111.308 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.87 145.09 49.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.671 1.588 . . . . 0.0 110.635 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.17 1.788 . . . . 0.0 111.79 -177.385 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 CA-C-O 118.118 -1.379 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.39 -28.3 22.39 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.532 2.154 . . . . 0.0 111.164 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -143.68 176.57 9.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.766 3.226 . . . . 0.0 108.08 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.04 -143.45 6.54 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.162 1.363 . . . . 0.0 112.63 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.2 m -141.05 143.74 34.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.242 1.417 . . . . 0.0 110.491 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -98.68 28.46 4.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.322 1.449 . . . . 0.0 112.885 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.93 -28.32 69.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.741 1.216 . . . . 0.0 113.303 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -86.51 119.81 71.65 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.333 1.053 . . . . 0.0 109.116 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.34 5.59 6.09 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.498 2.798 . . . . 0.0 114.637 -171.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -133.91 96.19 16.49 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.653 1.181 . . . . 0.0 111.767 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.34 150.53 52.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.298 2.665 . . . . 0.0 110.777 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -156.9 141.02 16.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.593 1.157 . . . . 0.0 110.837 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.67 -19.03 61.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 162' ' ' ALA . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -62.09 119.67 9.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.7 m -169.12 157.51 7.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.063 0.945 . . . . 0.0 113.222 -169.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.0 pt -138.85 161.7 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.627 1.971 . . . . 0.0 111.236 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.0 p -78.45 -17.68 55.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.431 1.493 . . . . 0.0 114.039 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -77.03 127.13 32.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.175 0.99 . . . . 0.0 112.245 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -76.21 136.52 68.94 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.502 1.121 . . . . 0.0 111.188 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.27 165.89 30.99 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.228 2.619 . . . . 0.0 111.473 170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -162.6 168.92 21.02 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 111.837 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.481 1.512 . . . . 0.0 113.439 173.012 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.65 155.84 54.05 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.071 3.181 . . . . 0.0 111.713 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.98 125.95 39.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.607 1.163 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.5 -151.8 40.34 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.561 1.077 . . . . 0.0 113.678 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.1 p -160.49 -160.1 0.74 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.94 1.696 . . . . 0.0 110.924 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -55.19 136.61 48.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.461 1.104 . . . . 0.0 111.799 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 13.08 0.52 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.91 119.26 15.68 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 111.866 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.29 -0.04 6.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.703 2.935 . . . . 0.0 114.59 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -96.08 114.79 64.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.966 1.306 . . . . 0.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -65.39 134.83 40.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.152 2.568 . . . . 0.0 113.216 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -157.87 96.95 1.52 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.332 1.453 . . . . 0.0 109.736 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m -85.73 11.05 11.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 162' ' ' ALA . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.08 136.35 57.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 66.8 p -100.26 174.19 6.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.202 1.001 . . . . 0.0 112.814 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.8 mt 71.74 -35.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.934 2.493 . . . . 0.0 113.589 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -63.36 146.58 53.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 111.935 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -73.05 153.31 40.91 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.674 1.19 . . . . 0.0 114.143 -172.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -71.24 150.85 94.46 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.818 1.247 . . . . 0.0 111.751 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.41 141.2 60.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.237 2.624 . . . . 0.0 110.382 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -155.31 9.45 0.29 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.323 1.849 . . . . 0.0 111.687 -173.341 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 CA-C-O 119.429 -0.65 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 -16.84 30.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.663 2.909 . . . . 0.0 114.472 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -65.24 -8.12 16.14 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.75 -3.83 89.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.253 1.406 . . . . 0.0 114.173 170.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.7 p -145.28 -51.58 0.26 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.991 1.396 . . . . 0.0 113.526 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -167.62 121.64 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.868 1.667 . . . . 0.0 111.211 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.38 152.56 22.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.875 1.67 . . . . 0.0 111.486 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.05 147.8 10.47 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.859 1.664 . . . . 0.0 111.222 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.32 137.19 11.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.681 . . . . 0.0 111.683 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -157.18 64.97 3.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.429 1.491 . . . . 0.0 110.469 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.29 140.7 27.92 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.5 2.8 . . . . 0.0 112.984 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -160.64 175.15 12.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.451 1.501 . . . . 0.0 111.713 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p -65.4 -17.71 64.75 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.37 141.69 58.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 154.42 35.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.487 1.115 . . . . 0.0 113.001 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.41 22.18 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.452 1.501 . . . . 0.0 112.365 -173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.1 m -77.08 70.0 3.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.753 2.021 . . . . 0.0 110.143 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.39 2.32 5.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.611 1.565 . . . . 0.0 113.857 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 71.35 149.57 0.13 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 129.217 3.007 . . . . 0.0 113.655 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -79.64 -153.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.342 3.361 . . . . 0.0 109.338 169.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -76.47 33.8 0.13 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.897 1.279 . . . . 0.0 112.908 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.909 2.483 . . . . 0.0 110.164 -178.776 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.06 157.95 46.17 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.131 3.221 . . . . 0.0 111.904 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.9 tp -144.38 -21.83 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.785 1.234 . . . . 0.0 113.72 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.34 73.42 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 119.175 0.898 . . . . 0.0 113.804 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.3 m -70.32 -8.31 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.728 1.211 . . . . 0.0 114.023 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -129.06 4.76 5.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.376 1.87 . . . . 0.0 112.841 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.62 154.78 40.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 112.928 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.38 132.42 4.23 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.771 1.628 . . . . 0.0 110.659 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 127.69 10.51 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.101 2.534 . . . . 0.0 110.989 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -165.99 131.12 1.85 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.181 1.792 . . . . 0.0 109.56 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 113.01 3.68 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.768 2.312 . . . . 0.0 111.046 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -158.08 31.23 0.25 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.702 1.201 . . . . 0.0 112.336 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -74.76 -4.26 36.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' HB3' ' HE ' ' A' ' 135' ' ' ARG . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 131' ' ' GLU . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.75 141.79 58.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.2 t -75.71 167.39 21.97 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.7 pt -146.81 174.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.806 2.042 . . . . 0.0 111.66 -169.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.4 t -143.69 148.48 35.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.666 1.586 . . . . 0.0 110.728 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -99.8 1.1 42.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.14 1.376 . . . . 0.0 113.342 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 133.89 91.17 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.562 1.145 . . . . 0.0 111.721 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 157.99 41.4 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.65 2.9 . . . . 0.0 111.647 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -160.51 145.03 14.24 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.267 1.427 . . . . 0.0 110.896 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.021 1.729 . . . . 0.0 112.122 -175.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 CA-C-O 119.065 -0.853 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.54 159.31 24.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.566 3.511 . . . . 0.0 113.511 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.79 -10.14 59.22 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.83 79.27 Favored Glycine 0 N--CA 1.475 1.29 0 C-N-CA 124.912 1.244 . . . . 0.0 115.298 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.4 p -166.39 167.99 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.763 1.625 . . . . 0.0 111.595 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.42 132.43 11.67 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.29 1.036 . . . . 0.0 111.96 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -165.01 155.56 14.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.006 2.122 . . . . 0.0 110.493 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.89 121.54 85.3 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.796 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.5 155.61 45.39 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.386 2.724 . . . . 0.0 111.25 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.02 127.73 78.66 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.247 1.019 . . . . 0.0 110.81 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.34 95.15 0.76 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.06 2.507 . . . . 0.0 109.819 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -163.44 123.62 2.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.292 1.437 . . . . 0.0 110.404 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p -79.63 -7.94 58.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -65.87 140.41 58.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.8 t -109.05 179.78 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.266 1.027 . . . . 0.0 113.437 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.6 tt -161.19 145.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.419 2.288 . . . . 0.0 110.037 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.8 t -161.14 156.61 24.64 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.073 1.749 . . . . 0.0 110.486 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -160.98 149.3 16.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.754 1.621 . . . . 0.0 112.552 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -84.97 149.53 53.43 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 111.683 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.53 153.7 65.19 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.424 2.749 . . . . 0.0 111.027 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -151.59 22.67 0.7 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.172 0.989 . . . . 0.0 112.49 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.525 1.93 . . . . 0.0 112.301 -171.333 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 119.531 -0.594 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.2 -11.3 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.11 3.206 . . . . 0.0 114.638 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.5 tp 70.23 -29.84 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.733 2.813 . . . . 0.0 114.784 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.98 11.54 84.66 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.956 1.265 . . . . 0.0 114.211 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.1 t -164.82 162.37 20.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.248 1.819 . . . . 0.0 110.832 -174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -164.72 156.2 15.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.036 1.735 . . . . 0.0 112.104 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.5 154.77 25.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.238 1.815 . . . . 0.0 111.019 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -69.92 120.64 79.06 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.96 0.904 . . . . 0.0 111.868 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.2 161.32 26.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.334 2.69 . . . . 0.0 111.745 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -158.19 130.82 4.37 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.406 1.482 . . . . 0.0 110.214 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.57 98.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.556 3.504 . . . . 0.0 114.182 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -160.42 29.37 0.16 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.279 1.831 . . . . 0.0 110.513 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m -80.73 6.62 12.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.305 1.842 . . . . 0.0 114.094 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -70.27 150.91 45.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.8 m -132.98 134.46 44.51 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.594 1.558 . . . . 0.0 110.202 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.63 123.4 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.357 -0.839 . . . . 0.0 109.581 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.2 m -67.92 131.7 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.175 0.99 . . . . 0.0 108.376 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.19 140.31 44.83 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -163.53 147.59 8.57 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.049 2.139 . . . . 0.0 111.042 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 160.65 38.73 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.697 2.931 . . . . 0.0 112.044 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -160.27 144.28 14.16 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.589 1.556 . . . . 0.0 110.634 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.064 2.146 . . . . 0.0 110.274 -178.807 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 155.3 49.21 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.09 3.193 . . . . 0.0 112.022 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 pp -93.36 10.72 30.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.02 1.328 . . . . 0.0 114.386 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.37 126.6 40.33 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.313 0.959 . . . . 0.0 111.56 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.5 m 59.84 12.83 3.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.548 1.539 . . . . 0.0 113.764 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.25 -34.29 0.27 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.902 2.881 . . . . 0.0 114.413 -173.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -178.47 178.18 0.87 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.059 3.343 . . . . 0.0 109.02 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.57 160.22 36.36 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.429 -0.795 . . . . 0.0 112.947 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.75 157.65 36.73 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.725 2.95 . . . . 0.0 112.255 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.51 137.39 10.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.292 1.437 . . . . 0.0 109.953 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.46 91.05 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.142 2.562 . . . . 0.0 110.644 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -158.61 126.42 5.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.874 1.669 . . . . 0.0 110.577 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p -79.59 -9.21 59.59 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -67.68 150.68 48.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.7 p -141.2 154.69 45.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.418 1.087 . . . . 0.0 111.914 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt -154.63 145.28 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.976 1.31 . . . . 0.0 110.578 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.2 p -96.81 3.25 52.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 113.948 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.87 137.94 18.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.202 1.401 . . . . 0.0 111.801 -172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -66.16 131.21 94.38 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.85 158.11 53.62 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.332 2.688 . . . . 0.0 111.439 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -76.91 -16.46 59.37 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.634 1.974 . . . . 0.0 112.937 -178.255 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.66 -8.71 12.38 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.134 3.223 . . . . 0.0 114.386 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -142.2 155.72 45.29 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.269 1.828 . . . . 0.0 110.745 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.76 28.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.561 1.077 . . . . 0.0 112.89 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.0 m -140.82 18.4 2.32 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.347 1.059 . . . . 0.0 113.366 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.02 150.79 28.62 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.776 1.23 . . . . 0.0 112.436 -173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.66 173.61 16.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.09 2.156 . . . . 0.0 110.64 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -154.34 128.72 4.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.392 1.077 . . . . 0.0 111.935 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.32 158.01 45.13 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.536 2.824 . . . . 0.0 111.455 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.24 58.91 9.1 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.92 1.688 . . . . 0.0 113.834 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.74 173.82 13.3 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.168 3.245 . . . . 0.0 111.613 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -154.54 156.57 36.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.52 1.128 . . . . 0.0 112.405 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -56.55 -27.71 58.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.006 1.722 . . . . 0.0 114.073 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -68.17 143.26 55.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.0 m -134.37 151.97 51.53 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.165 1.386 . . . . 0.0 111.207 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.7 mt -140.38 129.57 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.176 1.39 . . . . 0.0 108.145 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.1 m -149.39 140.17 22.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.436 1.494 . . . . 0.0 109.661 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.88 147.15 53.85 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.984 0.913 . . . . 0.0 112.552 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -158.3 128.34 3.39 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.477 1.511 . . . . 0.0 110.625 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.97 151.0 34.81 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.497 2.798 . . . . 0.0 111.38 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -147.87 150.43 34.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.333 1.453 . . . . 0.0 110.885 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.078 1.751 . . . . 0.0 112.285 -175.589 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 119.501 -0.611 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.04 156.38 51.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.096 3.198 . . . . 0.0 111.93 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.24 162.94 31.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.009 1.723 . . . . 0.0 111.621 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.59 77.67 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.134 0.873 . . . . 0.0 114.235 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.8 m -58.36 143.54 44.7 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.695 1.598 . . . . 0.0 113.59 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -119.11 141.77 48.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.971 1.308 . . . . 0.0 111.375 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.49 173.09 14.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.613 1.965 . . . . 0.0 110.967 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.11 72.25 12.14 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.199 1.0 . . . . 0.0 112.06 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.78 160.47 46.13 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.624 2.883 . . . . 0.0 110.607 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.33 116.41 25.2 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.984 0.914 . . . . 0.0 111.733 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.73 161.03 12.28 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.282 2.655 . . . . 0.0 112.085 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -159.39 161.86 35.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.128 1.371 . . . . 0.0 111.736 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.86 -13.5 25.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.536 1.534 . . . . 0.0 115.088 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -61.55 146.63 48.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.1 p -131.13 172.74 11.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.216 1.406 . . . . 0.0 111.528 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.5 pt -144.18 161.35 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.161 1.384 . . . . 0.0 111.838 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -113.92 138.9 49.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.957 1.703 . . . . 0.0 108.692 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.84 156.8 43.05 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.08 1.352 . . . . 0.0 112.071 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -157.94 137.46 8.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.739 1.616 . . . . 0.0 110.519 -174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.19 154.4 46.66 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.388 2.725 . . . . 0.0 111.259 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -145.59 151.05 37.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.029 1.332 . . . . 0.0 111.25 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.148 1.779 . . . . 0.0 112.26 -175.567 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 119.447 -0.64 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.57 -8.2 12.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 124.157 3.238 . . . . 0.0 114.568 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -156.11 124.35 5.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 109.508 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.33 133.63 11.88 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.806 1.193 . . . . 0.0 112.078 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -165.46 168.72 16.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.675 1.59 . . . . 0.0 111.065 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -140.63 132.02 26.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.764 1.626 . . . . 0.0 110.873 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.89 175.76 9.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.205 2.202 . . . . 0.0 110.608 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -158.85 123.97 2.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.142 0.977 . . . . 0.0 112.584 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -80.25 170.73 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.746 2.964 . . . . 0.0 111.843 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -155.44 138.33 10.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.206 1.803 . . . . 0.0 109.545 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.04 97.01 0.97 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.757 2.305 . . . . 0.0 111.596 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -163.04 126.5 2.82 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 110.923 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.21 -13.93 60.49 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -74.99 155.21 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.0 t -144.96 166.6 24.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.635 1.174 . . . . 0.0 112.121 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.2 pt -146.32 155.33 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.48 1.512 . . . . 0.0 111.999 -173.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.1 m -69.65 137.57 52.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.231 1.413 . . . . 0.0 110.075 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -78.75 37.75 0.3 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.348 1.459 . . . . 0.0 113.228 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.59 132.55 88.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.856 1.663 . . . . 0.0 111.532 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.21 147.39 29.52 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.423 2.749 . . . . 0.0 111.304 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -138.28 14.05 2.81 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.668 1.187 . . . . 0.0 113.289 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 127.317 2.247 . . . . 0.0 110.173 -179.23 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.42 -19.73 65.53 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.029 3.152 . . . . 0.0 116.988 -172.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.88 0.51 54.85 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.154 1.382 . . . . 0.0 113.094 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.8 135.79 9.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.103 1.811 . . . . 0.0 110.861 -169.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 m -81.4 -0.29 40.77 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -157.58 143.28 17.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.078 1.751 . . . . 0.0 110.525 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.99 157.33 37.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.256 1.822 . . . . 0.0 111.042 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -157.48 72.28 4.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.376 1.47 . . . . 0.0 111.022 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.57 153.63 60.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.63 2.887 . . . . 0.0 111.464 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -148.87 136.54 11.15 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.388 1.475 . . . . 0.0 110.357 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.19 102.35 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.794 2.33 . . . . 0.0 112.464 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -164.07 121.18 1.71 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.674 1.589 . . . . 0.0 110.749 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.79 -18.86 65.59 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.703 1.201 . . . . 0.0 114.004 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.02 141.43 54.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 m -76.09 81.36 2.92 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.776 0.798 . . . . 0.0 111.25 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.7 pt -84.45 4.51 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.307 1.443 . . . . 0.0 112.92 173.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 p -82.94 1.77 37.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.249 2.62 . . . . 0.0 113.931 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.22 139.89 46.35 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.274 1.429 . . . . 0.0 112.173 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -62.3 151.09 83.05 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.034 0.934 . . . . 0.0 112.903 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.18 156.34 55.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.241 2.627 . . . . 0.0 110.698 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -139.79 143.96 37.13 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.801 1.241 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.126 1.77 . . . . 0.0 112.336 -174.608 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.74 -8.32 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.186 3.258 . . . . 0.0 114.469 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.0 tp -159.59 144.71 15.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.652 1.581 . . . . 0.0 110.187 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.59 51.9 3.43 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.529 1.538 . . . . 0.0 114.007 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.2 m 68.77 12.88 8.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 114.711 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -73.04 123.31 23.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.255 1.022 . . . . 0.0 111.052 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.98 45.81 0.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.329 2.252 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.59 160.24 25.71 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.681 1.192 . . . . 0.0 113.641 -165.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.24 -179.89 4.82 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.01 3.14 . . . . 0.0 111.329 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.98 120.88 37.01 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.394 1.478 . . . . 0.0 112.785 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.64 161.51 33.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.021 3.147 . . . . 0.0 112.634 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -156.43 58.64 0.56 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m 73.5 5.82 5.0 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.825 2.05 . . . . 0.0 116.261 167.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.14 125.25 23.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 24.4 p -89.33 58.96 4.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.484 1.114 . . . . 0.0 110.788 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -14.97 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -169.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -81.01 139.12 35.95 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.351 1.861 . . . . 0.0 110.979 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -135.41 168.26 19.53 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.961 1.704 . . . . 0.0 111.201 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.91 140.94 68.14 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.957 1.303 . . . . 0.0 112.749 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.66 150.48 56.8 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.42 2.747 . . . . 0.0 111.29 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -134.36 15.23 3.77 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.139 1.376 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.733 2.013 . . . . 0.0 112.287 -173.112 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.08 156.74 51.56 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.104 3.202 . . . . 0.0 111.95 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.98 161.09 31.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.967 1.707 . . . . 0.0 111.679 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.38 14.64 78.19 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.232 0.92 . . . . 0.0 114.235 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -75.7 -1.33 24.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -138.51 155.4 48.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.217 1.807 . . . . 0.0 111.297 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.81 35.0 0.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.68 1.592 . . . . 0.0 111.541 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -160.09 153.16 18.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.708 1.603 . . . . 0.0 112.131 -169.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.67 163.11 36.53 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.481 2.787 . . . . 0.0 111.012 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -159.63 122.4 1.93 Allowed Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.562 1.545 . . . . 0.0 109.61 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.43 126.54 9.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.951 2.434 . . . . 0.0 111.583 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -152.53 90.39 1.49 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.722 1.609 . . . . 0.0 110.7 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m -79.41 -14.57 58.85 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.89 155.34 38.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.1 t -146.78 143.16 28.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.896 1.678 . . . . 0.0 111.181 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.2 pt -134.86 -9.41 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -168.32 148.35 4.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.849 . . . . 0.0 110.827 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -104.33 4.05 33.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.695 1.598 . . . . 0.0 111.943 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -154.32 111.94 2.44 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.884 1.674 . . . . 0.0 110.972 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.31 158.02 52.38 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.0 2.467 . . . . 0.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -148.89 25.17 0.93 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.496 1.118 . . . . 0.0 111.905 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.253 1.259 0 C-N-CA 127.044 2.138 . . . . 0.0 112.997 -171.218 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 CA-C-O 119.519 -0.601 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.25 156.16 51.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.047 3.165 . . . . 0.0 111.707 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -84.27 -11.15 56.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.962 0.905 . . . . 0.0 113.296 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.71 150.7 21.29 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.351 1.453 . . . . 0.0 112.144 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.9 p -165.19 166.32 19.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.892 1.277 . . . . 0.0 112.182 -175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -67.33 141.52 57.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.365 1.066 . . . . 0.0 111.656 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.65 174.96 9.98 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.926 1.69 . . . . 0.0 111.954 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 57.69 62.0 5.59 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 126.111 1.764 . . . . 0.0 112.875 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 179.81 5.81 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.03 3.153 . . . . 0.0 112.133 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.57 76.59 71.4 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.694 1.598 . . . . 0.0 109.672 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.83 149.54 78.24 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.881 3.054 . . . . 0.0 115.939 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -169.57 170.09 8.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.756 2.422 . . . . 0.0 111.319 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m -64.72 -16.89 63.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -60.1 140.48 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.8 t -75.55 153.15 37.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -169.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.5 pt -85.61 3.83 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.264 1.826 . . . . 0.0 113.197 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.6 t -64.92 -12.49 49.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.971 1.708 . . . . 0.0 114.006 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -49.61 132.45 21.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.763 1.625 . . . . 0.0 113.057 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -163.89 150.87 10.25 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.52 162.29 40.31 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.529 2.819 . . . . 0.0 111.463 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -69.76 -33.76 72.87 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.586 0.754 . . . . 0.0 112.982 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.399 1.88 . . . . 0.0 110.772 -171.254 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.31 147.65 95.0 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.102 3.201 . . . . 0.0 112.669 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -153.92 108.31 3.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.265 1.026 . . . . 0.0 110.06 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.15 85.16 1.03 Allowed Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 111.62 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.3 p -78.49 5.82 9.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.342 1.857 . . . . 0.0 115.754 -170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -49.57 124.83 10.17 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 0.0 112.015 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.18 131.88 31.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 110.378 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -174.76 170.78 1.45 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 127.317 2.247 . . . . 0.0 109.771 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -56.11 123.95 15.08 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.121 2.547 . . . . 0.0 111.362 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -167.43 162.84 10.1 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.91 2.084 . . . . 0.0 110.081 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.51 155.47 3.51 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.891 3.727 . . . . 0.0 116.174 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -108.85 140.27 42.53 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.678 1.991 . . . . 0.0 111.327 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m 71.45 -36.23 0.35 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.34 2.656 . . . . 0.0 115.377 171.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.01 139.43 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 t -157.79 -173.72 4.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.0 pt -145.05 156.86 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 111.045 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 t -116.28 -15.73 10.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.138 1.375 . . . . 0.0 113.536 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -158.54 148.23 19.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.854 1.661 . . . . 0.0 111.08 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -156.02 109.11 2.11 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 125.232 1.413 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.03 140.23 86.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.463 2.775 . . . . 0.0 111.171 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -95.98 1.26 52.66 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.898 . . . . 0.0 113.307 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.873 2.069 . . . . 0.0 112.139 -177.751 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.83 153.02 58.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.105 3.203 . . . . 0.0 111.76 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.1 mt -144.39 158.37 43.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.049 1.739 . . . . 0.0 110.748 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.41 -10.38 85.63 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.28 0.943 . . . . 0.0 114.305 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.0 t -165.9 160.03 16.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.213 1.805 . . . . 0.0 111.424 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -90.11 0.57 57.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.138 1.375 . . . . 0.0 112.676 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.0 -166.47 2.56 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.468 1.907 . . . . 0.0 111.088 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -139.87 69.99 36.33 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.305 1.042 . . . . 0.0 112.236 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.8 160.45 46.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.676 2.917 . . . . 0.0 110.787 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.68 116.77 34.96 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.984 0.914 . . . . 0.0 112.084 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.06 128.99 15.54 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.891 2.394 . . . . 0.0 110.315 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -161.17 172.1 17.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.984 1.314 . . . . 0.0 111.43 -173.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -69.06 -14.19 62.88 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -64.05 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.1 t -152.16 -152.9 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 111.108 -171.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.52 169.62 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.87 2.068 . . . . 0.0 110.893 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.7 t -68.01 141.54 56.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.479 0.711 . . . . 0.0 110.999 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -72.75 -13.38 61.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.251 1.02 . . . . 0.0 112.633 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -62.57 138.1 96.55 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.704 1.202 . . . . 0.0 111.557 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 171.13 2.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.064 3.176 . . . . 0.0 113.162 168.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -83.3 2.39 36.31 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.897 2.079 . . . . 0.0 113.505 -174.028 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.42 -7.65 12.76 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.057 3.171 . . . . 0.0 114.613 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.4 mt -137.82 129.6 28.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.589 1.556 . . . . 0.0 110.363 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.81 -11.83 39.24 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.796 1.189 . . . . 0.0 114.523 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.4 p -101.56 -8.99 21.39 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -165.32 147.17 7.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.571 1.548 . . . . 0.0 112.271 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.29 15.34 0.46 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.355 1.462 . . . . 0.0 113.798 -176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -63.74 121.43 70.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.185 0.994 . . . . 0.0 112.064 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.53 156.31 32.15 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.303 2.669 . . . . 0.0 111.864 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -156.41 127.26 3.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.39 1.476 . . . . 0.0 110.19 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.48 117.86 3.47 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.938 2.426 . . . . 0.0 111.004 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -160.41 121.81 3.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.076 1.35 . . . . 0.0 111.133 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.5 -0.03 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.456 1.502 . . . . 0.0 114.83 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -60.79 150.54 32.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.9 p -142.42 -175.51 4.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.991 0.916 . . . . 0.0 113.136 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -144.19 170.48 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.306 1.843 . . . . 0.0 111.082 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 t -147.38 179.66 7.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.96 1.704 . . . . 0.0 110.76 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -141.66 172.16 13.06 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.703 1.601 . . . . 0.0 113.577 -169.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -152.99 136.51 10.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.852 1.661 . . . . 0.0 110.597 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -62.88 141.87 86.2 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.652 2.901 . . . . 0.0 112.602 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -139.98 19.05 2.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.972 1.309 . . . . 0.0 112.747 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.34 1.856 . . . . 0.0 110.907 -173.295 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.07 156.76 51.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.092 3.195 . . . . 0.0 111.812 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -157.67 128.99 6.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.044 1.338 . . . . 0.0 110.538 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.4 172.67 36.45 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.26 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -161.75 151.98 17.18 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.142 1.377 . . . . 0.0 111.282 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -77.06 135.61 38.63 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.337 1.055 . . . . 0.0 111.417 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.46 132.92 15.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.446 1.498 . . . . 0.0 110.949 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -165.79 139.24 3.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.991 1.716 . . . . 0.0 110.151 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.08 82.49 2.34 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.464 2.776 . . . . 0.0 110.968 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -161.41 126.08 2.1 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.856 1.663 . . . . 0.0 110.34 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.29 135.35 18.44 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.029 2.486 . . . . 0.0 111.364 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -156.58 39.19 0.33 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.34 1.456 . . . . 0.0 110.509 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m -77.75 -8.66 58.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.891 1.677 . . . . 0.0 115.273 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -63.82 151.24 42.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.4 t -153.27 -168.14 2.92 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.428 1.491 . . . . 0.0 111.469 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.7 pt -144.72 168.27 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.886 2.075 . . . . 0.0 111.257 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.6 t -61.96 144.87 54.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.411 1.084 . . . . 0.0 110.618 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -80.63 -3.76 51.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -156.89 95.32 2.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.053 1.741 . . . . 0.0 110.153 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -61.8 156.67 47.09 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.921 3.081 . . . . 0.0 112.298 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -145.86 152.04 38.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.432 1.493 . . . . 0.0 110.808 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.866 2.066 . . . . 0.0 110.25 179.364 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 162' ' ' ALA . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 162' ' ' ALA . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.416 ' HB3' ' HE ' ' A' ' 135' ' ' ARG . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 131' ' ' GLU . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-O 119.055 -0.858 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 151.19 59.68 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.565 3.51 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.1 tp -157.96 117.66 3.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.761 1.224 . . . . 0.0 110.517 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.41 -18.73 12.5 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.601 1.096 . . . . 0.0 114.472 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.3 m -78.3 -14.13 59.55 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -99.26 117.03 32.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.605 1.162 . . . . 0.0 110.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.09 158.49 19.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.781 1.632 . . . . 0.0 111.217 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -128.36 84.39 63.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.427 1.091 . . . . 0.0 110.352 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.82 71.79 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.983 3.122 . . . . 0.0 111.413 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -159.53 94.61 1.7 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.759 1.624 . . . . 0.0 109.991 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -59.31 141.85 98.31 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 124.023 3.149 . . . . 0.0 114.751 -173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -162.54 159.57 24.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.13 1.772 . . . . 0.0 110.917 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.3 p -66.63 -15.39 63.43 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 58.7 m -94.12 127.21 39.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.937 1.295 . . . . 0.0 110.263 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.6 mt -118.49 138.69 52.33 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.292 1.437 . . . . 0.0 110.492 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.44 142.62 16.18 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 167.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 40.7 t -131.46 126.48 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.578 1.551 . . . . 0.0 107.848 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -131.96 157.75 43.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 111.398 -168.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.51 31.28 51.23 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.458 0.552 . . . . 0.0 113.283 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -77.56 172.29 13.59 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.418 1.487 . . . . 0.0 112.499 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.9 t -87.17 154.89 20.37 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.833 0.853 . . . . 0.0 111.642 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.26 -22.32 66.84 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.425 -0.797 . . . . 0.0 111.946 170.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.03 0.38 55.94 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.804 1.642 . . . . 0.0 114.362 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 94.7 m -66.43 138.99 57.95 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.45 1.023 . . . . 0.0 109.446 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 51.1 p -125.14 165.41 18.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.367 1.467 . . . . 0.0 111.333 177.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -63.19 -22.13 66.67 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.226 1.01 . . . . 0.0 112.346 177.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -67.05 -47.32 71.69 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.812 1.645 . . . . 0.0 110.776 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -68.56 -40.32 80.66 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.414 0.686 . . . . 0.0 110.748 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.59 -47.26 84.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.151 171.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -55.05 -41.73 71.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.222 1.374 . . . . 0.0 112.193 171.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.74 -34.38 77.72 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.346 0.975 . . . . 0.0 112.772 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.0 t -74.35 -44.0 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.01 0.924 . . . . 0.0 112.572 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -93.96 -21.77 18.99 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -168.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.5 p -71.47 -8.58 54.77 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 120.303 1.411 . . . . 0.0 113.843 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -61.19 -18.65 59.3 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.909 1.284 . . . . 0.0 113.313 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -111.91 -2.3 15.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.408 1.483 . . . . 0.0 114.362 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.84 179.44 17.76 Favored Glycine 0 CA--C 1.54 1.594 0 C-N-CA 125.488 1.518 . . . . 0.0 114.6 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -60.17 134.89 58.68 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 124.651 3.567 . . . . 0.0 113.339 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 42.2 mt -109.63 131.63 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.41 1.484 . . . . 0.0 109.646 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.31 -43.01 19.72 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.977 1.311 . . . . 0.0 111.464 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -167.74 176.17 6.51 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.537 1.535 . . . . 0.0 112.746 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.0 t -149.08 137.46 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 127.168 2.187 . . . . 0.0 108.817 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 72.1 m -137.58 122.09 18.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.698 1.199 . . . . 0.0 111.812 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 65.9 mt -89.48 146.91 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.597 1.159 . . . . 0.0 109.825 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.31 130.07 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.165 0.986 . . . . 0.0 109.97 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -122.83 149.15 44.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.43 1.492 . . . . 0.0 112.135 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.05 138.71 50.04 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.342 1.057 . . . . 0.0 111.824 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -89.49 4.32 49.58 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -126.18 -36.46 2.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.23 1.012 . . . . 0.0 112.173 173.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 68.6 m -100.97 -13.37 18.31 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 63.15 5.99 2.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.734 2.013 . . . . 0.0 115.912 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -74.37 164.78 26.19 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.115 1.366 . . . . 0.0 111.365 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -65.11 150.84 47.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.755 -0.59 . . . . 0.0 110.752 168.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -94.29 2.64 55.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.308 1.043 . . . . 0.0 112.916 170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 18.46 59.56 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.554 1.073 . . . . 0.0 114.33 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -151.39 163.69 38.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.441 1.121 . . . . 0.0 113.258 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.56 173.41 16.18 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.071 1.748 . . . . 0.0 112.177 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -134.09 137.9 44.91 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.56 1.544 . . . . 0.0 110.222 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 75.0 t -120.0 133.85 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 127.031 2.132 . . . . 0.0 108.224 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -121.67 110.09 15.54 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.321 1.048 . . . . 0.0 110.625 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -88.21 159.4 18.16 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.995 0.918 . . . . 0.0 111.85 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -70.07 -27.28 64.49 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.321 0.648 . . . . 0.0 112.267 174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -141.17 151.14 43.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.061 1.344 . . . . 0.0 111.614 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -63.22 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.84 -29.52 65.68 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -72.73 -41.21 65.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.547 0.739 . . . . 0.0 110.559 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.29 79.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.049 0.94 . . . . 0.0 112.493 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -61.92 -49.18 77.19 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.461 -0.774 . . . . 0.0 111.388 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -58.34 -47.41 83.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.154 0.581 . . . . 0.0 111.272 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.7 87.89 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.21 -32.5 73.91 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.821 0.848 . . . . 0.0 112.003 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.28 -18.24 55.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -105.7 -44.42 4.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.635 1.174 . . . . 0.0 113.73 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.2 -21.24 24.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.555 1.142 . . . . 0.0 113.599 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -62.09 112.86 2.53 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.882 -1.136 . . . . 0.0 112.355 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.18 -1.81 70.62 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.319 1.438 . . . . 0.0 115.873 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -68.08 -176.36 0.7 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 119.259 1.53 . . . . 0.0 113.997 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -114.78 136.48 53.03 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.23 1.412 . . . . 0.0 111.043 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.0 tp -140.59 122.52 15.52 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.614 1.966 . . . . 0.0 108.738 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.3 t70 60.36 22.7 12.22 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.727 1.611 . . . . 0.0 113.336 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.52 -1.73 88.22 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.172 1.368 . . . . 0.0 114.268 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -100.88 133.81 44.8 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.94 1.696 . . . . 0.0 109.859 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -94.2 109.37 21.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.699 0.761 . . . . 0.0 110.384 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.8 pt -80.97 -179.48 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 126.128 1.771 . . . . 0.0 113.388 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -149.92 146.74 27.23 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 108.605 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.2 t -139.35 133.4 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.793 1.237 . . . . 0.0 109.975 -170.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -149.15 157.96 43.8 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.634 1.574 . . . . 0.0 111.853 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -69.17 150.95 46.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.35 0.66 . . . . 0.0 111.904 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 55.9 m -142.86 170.36 15.84 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.072 1.349 . . . . 0.0 111.503 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 pt -140.71 155.59 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.171 1.389 . . . . 0.0 111.438 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.6 p -83.44 163.07 20.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.533 1.533 . . . . 0.0 111.159 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -135.34 160.51 38.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.548 1.539 . . . . 0.0 111.905 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -157.6 137.11 8.41 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.572 1.549 . . . . 0.0 110.609 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -57.66 150.19 63.14 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.729 2.953 . . . . 0.0 112.991 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -159.97 142.96 13.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.011 1.324 . . . . 0.0 110.914 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.139 1.776 . . . . 0.0 112.253 -174.394 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.559 -0.578 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.65 159.91 47.64 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 124.149 3.233 . . . . 0.0 111.904 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.0 mt -139.45 142.12 37.41 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.599 1.56 . . . . 0.0 110.626 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.03 173.7 41.52 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.823 1.201 . . . . 0.0 113.44 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 m -64.98 142.84 58.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.35 1.06 . . . . 0.0 112.515 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -156.27 -47.26 0.07 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.566 1.146 . . . . 0.0 112.296 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 63.17 -163.2 0.27 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.347 1.859 . . . . 0.0 113.4 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -153.99 132.69 6.87 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.913 1.285 . . . . 0.0 110.203 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.28 157.18 62.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.241 2.627 . . . . 0.0 111.711 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.7 t0 49.06 53.38 14.48 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 126.251 1.82 . . . . 0.0 114.848 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.09 169.35 17.76 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.624 2.882 . . . . 0.0 112.097 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -157.54 158.13 35.07 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.385 1.474 . . . . 0.0 111.329 170.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.09 -21.21 65.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.2 m -89.24 120.69 30.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.565 1.146 . . . . 0.0 109.999 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.08 130.86 56.55 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.851 1.26 . . . . 0.0 109.945 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.71 147.62 19.96 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -134.01 126.58 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.052 1.741 . . . . 0.0 107.602 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.25 148.66 50.86 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.084 0.954 . . . . 0.0 111.912 -167.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.05 30.41 28.65 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.942 0.782 . . . . 0.0 113.028 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 98.2 mt -80.7 169.04 18.14 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.751 1.621 . . . . 0.0 112.707 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.2 t -87.88 159.13 18.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 0.0 112.412 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.25 -19.5 62.35 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.578 -0.701 . . . . 0.0 112.034 170.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -90.9 -4.84 56.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.505 1.522 . . . . 0.0 114.244 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 79.1 m -68.84 142.5 54.83 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.424 1.09 . . . . 0.0 109.759 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 30.5 p -122.5 163.22 20.31 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.814 1.245 . . . . 0.0 110.986 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.27 -27.65 68.62 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.479 0.712 . . . . 0.0 111.625 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.75 -44.92 63.25 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.025 0.93 . . . . 0.0 111.449 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -62.26 -44.61 96.16 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.46 1.027 . . . . 0.0 110.922 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 60.0 mt -55.91 -52.75 63.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.121 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -51.88 -50.23 61.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.345 0.975 . . . . 0.0 112.228 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -70.96 -26.47 63.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.6 t -82.24 -37.18 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.125 0.875 . . . . 0.0 111.604 174.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -89.6 -18.2 27.01 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 96.5 p -68.58 -12.88 61.88 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.291 -1.506 . . . . 0.0 114.268 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -64.76 -18.53 65.13 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 170.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -85.47 -31.18 22.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.141 0.976 . . . . 0.0 112.986 177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.01 -162.05 30.29 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.763 1.173 . . . . 0.0 114.51 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.08 132.78 18.64 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.529 3.486 . . . . 0.0 112.953 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.1 mt -121.71 130.47 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.981 1.712 . . . . 0.0 109.3 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.8 -30.88 15.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.725 1.61 . . . . 0.0 113.192 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.6 168.06 14.87 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.306 1.442 . . . . 0.0 111.864 -175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.1 t -151.48 137.19 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.982 2.113 . . . . 0.0 108.825 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.4 m -138.42 114.43 10.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.169 0.987 . . . . 0.0 111.744 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.8 mt -84.1 145.89 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.72 128.7 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.804 0.842 . . . . 0.0 109.14 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -121.25 151.77 39.63 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.213 1.405 . . . . 0.0 112.934 -172.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -62.09 143.25 56.91 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.775 1.63 . . . . 0.0 113.21 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -67.2 -15.52 63.75 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.191 1.397 . . . . 0.0 114.599 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -138.68 -29.25 0.8 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.8 m -101.47 -9.95 20.61 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 61.14 10.79 3.1 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.788 2.035 . . . . 0.0 115.435 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.99 155.13 41.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.653 1.181 . . . . 0.0 110.161 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.3 t -62.54 140.93 58.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.097 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -79.18 -2.71 42.16 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.273 0.629 . . . . 0.0 112.637 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.24 18.7 48.82 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.218 1.389 . . . . 0.0 113.747 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.69 161.36 41.58 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.606 1.203 . . . . 0.0 113.528 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.92 177.6 10.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.095 1.758 . . . . 0.0 112.458 -167.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -134.99 142.37 46.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.217 1.807 . . . . 0.0 110.051 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.5 t -126.17 130.16 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.6 1.96 . . . . 0.0 107.985 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -114.36 111.77 21.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.251 1.021 . . . . 0.0 110.978 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -88.87 154.98 19.81 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.939 0.896 . . . . 0.0 111.638 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.37 -8.16 57.24 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -149.15 134.18 18.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 111.526 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.91 -30.3 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 112.327 171.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.29 -27.09 62.24 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -83.56 -35.66 24.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.225 1.01 . . . . 0.0 112.04 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.36 -30.38 70.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.456 1.102 . . . . 0.0 113.146 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -56.77 -54.59 44.56 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.603 0.638 . . . . 0.0 111.557 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.68 -43.66 96.0 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.531 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.39 80.02 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 118.921 0.782 . . . . 0.0 112.38 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.46 -48.88 79.94 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.813 0.845 . . . . 0.0 111.773 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.01 -32.7 74.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.766 0.826 . . . . 0.0 113.127 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -80.44 -42.7 22.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 112.332 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.35 -27.95 29.34 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -171.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -61.24 113.66 2.73 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.313 -0.867 . . . . 0.0 112.096 -175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.57 3.46 68.92 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.092 1.33 . . . . 0.0 115.63 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -64.38 178.71 0.68 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.523 1.661 . . . . 0.0 113.103 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -118.02 129.53 55.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.774 1.23 . . . . 0.0 110.456 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 32.3 tp -136.89 121.4 18.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.127 1.771 . . . . 0.0 109.54 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.71 26.09 15.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.16 1.784 . . . . 0.0 112.792 -175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.93 -5.54 75.25 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.197 1.379 . . . . 0.0 113.979 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -88.24 137.43 32.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 110.208 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -98.79 105.53 17.69 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.882 0.848 . . . . 0.0 109.831 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 pt -86.14 178.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.326 1.85 . . . . 0.0 114.745 -168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -134.63 144.36 47.82 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 128.016 2.526 . . . . 0.0 107.939 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.82 132.63 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 125.279 1.432 . . . . 0.0 109.47 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -159.48 163.54 35.22 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.528 1.131 . . . . 0.0 111.869 -172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.08 148.43 41.89 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.08 0.952 . . . . 0.0 112.347 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 49.4 m -136.48 150.36 48.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.895 1.278 . . . . 0.0 110.832 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 63.1 mt -139.96 129.58 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.716 1.207 . . . . 0.0 109.161 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.3 m -73.15 130.57 40.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.242 1.417 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -140.39 153.89 46.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.7 1.6 . . . . 0.0 111.619 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -158.63 131.41 4.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.499 1.519 . . . . 0.0 110.803 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.23 151.73 38.85 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.549 2.833 . . . . 0.0 111.308 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.87 145.09 49.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.671 1.588 . . . . 0.0 110.635 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.17 1.788 . . . . 0.0 111.79 -177.385 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 CA-C-O 118.118 -1.379 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.39 -28.3 22.39 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.532 2.154 . . . . 0.0 111.164 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -143.68 176.57 9.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 129.766 3.226 . . . . 0.0 108.08 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -122.04 -143.45 6.54 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.162 1.363 . . . . 0.0 112.63 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.2 m -141.05 143.74 34.56 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.242 1.417 . . . . 0.0 110.491 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -98.68 28.46 4.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.322 1.449 . . . . 0.0 112.885 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.93 -28.32 69.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.741 1.216 . . . . 0.0 113.303 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -86.51 119.81 71.65 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.333 1.053 . . . . 0.0 109.116 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -85.34 5.59 6.09 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.498 2.798 . . . . 0.0 114.637 -171.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -133.91 96.19 16.49 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.653 1.181 . . . . 0.0 111.767 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.34 150.53 52.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.298 2.665 . . . . 0.0 110.777 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -156.9 141.02 16.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.593 1.157 . . . . 0.0 110.837 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.67 -19.03 61.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 16.5 m -90.94 121.79 33.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.245 1.818 . . . . 0.0 111.178 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.8 mt -119.48 138.66 53.0 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 110.516 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.14 146.14 18.16 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 167.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.83 130.28 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.981 1.712 . . . . 0.0 107.941 -174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -137.01 154.26 50.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.407 1.083 . . . . 0.0 111.906 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.7 29.75 54.31 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.582 0.61 . . . . 0.0 113.163 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -77.2 160.51 28.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.18 1.392 . . . . 0.0 112.188 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -68.73 145.32 53.93 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.164 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.9 mt -67.89 -11.51 58.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -100.21 1.81 42.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.39 1.876 . . . . 0.0 113.765 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 11.1 m -64.73 143.1 58.17 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.634 1.174 . . . . 0.0 110.203 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -123.2 160.54 26.32 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.256 1.422 . . . . 0.0 110.007 169.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.4 mp0 -60.3 -20.92 61.14 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -62.13 -45.11 94.92 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.063 0.945 . . . . 0.0 110.771 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -65.49 -49.02 70.59 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.083 0.953 . . . . 0.0 110.309 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.0 -49.09 79.21 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.369 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -55.82 -47.71 76.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 111.627 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -65.99 -35.95 81.99 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -80.86 -35.48 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.688 0.676 . . . . 0.0 112.176 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -92.54 -17.04 24.96 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 99.8 p -67.99 -16.4 64.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 120.595 1.543 . . . . 0.0 114.337 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -65.01 -13.99 59.27 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -93.95 -7.09 43.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 113.918 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.6 -177.99 19.45 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.091 1.329 . . . . 0.0 114.811 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.19 134.19 41.36 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.097 3.865 . . . . 0.0 112.29 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.0 mt -114.43 130.7 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.858 1.663 . . . . 0.0 109.459 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.92 -33.58 14.84 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.851 1.66 . . . . 0.0 112.897 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -166.19 161.93 17.24 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.735 1.614 . . . . 0.0 111.413 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 91.5 t -154.43 141.65 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.469 2.308 . . . . 0.0 108.094 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.3 t -152.81 124.26 7.69 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.564 0.746 . . . . 0.0 112.262 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 162' ' ' ALA . 67.8 mt -89.69 144.26 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.879 1.272 . . . . 0.0 110.029 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.3 t -84.89 107.07 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.4 146.62 25.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.246 1.419 . . . . 0.0 111.327 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -65.54 139.83 58.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.958 0.903 . . . . 0.0 113.081 -174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -69.46 -10.48 58.21 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.459 1.504 . . . . 0.0 114.057 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -131.16 -50.17 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.369 1.068 . . . . 0.0 111.443 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 49.0 m -82.48 -12.84 57.55 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -174.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.0 mmt-85 65.55 -4.63 0.56 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 127.58 2.352 . . . . 0.0 116.072 174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.58 159.04 32.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.137 1.375 . . . . 0.0 111.117 171.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -62.86 143.51 57.53 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.288 -0.882 . . . . 0.0 111.257 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -88.12 0.66 55.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.297 1.039 . . . . 0.0 112.979 171.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.73 19.06 45.5 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 124.817 1.199 . . . . 0.0 114.672 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.0 160.9 43.05 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.512 1.156 . . . . 0.0 113.138 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -159.24 175.67 13.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.969 1.708 . . . . 0.0 112.769 -167.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -132.49 146.85 52.24 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.88 1.672 . . . . 0.0 110.329 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.0 t -133.47 133.36 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.776 2.031 . . . . 0.0 108.114 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -125.79 116.31 21.39 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.386 1.074 . . . . 0.0 111.427 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -89.22 157.28 18.3 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.332 1.053 . . . . 0.0 111.81 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.07 -22.29 62.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.192 0.597 . . . . 0.0 112.572 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -139.49 148.27 42.45 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.45 1.5 . . . . 0.0 110.931 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.6 p -62.68 -31.36 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.31 -20.65 58.97 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -77.29 -37.03 53.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.207 0.603 . . . . 0.0 110.674 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.94 -28.29 66.51 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.14 -50.7 72.64 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.645 1.111 . . . . 0.0 111.017 172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.07 -47.63 85.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.631 0.772 . . . . 0.0 111.232 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -47.2 86.15 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -58.4 -49.78 76.03 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.995 0.918 . . . . 0.0 111.287 176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -69.66 -35.16 74.93 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -77.26 -51.16 11.39 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.819 -0.551 . . . . 0.0 111.963 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.67 63.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -59.21 117.82 5.19 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 111.838 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.91 2.67 89.58 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.554 1.549 . . . . 0.0 115.916 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -65.18 177.65 1.02 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.255 1.528 . . . . 0.0 112.32 169.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -112.95 128.35 56.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.375 1.07 . . . . 0.0 110.636 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.3 tp -132.79 120.54 21.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.455 1.502 . . . . 0.0 109.173 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.9 t70 55.27 34.78 23.51 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.991 1.716 . . . . 0.0 112.564 -173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.34 -1.92 73.93 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.068 -1.02 . . . . 0.0 114.589 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -96.46 132.05 42.41 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.843 1.321 . . . . 0.0 110.675 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -85.65 94.33 9.05 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 110.43 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.7 pt -71.71 174.55 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.715 1.606 . . . . 0.0 114.019 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.93 144.88 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.194 1.797 . . . . 0.0 109.285 169.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.2 t -143.46 133.15 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.852 1.261 . . . . 0.0 110.373 -172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -158.13 158.88 35.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.441 1.096 . . . . 0.0 112.999 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -62.09 119.67 9.37 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.095 1.358 . . . . 0.0 110.21 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 3.7 m -169.12 157.51 7.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.063 0.945 . . . . 0.0 113.222 -169.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 35.0 pt -138.85 161.7 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.627 1.971 . . . . 0.0 111.236 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 27.0 p -78.45 -17.68 55.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.431 1.493 . . . . 0.0 114.039 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -77.03 127.13 32.14 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.175 0.99 . . . . 0.0 112.245 -175.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -76.21 136.52 68.94 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.502 1.121 . . . . 0.0 111.188 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.27 165.89 30.99 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.228 2.619 . . . . 0.0 111.473 170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -162.6 168.92 21.02 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.28 1.432 . . . . 0.0 111.837 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.481 1.512 . . . . 0.0 113.439 173.012 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.65 155.84 54.05 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.071 3.181 . . . . 0.0 111.713 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.6 tp -94.98 125.95 39.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.607 1.163 . . . . 0.0 110.865 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 76.5 -151.8 40.34 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.561 1.077 . . . . 0.0 113.678 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.1 p -160.49 -160.1 0.74 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.94 1.696 . . . . 0.0 110.924 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -55.19 136.61 48.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.461 1.104 . . . . 0.0 111.799 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 13.08 0.52 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 -170.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.91 119.26 15.68 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 124.984 1.314 . . . . 0.0 111.866 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -89.29 -0.04 6.05 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.703 2.935 . . . . 0.0 114.59 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -96.08 114.79 64.89 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.966 1.306 . . . . 0.0 110.956 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -65.39 134.83 40.29 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.152 2.568 . . . . 0.0 113.216 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -157.87 96.95 1.52 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.332 1.453 . . . . 0.0 109.736 169.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.6 m -85.73 11.05 11.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -169.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.1 p -144.87 151.0 38.04 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 56.9 mt -130.53 145.75 51.92 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.259 1.823 . . . . 0.0 110.699 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -95.04 145.02 17.53 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 166.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.03 120.99 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.873 1.669 . . . . 0.0 107.544 -174.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -126.25 152.5 46.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.022 1.329 . . . . 0.0 111.857 -167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.4 30.27 41.56 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.642 0.639 . . . . 0.0 113.02 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.1 mt -80.35 167.23 20.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.535 1.534 . . . . 0.0 112.186 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -85.75 157.73 20.19 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.583 0.753 . . . . 0.0 112.655 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.4 -22.03 65.56 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.661 -0.65 . . . . 0.0 111.719 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -89.25 -5.3 57.73 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.63 1.572 . . . . 0.0 114.392 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 73.3 m -69.75 140.77 53.47 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.069 0.947 . . . . 0.0 109.806 174.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -126.31 162.63 25.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.519 1.528 . . . . 0.0 110.358 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mp0 -60.55 -22.73 63.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.728 -0.607 . . . . 0.0 112.461 171.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.72 -27.21 62.85 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.786 0.834 . . . . 0.0 112.563 173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.74 -48.29 15.18 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.065 0.848 . . . . 0.0 110.397 170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.9 mt -57.56 -49.32 76.74 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.316 0.646 . . . . 0.0 111.702 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -57.61 -36.03 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.232 0.924 . . . . 0.0 112.159 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.23 -24.62 27.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.039 1.336 . . . . 0.0 113.325 -174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.78 -36.69 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.1 0.96 . . . . 0.0 111.449 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -92.02 -12.52 32.98 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -67.06 -16.3 64.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.647 1.567 . . . . 0.0 114.647 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -63.38 -14.28 48.54 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -97.45 -0.79 45.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.579 1.551 . . . . 0.0 113.836 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.22 -177.46 17.93 Favored Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.248 1.404 . . . . 0.0 114.988 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.84 134.12 51.76 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 125.169 3.912 . . . . 0.0 112.493 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.0 mt -111.83 130.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.931 1.693 . . . . 0.0 109.073 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.53 -31.47 13.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.901 1.68 . . . . 0.0 112.877 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -166.61 165.03 16.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.68 1.592 . . . . 0.0 111.582 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -156.15 137.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 127.026 2.13 . . . . 0.0 108.886 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 58.7 m -149.65 123.64 9.39 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 0.0 112.694 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 162' ' ' ALA . 89.3 mt -88.46 147.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.553 1.141 . . . . 0.0 110.234 170.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 72.6 t -91.75 128.8 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.231 1.012 . . . . 0.0 110.119 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -123.65 149.15 45.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.779 1.631 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.03 142.13 57.3 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.872 1.269 . . . . 0.0 113.091 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -83.88 -0.14 50.07 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -125.93 -38.33 2.2 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.61 1.164 . . . . 0.0 112.446 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.1 p -104.31 -14.22 15.86 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.53 12.36 4.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.089 1.756 . . . . 0.0 114.145 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -71.48 153.78 41.98 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.278 170.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.55 138.71 58.56 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.38 -0.825 . . . . 0.0 110.848 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -86.2 2.67 46.13 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.69 0.796 . . . . 0.0 112.918 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.38 59.04 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 124.443 1.021 . . . . 0.0 114.34 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -152.15 163.77 38.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.439 1.12 . . . . 0.0 113.339 177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.4 175.38 14.06 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.929 1.692 . . . . 0.0 112.265 -168.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -134.35 142.44 47.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.877 1.671 . . . . 0.0 110.066 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.94 127.31 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.931 1.693 . . . . 0.0 108.349 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -117.93 123.99 47.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.1 1.36 . . . . 0.0 110.364 -171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -103.14 162.44 12.96 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.512 1.525 . . . . 0.0 111.215 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.23 -21.44 59.79 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -144.14 154.18 42.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.873 1.269 . . . . 0.0 112.261 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -63.23 -30.54 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.769 0.828 . . . . 0.0 112.607 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.1 -33.97 75.52 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.029 0.831 . . . . 0.0 112.696 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -73.58 -39.06 64.92 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.869 0.868 . . . . 0.0 111.061 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.03 89.03 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.491 0.716 . . . . 0.0 112.158 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.96 -45.81 90.71 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.321 -0.862 . . . . 0.0 111.673 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.42 -45.54 92.65 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.453 0.57 . . . . 0.0 112.219 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.14 -46.37 88.53 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.445 -0.784 . . . . 0.0 112.174 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -62.08 -43.41 98.9 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.324 -0.86 . . . . 0.0 112.056 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -72.04 -24.88 61.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -97.72 -40.28 8.65 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.18 -24.28 27.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -62.03 113.5 2.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.168 -0.957 . . . . 0.0 112.051 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.66 2.68 72.26 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.082 1.325 . . . . 0.0 115.767 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -64.2 177.91 0.76 Allowed 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 119.248 1.524 . . . . 0.0 113.189 171.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -110.74 129.09 55.93 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.567 1.147 . . . . 0.0 111.088 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.67 122.22 17.35 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.68 1.592 . . . . 0.0 109.324 175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.0 t70 57.89 27.51 14.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.238 1.815 . . . . 0.0 112.802 -171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.51 -2.67 77.12 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.565 1.079 . . . . 0.0 113.971 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -91.32 135.0 34.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.816 1.247 . . . . 0.0 110.301 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.1 mmt85 -89.78 92.32 8.99 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 0.0 110.244 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -72.23 173.84 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.577 1.551 . . . . 0.0 113.728 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.46 144.2 44.27 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.79 1.636 . . . . 0.0 109.198 169.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.04 131.92 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.674 1.19 . . . . 0.0 110.351 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -159.3 158.58 32.68 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.29 1.436 . . . . 0.0 111.899 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.08 136.35 57.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.324 1.05 . . . . 0.0 112.198 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 66.8 p -100.26 174.19 6.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.202 1.001 . . . . 0.0 112.814 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.8 mt 71.74 -35.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 127.934 2.493 . . . . 0.0 113.589 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 t -63.36 146.58 53.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 111.935 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -73.05 153.31 40.91 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.674 1.19 . . . . 0.0 114.143 -172.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -71.24 150.85 94.46 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.818 1.247 . . . . 0.0 111.751 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.41 141.2 60.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.237 2.624 . . . . 0.0 110.382 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 39.1 p-80 -155.31 9.45 0.29 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.323 1.849 . . . . 0.0 111.687 -173.341 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.862 0 CA-C-O 119.429 -0.65 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.58 -16.84 30.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.663 2.909 . . . . 0.0 114.472 -172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -65.24 -8.12 16.14 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.75 -3.83 89.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.253 1.406 . . . . 0.0 114.173 170.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.7 p -145.28 -51.58 0.26 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.991 1.396 . . . . 0.0 113.526 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -167.62 121.64 0.97 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.868 1.667 . . . . 0.0 111.211 176.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.38 152.56 22.22 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.875 1.67 . . . . 0.0 111.486 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.05 147.8 10.47 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.859 1.664 . . . . 0.0 111.222 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.32 137.19 11.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.321 2.681 . . . . 0.0 111.683 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -157.18 64.97 3.44 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.429 1.491 . . . . 0.0 110.469 171.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.29 140.7 27.92 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.5 2.8 . . . . 0.0 112.984 -169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -160.64 175.15 12.99 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.451 1.501 . . . . 0.0 111.713 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 22.2 p -65.4 -17.71 64.75 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -102.53 130.81 49.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.818 1.247 . . . . 0.0 111.143 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.0 mt -121.21 142.68 49.67 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.868 1.667 . . . . 0.0 110.803 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.4 145.08 17.08 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.659 1.599 . . . . 0.0 109.227 167.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.14 126.24 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.764 1.626 . . . . 0.0 107.746 -174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -133.5 153.24 51.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.65 1.18 . . . . 0.0 111.43 -168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.15 31.48 47.33 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.319 0.485 . . . . 0.0 113.021 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.61 159.78 26.66 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.32 1.448 . . . . 0.0 112.424 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.1 t -69.41 143.15 53.71 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.625 169.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.0 mt -70.11 -8.31 48.51 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.496 -0.753 . . . . 0.0 112.97 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -98.24 1.54 47.37 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.125 1.77 . . . . 0.0 113.689 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 25.1 m -64.1 144.04 57.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.123 1.369 . . . . 0.0 110.321 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.3 p -120.07 164.6 15.91 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.15 1.38 . . . . 0.0 111.521 173.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -65.4 -7.66 14.97 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -93.62 -34.51 13.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 111.972 171.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -64.39 -48.73 74.32 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.699 0.682 . . . . 0.0 110.235 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.64 -41.5 90.66 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.928 175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -54.64 -54.29 43.53 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.231 0.923 . . . . 0.0 111.144 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.7 -35.35 80.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 119.079 0.854 . . . . 0.0 113.148 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.1 t -77.98 -29.66 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.397 1.079 . . . . 0.0 112.67 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -105.71 -17.38 14.41 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.1 p -71.18 -15.45 62.48 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.836 1.653 . . . . 0.0 113.883 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -61.25 -12.84 14.73 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.447 1.099 . . . . 0.0 113.788 169.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -103.37 -11.31 17.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.456 1.502 . . . . 0.0 114.366 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.87 -173.16 29.68 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.96 134.14 19.27 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.92 3.747 . . . . 0.0 111.018 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.3 mt -120.26 128.7 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.17 1.388 . . . . 0.0 109.261 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.1 -43.87 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 111.931 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -166.12 175.47 8.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.492 1.517 . . . . 0.0 111.749 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 92.6 t -148.48 142.81 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.581 2.353 . . . . 0.0 108.817 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.9 m -138.28 116.2 11.6 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.552 1.141 . . . . 0.0 111.514 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.12 148.27 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.127 -0.983 . . . . 0.0 109.611 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.74 130.77 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.962 0.905 . . . . 0.0 109.813 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.08 155.31 40.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.306 1.442 . . . . 0.0 112.882 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.6 134.35 55.33 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.832 1.653 . . . . 0.0 112.489 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -70.81 -9.68 57.98 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -119.55 -43.97 2.57 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.659 1.118 . . . . 0.0 112.248 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 m -99.73 -12.43 19.98 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -170.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 62.18 14.05 6.34 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.871 1.668 . . . . 0.0 114.476 -176.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -60.72 148.05 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.142 1.377 . . . . 0.0 110.006 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -64.4 144.07 57.44 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.349 -0.844 . . . . 0.0 110.917 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -93.52 -3.3 53.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.794 0.838 . . . . 0.0 112.953 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.08 20.36 55.48 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.453 1.025 . . . . 0.0 114.283 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.85 160.61 43.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.254 1.021 . . . . 0.0 112.999 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -160.34 175.54 12.71 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.943 1.697 . . . . 0.0 112.574 -167.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -135.57 143.58 45.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.163 1.785 . . . . 0.0 110.381 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 85.8 t -131.86 130.71 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.656 1.983 . . . . 0.0 108.444 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -120.61 113.46 20.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.685 0.794 . . . . 0.0 111.543 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -84.64 148.17 26.57 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.618 0.767 . . . . 0.0 111.296 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -76.11 -13.75 60.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.483 0.713 . . . . 0.0 112.142 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -120.73 135.23 55.19 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.137 1.775 . . . . 0.0 110.88 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.04 -29.02 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.301 1.04 . . . . 0.0 112.712 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.96 -27.3 17.95 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -74.93 -26.0 59.3 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.444 -0.785 . . . . 0.0 112.643 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.34 72.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.438 0.695 . . . . 0.0 112.31 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -66.15 -49.32 67.84 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.747 -0.596 . . . . 0.0 110.842 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -59.95 -45.74 91.66 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.006 0.922 . . . . 0.0 111.322 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.3 -49.89 74.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.626 0.77 . . . . 0.0 112.56 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -59.19 -45.55 90.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.05 0.94 . . . . 0.0 112.148 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.26 -32.96 73.5 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -82.27 -42.21 19.15 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.948 . . . . 0.0 112.743 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -85.81 -26.41 25.75 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -170.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -61.86 110.87 1.67 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.534 1.061 . . . . 0.0 112.3 -174.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.44 3.42 66.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.366 1.46 . . . . 0.0 116.161 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -69.03 -176.4 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 119.201 1.501 . . . . 0.0 112.815 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -114.58 127.7 55.93 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.597 1.159 . . . . 0.0 111.138 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.9 tp -126.65 122.83 36.09 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.819 1.648 . . . . 0.0 108.991 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.2 t70 56.29 33.81 22.93 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.003 1.721 . . . . 0.0 112.784 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.31 -0.07 81.47 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.039 -1.038 . . . . 0.0 114.439 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 -98.91 132.38 44.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.817 1.309 . . . . 0.0 110.761 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -80.62 93.89 6.21 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.326 1.05 . . . . 0.0 111.073 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -71.49 166.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.091 0.956 . . . . 0.0 112.701 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.01 143.97 50.45 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 108.255 169.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.3 t -142.05 132.56 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.768 1.227 . . . . 0.0 110.205 -171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -157.24 161.29 39.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.876 1.27 . . . . 0.0 111.615 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -64.37 141.69 58.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.955 0.902 . . . . 0.0 111.806 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 88.0 p -120.72 154.42 35.63 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.487 1.115 . . . . 0.0 113.001 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.2 pt -133.41 22.18 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.452 1.501 . . . . 0.0 112.365 -173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 8.1 m -77.08 70.0 3.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.753 2.021 . . . . 0.0 110.143 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -128.39 2.32 5.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.611 1.565 . . . . 0.0 113.857 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 71.35 149.57 0.13 Allowed Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 129.217 3.007 . . . . 0.0 113.655 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -79.64 -153.82 0.05 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.342 3.361 . . . . 0.0 109.338 169.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 29.9 t60 -76.47 33.8 0.13 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 124.897 1.279 . . . . 0.0 112.908 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 51.7 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.909 2.483 . . . . 0.0 110.164 -178.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 119.492 -0.615 . . . . 0.0 112.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.06 157.95 46.17 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 124.131 3.221 . . . . 0.0 111.904 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.9 tp -144.38 -21.83 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.785 1.234 . . . . 0.0 113.72 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -62.64 -29.34 73.42 Favored Glycine 0 N--CA 1.473 1.163 0 CA-C-N 119.175 0.898 . . . . 0.0 113.804 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.3 m -70.32 -8.31 49.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.728 1.211 . . . . 0.0 114.023 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -129.06 4.76 5.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.376 1.87 . . . . 0.0 112.841 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.62 154.78 40.59 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 112.928 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -160.38 132.42 4.23 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 125.771 1.628 . . . . 0.0 110.659 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.53 127.69 10.51 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.101 2.534 . . . . 0.0 110.989 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -165.99 131.12 1.85 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 126.181 1.792 . . . . 0.0 109.56 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.23 113.01 3.68 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.768 2.312 . . . . 0.0 111.046 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -158.08 31.23 0.25 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.702 1.201 . . . . 0.0 112.336 -173.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 28.2 p -74.76 -4.26 36.5 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 9.0 p -84.24 122.3 28.69 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.407 1.883 . . . . 0.0 111.551 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.6 mt -117.61 141.38 48.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.714 1.606 . . . . 0.0 110.503 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.67 146.04 18.07 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.0 t -133.78 132.68 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.875 1.67 . . . . 0.0 108.118 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -140.57 162.1 36.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.44 1.096 . . . . 0.0 111.08 -169.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.87 25.69 68.8 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.602 -0.554 . . . . 0.0 113.269 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.08 174.72 7.51 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.36 1.464 . . . . 0.0 111.585 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.2 t -83.74 155.03 23.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.445 -0.784 . . . . 0.0 111.87 172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -62.21 -24.02 66.98 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.639 0.776 . . . . 0.0 111.846 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -100.69 2.05 41.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.829 2.052 . . . . 0.0 114.564 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 89.0 m -63.06 136.71 57.95 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 119.678 1.126 . . . . 0.0 109.535 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 p -119.49 163.51 17.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.252 1.421 . . . . 0.0 110.548 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.416 ' HB3' ' HE ' ' A' ' 135' ' ' ARG . 82.6 mt-10 -66.26 -18.37 65.31 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.796 -0.565 . . . . 0.0 112.394 175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.5 mtm180 -60.79 -42.71 98.11 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.594 0.758 . . . . 0.0 110.432 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -66.86 -52.11 47.46 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.015 0.926 . . . . 0.0 110.18 178.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -62.17 -46.67 87.92 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 131' ' ' GLU . 82.7 mtt-85 -61.31 -32.59 72.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.943 0.792 . . . . 0.0 112.048 177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -76.28 -48.74 19.1 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 119.443 1.02 . . . . 0.0 111.829 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.95 -27.15 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.307 1.443 . . . . 0.0 112.992 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -100.2 -17.69 17.25 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.1 t -69.16 -19.74 64.01 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.308 1.413 . . . . 0.0 113.621 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.49 -14.08 17.49 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.682 -1.261 . . . . 0.0 114.289 170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -101.42 -5.69 24.98 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.272 1.429 . . . . 0.0 114.247 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.59 -172.4 23.32 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.459 1.028 . . . . 0.0 115.318 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.1 133.57 23.4 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.83 3.687 . . . . 0.0 111.701 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 59.4 mt -113.28 128.08 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.083 1.353 . . . . 0.0 109.307 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.88 -39.11 18.64 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.076 1.351 . . . . 0.0 111.945 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -166.76 174.57 8.52 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.855 1.262 . . . . 0.0 113.053 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.01 146.7 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.795 2.438 . . . . 0.0 108.126 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.3 m -140.32 108.82 5.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.309 1.043 . . . . 0.0 111.35 177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.68 142.11 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.149 -0.969 . . . . 0.0 110.309 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.96 108.55 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -100.41 141.27 33.49 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.116 1.366 . . . . 0.0 111.647 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.35 132.66 48.84 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.973 1.309 . . . . 0.0 113.081 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -77.87 -0.05 25.86 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -121.3 -15.81 8.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.284 1.033 . . . . 0.0 113.344 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 94.6 p -143.02 -6.73 0.84 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 65.24 6.48 3.62 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 127.213 2.205 . . . . 0.0 115.353 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -65.87 152.32 44.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.067 1.347 . . . . 0.0 110.533 170.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.7 t -66.42 132.9 49.33 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.144 -0.972 . . . . 0.0 109.916 169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.19 1.46 18.35 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.54 17.56 51.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.827 1.203 . . . . 0.0 113.984 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.15 160.22 42.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.633 1.217 . . . . 0.0 113.278 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.43 10.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.232 1.813 . . . . 0.0 112.31 -167.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -133.9 145.15 49.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.73 1.612 . . . . 0.0 110.068 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.68 131.36 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.328 1.851 . . . . 0.0 108.226 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -121.44 110.92 16.65 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.24 1.016 . . . . 0.0 110.87 -171.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -85.01 155.38 21.58 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.62 0.768 . . . . 0.0 111.594 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.39 -4.55 51.57 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.632 0.773 . . . . 0.0 112.444 174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -144.53 134.63 24.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.529 1.932 . . . . 0.0 110.952 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.95 -32.01 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -76.5 -26.36 55.21 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.316 0.962 . . . . 0.0 112.615 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -76.61 -29.51 56.54 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.67 0.668 . . . . 0.0 111.656 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.85 -36.11 81.58 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.235 0.614 . . . . 0.0 112.56 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -60.11 -47.67 84.94 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.785 . . . . 0.0 111.246 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -61.24 -50.08 74.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.709 0.804 . . . . 0.0 111.256 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.04 -49.77 72.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.535 0.734 . . . . 0.0 112.488 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -58.02 -48.03 81.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.968 0.907 . . . . 0.0 112.059 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.91 -28.66 61.65 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -81.23 -40.32 23.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.734 0.814 . . . . 0.0 112.888 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.71 -26.55 24.19 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -59.86 113.08 2.1 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.538 1.063 . . . . 0.0 112.475 -174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.52 -1.88 76.61 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.404 1.478 . . . . 0.0 116.095 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.1 ptt? -66.09 179.97 0.84 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.288 1.544 . . . . 0.0 113.979 174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -98.8 131.1 45.18 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.933 1.293 . . . . 0.0 111.633 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.0 tp -137.6 120.9 16.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.894 1.677 . . . . 0.0 108.473 168.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 22.4 t70 60.73 23.51 13.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.883 1.673 . . . . 0.0 113.335 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.94 -8.06 74.78 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.408 1.48 . . . . 0.0 114.09 -174.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -87.72 139.65 30.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.385 1.474 . . . . 0.0 110.693 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -84.78 101.41 12.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.893 0.877 . . . . 0.0 109.83 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.4 pt -76.41 177.69 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.576 1.151 . . . . 0.0 113.218 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -141.84 143.71 33.52 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.504 2.322 . . . . 0.0 108.13 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -142.15 132.73 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.902 1.281 . . . . 0.0 109.963 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -158.15 164.19 36.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.28 1.432 . . . . 0.0 111.302 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -63.75 141.79 58.64 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.713 0.805 . . . . 0.0 111.651 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.2 t -75.71 167.39 21.97 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.7 pt -146.81 174.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.806 2.042 . . . . 0.0 111.66 -169.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.4 t -143.69 148.48 35.8 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.666 1.586 . . . . 0.0 110.728 174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -99.8 1.1 42.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.14 1.376 . . . . 0.0 113.342 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.43 133.89 91.17 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.562 1.145 . . . . 0.0 111.721 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.26 157.99 41.4 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.65 2.9 . . . . 0.0 111.647 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -160.51 145.03 14.24 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.267 1.427 . . . . 0.0 110.896 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.021 1.729 . . . . 0.0 112.122 -175.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 CA-C-O 119.065 -0.853 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.54 159.31 24.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 124.566 3.511 . . . . 0.0 113.511 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -74.79 -10.14 59.22 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.02 8.83 79.27 Favored Glycine 0 N--CA 1.475 1.29 0 C-N-CA 124.912 1.244 . . . . 0.0 115.298 171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 79.4 p -166.39 167.99 15.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.763 1.625 . . . . 0.0 111.595 -172.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -154.42 132.43 11.67 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.29 1.036 . . . . 0.0 111.96 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -165.01 155.56 14.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.006 2.122 . . . . 0.0 110.493 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.89 121.54 85.3 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-O 118.373 -0.822 . . . . 0.0 111.796 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.5 155.61 45.39 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.386 2.724 . . . . 0.0 111.25 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.02 127.73 78.66 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.247 1.019 . . . . 0.0 110.81 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.34 95.15 0.76 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.06 2.507 . . . . 0.0 109.819 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -163.44 123.62 2.21 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.292 1.437 . . . . 0.0 110.404 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.6 p -79.63 -7.94 58.87 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.0 p -117.87 135.01 54.37 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.559 1.072 . . . . 0.0 113.026 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.4 mt -124.4 141.6 51.95 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.231 1.812 . . . . 0.0 110.196 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.12 144.5 17.19 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 167.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -130.95 123.52 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.947 1.699 . . . . 0.0 107.437 -173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -131.14 150.66 52.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.59 1.156 . . . . 0.0 111.539 -168.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.32 31.79 24.33 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.902 0.763 . . . . 0.0 113.12 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.92 167.47 17.98 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.689 1.596 . . . . 0.0 112.724 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -86.56 156.74 19.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.177 0.991 . . . . 0.0 112.388 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.75 -18.53 62.77 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.347 -0.846 . . . . 0.0 111.799 169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -87.84 -6.13 58.26 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.153 1.381 . . . . 0.0 114.014 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 56.8 m -70.96 138.31 49.89 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 119.3 0.955 . . . . 0.0 109.141 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.5 p -126.97 166.12 18.13 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.567 1.547 . . . . 0.0 110.172 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -61.78 -13.22 21.67 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 172.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.1 -34.85 61.78 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.903 1.281 . . . . 0.0 111.411 171.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -73.86 -48.61 29.86 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.924 0.89 . . . . 0.0 109.598 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.82 -46.37 89.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.272 -0.87 . . . . 0.0 111.984 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -61.6 -35.39 77.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 112.394 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 -38.42 66.5 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.993 0.815 . . . . 0.0 112.149 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.4 t -78.69 -26.96 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.769 1.227 . . . . 0.0 112.833 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -103.93 -17.14 15.13 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.4 p -72.99 -3.48 26.31 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 120.789 1.631 . . . . 0.0 113.623 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -57.31 -20.54 29.18 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.235 1.414 . . . . 0.0 113.23 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -113.08 -11.38 13.34 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.215 1.406 . . . . 0.0 114.634 -168.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.61 -176.83 34.64 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.302 0.954 . . . . 0.0 115.051 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.32 135.22 26.35 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.731 3.621 . . . . 0.0 110.968 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.35 133.65 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.971 1.309 . . . . 0.0 110.409 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.15 -29.77 13.03 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.074 1.75 . . . . 0.0 113.119 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -164.4 159.79 20.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.451 1.5 . . . . 0.0 111.817 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.5 t -154.76 136.62 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 127.748 2.419 . . . . 0.0 107.993 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.7 t -155.15 124.71 6.43 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 61.8 mt -89.18 144.69 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.221 1.408 . . . . 0.0 110.207 172.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 71.1 t -85.0 110.01 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -101.51 142.0 33.54 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.329 1.451 . . . . 0.0 111.288 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -64.63 139.43 58.76 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.835 1.254 . . . . 0.0 113.078 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -82.49 0.79 40.76 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -122.28 -39.68 2.55 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.52 1.128 . . . . 0.0 112.018 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.2 m -110.94 -6.68 14.65 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -173.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 62.02 3.3 0.93 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 126.555 1.942 . . . . 0.0 115.723 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 50.8 mmt-85 -71.02 155.53 40.71 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.758 1.223 . . . . 0.0 110.445 170.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.0 t -64.03 136.06 56.97 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.299 -0.876 . . . . 0.0 110.932 171.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -80.41 2.81 23.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.936 0.894 . . . . 0.0 112.814 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.79 18.97 49.7 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.852 1.215 . . . . 0.0 114.339 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.11 161.64 42.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.75 1.275 . . . . 0.0 113.878 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.71 173.85 16.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.27 1.828 . . . . 0.0 112.369 -168.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -135.32 145.34 47.37 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.688 1.595 . . . . 0.0 110.487 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.7 t -134.03 134.82 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.441 1.896 . . . . 0.0 108.714 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.35 119.2 25.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.558 1.143 . . . . 0.0 110.903 -171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -92.02 146.53 23.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.17 0.988 . . . . 0.0 111.079 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -73.94 -20.53 60.34 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.083 0.553 . . . . 0.0 111.91 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -114.18 127.71 56.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.755 1.622 . . . . 0.0 110.992 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.14 -28.82 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.6 -15.67 39.09 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -90.88 -28.22 18.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.067 0.947 . . . . 0.0 112.615 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.55 -28.84 68.75 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.605 0.762 . . . . 0.0 112.394 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -60.46 -55.81 29.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.876 0.87 . . . . 0.0 111.136 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -66.44 -38.19 86.85 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.532 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.89 -46.87 78.22 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.824 0.738 . . . . 0.0 112.294 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -61.6 -45.43 94.11 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.616 -0.677 . . . . 0.0 111.643 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.41 -38.17 90.09 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.27 -42.73 25.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.582 1.153 . . . . 0.0 112.525 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 -24.94 23.22 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -62.27 114.93 3.75 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.831 1.196 . . . . 0.0 112.318 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.88 0.7 71.41 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.224 1.392 . . . . 0.0 115.813 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.3 ptt? -67.69 -171.84 0.22 Allowed 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 119.28 1.54 . . . . 0.0 113.526 170.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -125.64 128.4 47.81 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.106 1.363 . . . . 0.0 110.752 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 44.0 tp -128.96 125.57 37.74 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.164 1.786 . . . . 0.0 109.174 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.2 t70 57.42 31.89 20.92 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.025 1.73 . . . . 0.0 112.775 -174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.46 -1.97 64.17 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.088 -1.008 . . . . 0.0 114.171 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 21.1 mmt-85 -97.45 128.31 44.13 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.947 1.299 . . . . 0.0 109.95 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -86.86 109.25 19.17 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.693 0.797 . . . . 0.0 110.107 -177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.4 pt -84.35 177.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.891 1.677 . . . . 0.0 114.103 -169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -139.34 141.73 37.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.218 2.607 . . . . 0.0 107.604 169.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.76 130.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.761 1.224 . . . . 0.0 109.707 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -151.28 157.89 43.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.52 1.528 . . . . 0.0 111.848 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -65.87 140.41 58.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 111.766 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.8 t -109.05 179.78 4.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.266 1.027 . . . . 0.0 113.437 -172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 18.6 tt -161.19 145.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.419 2.288 . . . . 0.0 110.037 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.8 t -161.14 156.61 24.64 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.073 1.749 . . . . 0.0 110.486 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -160.98 149.3 16.05 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.754 1.621 . . . . 0.0 112.552 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -84.97 149.53 53.43 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.785 1.234 . . . . 0.0 111.683 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -70.53 153.7 65.19 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.424 2.749 . . . . 0.0 111.027 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -151.59 22.67 0.7 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.172 0.989 . . . . 0.0 112.49 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.525 1.93 . . . . 0.0 112.301 -171.333 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 CA-C-O 119.531 -0.594 . . . . 0.0 112.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.2 -11.3 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.11 3.206 . . . . 0.0 114.638 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.5 tp 70.23 -29.84 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 128.733 2.813 . . . . 0.0 114.784 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.98 11.54 84.66 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.956 1.265 . . . . 0.0 114.211 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.1 t -164.82 162.37 20.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.248 1.819 . . . . 0.0 110.832 -174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -164.72 156.2 15.36 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.036 1.735 . . . . 0.0 112.104 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.5 154.77 25.31 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.238 1.815 . . . . 0.0 111.019 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -69.92 120.64 79.06 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.96 0.904 . . . . 0.0 111.868 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.2 161.32 26.17 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.334 2.69 . . . . 0.0 111.745 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -158.19 130.82 4.37 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 125.406 1.482 . . . . 0.0 110.214 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.57 98.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.556 3.504 . . . . 0.0 114.182 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -160.42 29.37 0.16 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.279 1.831 . . . . 0.0 110.513 -170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m -80.73 6.62 12.35 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.305 1.842 . . . . 0.0 114.094 -169.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.4 p -131.01 158.8 39.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.046 0.938 . . . . 0.0 112.775 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.5 mt -130.97 138.96 49.94 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.225 1.81 . . . . 0.0 109.551 -172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.9 144.78 17.46 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 167.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -130.96 122.85 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.893 1.677 . . . . 0.0 107.532 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -129.14 145.64 51.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.451 1.101 . . . . 0.0 111.989 -167.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.8 22.03 37.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.289 0.947 . . . . 0.0 113.527 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -73.89 165.88 24.33 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.427 1.491 . . . . 0.0 112.612 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.6 t -83.58 158.58 21.88 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.618 0.767 . . . . 0.0 112.502 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.8 mt -68.05 -20.97 65.02 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.674 -0.641 . . . . 0.0 111.919 171.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.7 -2.46 47.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.887 1.675 . . . . 0.0 114.469 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 90.8 m -66.52 138.94 57.87 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.311 1.044 . . . . 0.0 109.699 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.4 p -120.83 162.71 19.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.31 1.444 . . . . 0.0 110.857 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.97 -25.88 65.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.099 0.56 . . . . 0.0 112.157 172.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -68.93 -40.52 78.96 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.668 0.787 . . . . 0.0 111.69 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -63.17 -48.5 78.13 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.231 0.612 . . . . 0.0 110.263 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.4 mt -59.01 -48.57 81.1 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.446 -0.787 . . . . 0.0 111.399 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 -57.28 -46.5 83.06 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.702 1.137 . . . . 0.0 111.873 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -63.23 -38.94 93.15 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.146 0.885 . . . . 0.0 112.593 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.2 t -80.83 -30.55 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.7 0.8 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.56 -19.35 18.41 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -66.68 -19.08 65.68 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 120.352 1.433 . . . . 0.0 113.627 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -60.88 -14.5 22.61 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.693 -1.254 . . . . 0.0 114.309 170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -101.73 -3.21 28.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 114.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.25 -173.41 22.48 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.559 1.076 . . . . 0.0 115.379 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -71.45 134.27 24.16 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 125.108 3.872 . . . . 0.0 111.875 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -122.92 118.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.95 1.3 . . . . 0.0 109.368 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.89 -30.62 35.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.626 1.57 . . . . 0.0 113.302 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -164.89 164.01 20.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.238 1.415 . . . . 0.0 111.579 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.1 t -153.56 141.94 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.198 2.199 . . . . 0.0 108.137 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.9 t -150.05 127.45 11.45 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.502 0.721 . . . . 0.0 112.265 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 99.0 mt -93.76 145.47 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.043 1.337 . . . . 0.0 110.089 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 61.7 t -90.61 129.66 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.113 0.965 . . . . 0.0 110.487 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -127.09 161.19 29.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.926 1.691 . . . . 0.0 112.11 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.88 143.08 39.89 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.911 1.284 . . . . 0.0 113.45 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -78.8 -9.17 59.36 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -120.69 -51.12 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.525 1.057 . . . . 0.0 111.427 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.5 p -93.87 -11.82 30.28 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 62.62 13.59 6.43 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.195 1.798 . . . . 0.0 113.823 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -63.71 148.29 49.48 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.029 1.331 . . . . 0.0 110.82 169.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.5 t -69.19 139.49 54.58 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.754 -0.591 . . . . 0.0 110.573 169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -87.84 1.32 54.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.579 0.752 . . . . 0.0 112.972 173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.11 23.22 57.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.253 0.93 . . . . 0.0 114.313 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -152.0 162.98 40.24 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.544 1.172 . . . . 0.0 113.21 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.55 173.09 17.14 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.765 1.626 . . . . 0.0 112.249 -168.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -132.94 139.27 47.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.431 1.492 . . . . 0.0 110.409 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 92.8 t -124.11 126.59 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.599 1.96 . . . . 0.0 108.545 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -112.2 107.45 16.34 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 111.138 -170.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -82.13 153.57 25.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.493 0.717 . . . . 0.0 111.015 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -77.68 -0.19 25.78 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 0.0 112.673 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.72 136.99 14.85 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.465 1.906 . . . . 0.0 111.492 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -67.1 -28.4 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.496 0.718 . . . . 0.0 112.368 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.44 -30.79 53.51 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.432 -0.793 . . . . 0.0 112.801 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -76.39 -30.42 57.5 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.897 -0.502 . . . . 0.0 112.123 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.14 93.2 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.628 0.649 . . . . 0.0 112.086 171.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.05 -46.17 90.34 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.99 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -60.37 -46.2 90.82 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.367 0.667 . . . . 0.0 111.489 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.6 75.96 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.318 0.647 . . . . 0.0 112.495 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -58.55 -44.86 89.81 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.338 -0.851 . . . . 0.0 111.906 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -80.39 5.74 14.13 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.502 1.121 . . . . 0.0 113.725 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -124.81 -33.58 2.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.872 1.269 . . . . 0.0 113.752 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.55 -25.45 23.63 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.461 1.104 . . . . 0.0 113.668 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -62.58 117.31 6.07 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.757 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.0 72.98 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.329 -1.262 . . . . 0.0 115.53 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -66.32 -173.87 0.23 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.573 1.687 . . . . 0.0 112.96 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.23 134.42 53.26 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.328 1.451 . . . . 0.0 109.8 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 31.1 tp -137.58 123.82 20.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.121 1.369 . . . . 0.0 110.069 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.12 27.21 16.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.335 1.854 . . . . 0.0 112.945 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.48 -1.48 87.54 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.031 1.3 . . . . 0.0 114.043 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -93.7 136.72 33.69 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.815 1.246 . . . . 0.0 110.786 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -78.77 137.5 37.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.41 0.684 . . . . 0.0 110.168 169.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.86 174.88 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -170.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -135.06 145.24 47.79 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.283 2.233 . . . . 0.0 108.666 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 51.6 t -136.09 132.3 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.448 1.499 . . . . 0.0 109.122 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -157.44 157.89 34.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.231 1.012 . . . . 0.0 111.893 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -70.27 150.91 45.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.345 1.058 . . . . 0.0 113.762 -174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.8 m -132.98 134.46 44.51 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.594 1.558 . . . . 0.0 110.202 173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.63 123.4 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.357 -0.839 . . . . 0.0 109.581 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.2 m -67.92 131.7 45.98 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.175 0.99 . . . . 0.0 108.376 172.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.19 140.31 44.83 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -163.53 147.59 8.57 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.049 2.139 . . . . 0.0 111.042 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.37 160.65 38.73 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.697 2.931 . . . . 0.0 112.044 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -160.27 144.28 14.16 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.589 1.556 . . . . 0.0 110.634 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 127.064 2.146 . . . . 0.0 110.274 -178.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.74 155.3 49.21 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.09 3.193 . . . . 0.0 112.022 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 pp -93.36 10.72 30.96 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.02 1.328 . . . . 0.0 114.386 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.37 126.6 40.33 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.313 0.959 . . . . 0.0 111.56 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.5 m 59.84 12.83 3.22 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.548 1.539 . . . . 0.0 113.764 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.25 -34.29 0.27 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.902 2.881 . . . . 0.0 114.413 -173.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -178.47 178.18 0.87 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.059 3.343 . . . . 0.0 109.02 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.57 160.22 36.36 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.429 -0.795 . . . . 0.0 112.947 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.75 157.65 36.73 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.725 2.95 . . . . 0.0 112.255 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.51 137.39 10.56 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.292 1.437 . . . . 0.0 109.953 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.46 91.05 0.98 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.142 2.562 . . . . 0.0 110.644 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -158.61 126.42 5.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.874 1.669 . . . . 0.0 110.577 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 25.8 p -79.59 -9.21 59.59 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 12.4 p -121.62 141.39 51.16 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.916 1.234 . . . . 0.0 114.129 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -129.61 144.16 51.15 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.291 2.236 . . . . 0.0 110.515 -169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.85 143.63 16.81 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 167.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.1 122.68 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.028 1.731 . . . . 0.0 107.649 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -129.9 153.03 48.73 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.881 1.272 . . . . 0.0 111.739 -168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.83 28.65 37.44 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.722 0.677 . . . . 0.0 113.141 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.39 165.55 23.68 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.612 1.565 . . . . 0.0 112.29 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.1 t -83.94 158.47 21.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.552 0.691 . . . . 0.0 112.557 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -68.82 -21.12 64.33 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.644 -0.66 . . . . 0.0 111.703 169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.59 -5.98 57.83 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.5 1.52 . . . . 0.0 114.268 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.3 m -71.29 140.06 50.19 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.28 1.032 . . . . 0.0 109.775 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -124.23 165.07 18.25 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.711 1.604 . . . . 0.0 110.47 171.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -60.59 -24.51 65.52 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.83 -40.56 79.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.843 0.747 . . . . 0.0 111.353 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -64.43 -48.07 76.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.319 0.648 . . . . 0.0 110.468 173.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.15 -48.88 78.9 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.503 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -57.29 -48.15 79.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.346 0.975 . . . . 0.0 111.716 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.69 -34.8 79.16 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 90.2 t -80.97 -38.6 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.622 0.769 . . . . 0.0 112.171 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.95 -16.98 28.8 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.2 p -68.45 -14.76 63.22 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 120.601 1.546 . . . . 0.0 114.399 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -65.86 -11.15 44.5 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -95.49 -13.98 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.029 1.332 . . . . 0.0 114.113 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.37 -172.61 27.74 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.404 1.002 . . . . 0.0 115.324 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.31 133.33 19.11 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 125.021 3.814 . . . . 0.0 111.185 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 60.9 mt -121.39 118.06 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.525 1.13 . . . . 0.0 109.485 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.88 36.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.617 1.567 . . . . 0.0 113.207 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -163.97 159.95 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.085 1.354 . . . . 0.0 111.754 -175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 66.7 t -154.11 142.23 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.44 2.296 . . . . 0.0 108.246 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 14.6 t -151.26 124.2 8.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.779 0.832 . . . . 0.0 112.198 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.1 mt -85.77 144.58 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.956 1.302 . . . . 0.0 109.925 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.3 t -84.21 118.21 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.13 146.96 35.91 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.458 1.503 . . . . 0.0 111.611 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -61.98 146.55 49.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.296 1.438 . . . . 0.0 113.823 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -76.84 -5.45 48.36 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.418 1.487 . . . . 0.0 114.327 -171.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -138.8 -40.33 0.49 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.522 1.055 . . . . 0.0 112.896 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.0 t -99.68 -11.4 20.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.236 1.014 . . . . 0.0 113.2 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.13 13.23 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.476 1.911 . . . . 0.0 115.814 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -66.46 155.15 38.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.007 0.923 . . . . 0.0 110.2 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.4 t -64.3 137.92 58.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.164 -0.96 . . . . 0.0 110.747 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -85.78 3.55 40.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.811 0.844 . . . . 0.0 112.69 171.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.34 18.68 54.87 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.861 1.22 . . . . 0.0 114.61 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -153.96 162.85 40.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.752 1.276 . . . . 0.0 113.651 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.67 171.58 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.313 1.845 . . . . 0.0 112.32 -168.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.71 144.21 50.82 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.598 1.559 . . . . 0.0 110.343 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 91.1 t -131.48 136.22 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 126.882 2.073 . . . . 0.0 108.894 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -126.62 113.52 16.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.779 1.232 . . . . 0.0 110.923 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -87.77 151.07 23.17 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.417 -0.802 . . . . 0.0 111.197 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -78.66 -4.26 48.15 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 112.368 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -135.28 133.32 38.78 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.372 1.869 . . . . 0.0 111.342 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.59 -27.79 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.36 1.064 . . . . 0.0 112.702 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -83.89 -31.65 25.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -73.52 -29.06 62.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 118.777 0.717 . . . . 0.0 112.263 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.85 95.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.371 0.668 . . . . 0.0 112.481 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.32 -45.29 93.88 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.819 -0.551 . . . . 0.0 111.535 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.01 -46.6 80.7 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.445 0.566 . . . . 0.0 111.795 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.03 73.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.17 0.896 . . . . 0.0 112.445 177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -59.91 -39.05 84.11 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.728 1.211 . . . . 0.0 113.097 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -75.05 -37.82 61.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.272 0.629 . . . . 0.0 112.466 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -74.34 -42.58 59.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.221 1.009 . . . . 0.0 112.67 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.78 -26.91 27.23 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.01 115.3 3.63 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.065 -1.022 . . . . 0.0 112.095 -175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.52 1.34 81.0 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.131 1.348 . . . . 0.0 115.584 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -63.23 176.91 0.69 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.138 1.469 . . . . 0.0 112.525 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.31 126.06 53.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 111.02 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 30.3 tp -135.2 120.76 19.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.725 1.61 . . . . 0.0 109.261 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.5 t70 57.82 27.8 15.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 126.101 1.76 . . . . 0.0 112.662 -170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.71 75.08 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.506 1.05 . . . . 0.0 114.036 -174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -91.46 134.27 34.77 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.663 1.232 . . . . 0.0 110.344 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -88.3 101.92 14.33 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.784 0.802 . . . . 0.0 110.429 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.1 pt -77.39 174.87 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.86 1.664 . . . . 0.0 113.938 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -136.44 139.86 42.71 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.457 2.303 . . . . 0.0 108.427 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.8 t -137.54 133.23 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.788 1.235 . . . . 0.0 110.204 -173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -157.43 166.94 31.67 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.662 1.185 . . . . 0.0 111.592 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -67.68 150.68 48.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.025 0.93 . . . . 0.0 112.306 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 87.7 p -141.2 154.69 45.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.418 1.087 . . . . 0.0 111.914 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt -154.63 145.28 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.976 1.31 . . . . 0.0 110.578 -177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 38.2 p -96.81 3.25 52.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.003 1.721 . . . . 0.0 113.948 -174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -151.87 137.94 18.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.202 1.401 . . . . 0.0 111.801 -172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -66.16 131.21 94.38 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.608 1.163 . . . . 0.0 110.758 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.85 158.11 53.62 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.332 2.688 . . . . 0.0 111.439 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -76.91 -16.46 59.37 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.634 1.974 . . . . 0.0 112.937 -178.255 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 CA-C-O 119.471 -0.627 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -81.66 -8.71 12.38 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 124.134 3.223 . . . . 0.0 114.386 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.3 mt -142.2 155.72 45.29 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.269 1.828 . . . . 0.0 110.745 -175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.76 28.54 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.561 1.077 . . . . 0.0 112.89 177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.0 m -140.82 18.4 2.32 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.347 1.059 . . . . 0.0 113.366 -172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.02 150.79 28.62 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.776 1.23 . . . . 0.0 112.436 -173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.66 173.61 16.69 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.09 2.156 . . . . 0.0 110.64 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -154.34 128.72 4.7 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.392 1.077 . . . . 0.0 111.935 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.32 158.01 45.13 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.536 2.824 . . . . 0.0 111.455 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.24 58.91 9.1 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 125.92 1.688 . . . . 0.0 113.834 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.74 173.82 13.3 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 124.168 3.245 . . . . 0.0 111.613 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -154.54 156.57 36.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.52 1.128 . . . . 0.0 112.405 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 62.1 m -56.55 -27.71 58.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.006 1.722 . . . . 0.0 114.073 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 18.7 m -91.66 123.5 35.1 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.918 1.287 . . . . 0.0 110.584 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.5 mt -112.6 140.86 47.0 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.848 1.259 . . . . 0.0 110.392 171.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.14 146.41 18.24 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.7 t -133.62 123.98 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.541 1.536 . . . . 0.0 107.636 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -132.14 154.0 49.95 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.368 1.067 . . . . 0.0 111.517 -168.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.16 27.59 55.48 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.694 0.664 . . . . 0.0 113.138 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.2 mt -76.66 161.58 28.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.684 1.593 . . . . 0.0 112.583 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 t -67.99 141.82 56.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.686 169.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -71.06 -5.6 32.69 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -100.27 2.57 42.79 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.121 1.768 . . . . 0.0 113.536 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 37.0 m -63.6 138.32 58.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.088 1.355 . . . . 0.0 110.594 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 39.0 p -122.26 166.86 13.98 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.494 1.518 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -60.4 -24.21 64.96 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.575 0.75 . . . . 0.0 112.221 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -64.31 -44.96 89.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.942 1.297 . . . . 0.0 110.921 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -66.96 -45.26 78.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.16 0.984 . . . . 0.0 110.449 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.04 -43.9 97.37 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.527 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -60.08 -44.23 94.92 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 120.04 1.291 . . . . 0.0 111.977 171.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.3 -37.79 88.64 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.562 1.074 . . . . 0.0 112.693 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -83.7 -34.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.254 1.022 . . . . 0.0 112.986 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -104.76 -19.97 13.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.0 t -73.86 -10.97 60.2 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.626 1.557 . . . . 0.0 113.132 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -66.56 -10.28 43.64 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.996 -1.065 . . . . 0.0 113.577 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.25 -3.19 34.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.696 1.598 . . . . 0.0 113.932 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.45 -179.07 18.81 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.941 1.258 . . . . 0.0 115.182 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.28 135.93 48.96 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.288 3.992 . . . . 0.0 112.296 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 67.5 mt -122.04 119.12 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.533 1.533 . . . . 0.0 109.24 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.26 -32.28 43.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.064 1.746 . . . . 0.0 112.978 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -162.97 164.82 25.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.086 1.354 . . . . 0.0 111.748 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 94.1 t -152.69 140.22 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.282 2.233 . . . . 0.0 108.18 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.3 t -143.68 145.05 32.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.191 0.996 . . . . 0.0 111.194 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 59.4 mt -126.53 140.68 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.563 1.545 . . . . 0.0 108.558 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 57.4 t -86.27 123.05 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.067 0.547 . . . . 0.0 110.228 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.54 150.54 38.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.721 1.609 . . . . 0.0 112.06 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -72.25 138.03 47.19 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.92 -17.53 63.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.769 1.628 . . . . 0.0 114.111 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -123.08 -19.05 6.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.599 1.09 . . . . 0.0 113.566 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 88.9 p -136.23 -2.82 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 65.04 1.61 1.54 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.829 2.052 . . . . 0.0 115.931 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -62.43 163.49 8.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.109 168.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.8 t -68.11 151.48 46.96 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.179 -0.95 . . . . 0.0 110.902 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -99.83 4.04 45.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.751 1.22 . . . . 0.0 112.707 169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.54 58.11 Favored Glycine 0 N--CA 1.472 1.061 0 C-N-CA 124.492 1.044 . . . . 0.0 115.1 171.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -150.22 160.48 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.75 1.275 . . . . 0.0 113.814 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.89 173.47 16.73 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.309 1.844 . . . . 0.0 112.569 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -137.46 140.58 41.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.273 1.829 . . . . 0.0 109.882 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 99.2 t -130.4 129.27 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.453 1.901 . . . . 0.0 108.286 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -115.9 104.85 12.03 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.295 1.038 . . . . 0.0 110.797 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -77.98 152.05 33.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.358 0.663 . . . . 0.0 111.111 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -70.84 -21.29 62.46 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -147.09 147.53 30.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.987 1.715 . . . . 0.0 111.253 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.42 -24.56 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.035 0.934 . . . . 0.0 113.119 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.06 -23.21 64.01 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -89.36 -31.8 17.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.684 1.194 . . . . 0.0 111.848 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.36 -36.78 85.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.399 0.68 . . . . 0.0 112.101 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -57.21 -51.12 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.55 -0.719 . . . . 0.0 111.438 170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -59.15 -49.93 75.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.491 0.717 . . . . 0.0 111.357 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.29 79.6 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -62.88 -41.21 99.33 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.37 -0.831 . . . . 0.0 111.92 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.07 -8.69 58.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -108.58 -38.13 5.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.042 1.337 . . . . 0.0 113.617 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -93.08 -11.86 31.93 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -55.5 108.87 0.47 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.721 1.208 . . . . 0.0 113.427 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.66 7.31 86.23 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.065 1.316 . . . . 0.0 115.894 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.5 ptt? -66.37 -173.08 0.18 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 119.004 1.402 . . . . 0.0 113.522 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -125.78 129.84 50.26 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.082 1.353 . . . . 0.0 110.695 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.3 tp -128.42 125.15 37.96 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.168 1.787 . . . . 0.0 109.046 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.8 t70 57.49 32.97 22.63 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.979 1.712 . . . . 0.0 112.642 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.9 4.7 83.19 Favored Glycine 0 CA--C 1.532 1.151 0 O-C-N 121.086 -1.009 . . . . 0.0 114.301 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 10.7 mmt-85 -105.23 129.56 53.57 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 110.112 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.7 mtm-85 -86.5 110.64 19.9 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.921 0.889 . . . . 0.0 109.911 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 23.4 pt -89.08 179.26 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.631 1.572 . . . . 0.0 113.687 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 48.4 ttp85 -136.07 143.41 44.64 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.523 2.329 . . . . 0.0 107.804 168.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.99 129.14 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.168 1.387 . . . . 0.0 108.746 -177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -159.49 154.38 24.73 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.592 0.757 . . . . 0.0 112.92 -169.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -68.17 143.26 55.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.146 0.979 . . . . 0.0 111.921 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 67.0 m -134.37 151.97 51.53 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.165 1.386 . . . . 0.0 111.207 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 58.7 mt -140.38 129.57 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.176 1.39 . . . . 0.0 108.145 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.1 m -149.39 140.17 22.71 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.436 1.494 . . . . 0.0 109.661 -172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.88 147.15 53.85 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.984 0.913 . . . . 0.0 112.552 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.8 ttt85 -158.3 128.34 3.39 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.477 1.511 . . . . 0.0 110.625 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.97 151.0 34.81 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.497 2.798 . . . . 0.0 111.38 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -147.87 150.43 34.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.333 1.453 . . . . 0.0 110.885 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.4 p . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.078 1.751 . . . . 0.0 112.285 -175.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 119.501 -0.611 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.04 156.38 51.97 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.096 3.198 . . . . 0.0 111.93 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.24 162.94 31.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.009 1.723 . . . . 0.0 111.621 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.59 77.67 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.134 0.873 . . . . 0.0 114.235 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.8 m -58.36 143.54 44.7 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.695 1.598 . . . . 0.0 113.59 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -119.11 141.77 48.5 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.971 1.308 . . . . 0.0 111.375 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.49 173.09 14.5 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.613 1.965 . . . . 0.0 110.967 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -147.11 72.25 12.14 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.199 1.0 . . . . 0.0 112.06 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.78 160.47 46.13 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.624 2.883 . . . . 0.0 110.607 172.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.33 116.41 25.2 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.984 0.914 . . . . 0.0 111.733 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -84.73 161.03 12.28 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.282 2.655 . . . . 0.0 112.085 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -159.39 161.86 35.7 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.128 1.371 . . . . 0.0 111.736 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 63.1 m -61.86 -13.5 25.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.536 1.534 . . . . 0.0 115.088 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.4 p -128.77 151.75 49.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.595 1.089 . . . . 0.0 113.31 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.8 138.93 50.13 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.787 2.035 . . . . 0.0 109.912 -171.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.77 141.79 16.26 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 167.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.52 122.83 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.053 1.741 . . . . 0.0 107.627 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -129.93 149.84 51.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.463 1.105 . . . . 0.0 111.971 -168.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.48 30.52 27.13 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.014 0.816 . . . . 0.0 113.243 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.9 166.36 21.73 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.765 1.626 . . . . 0.0 112.688 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.8 t -80.35 156.26 26.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.669 0.788 . . . . 0.0 112.54 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -68.55 -19.91 64.52 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.597 -0.689 . . . . 0.0 111.995 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.55 -4.1 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.436 1.494 . . . . 0.0 114.148 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.0 m -69.85 146.21 51.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.172 0.989 . . . . 0.0 109.906 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 43.7 p -133.91 166.36 22.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.826 1.65 . . . . 0.0 110.566 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -63.93 -9.43 15.44 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -93.79 -36.6 12.19 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.869 1.267 . . . . 0.0 111.691 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.66 -46.64 87.26 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.148 0.979 . . . . 0.0 110.84 172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.05 -46.79 89.26 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.921 0.888 . . . . 0.0 111.579 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -52.96 -49.51 65.94 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.424 1.011 . . . . 0.0 111.47 170.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.0 -38.89 92.73 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.68 0.673 . . . . 0.0 112.644 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.7 t -78.98 -36.34 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.624 0.647 . . . . 0.0 112.605 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -93.88 -17.04 23.45 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.4 m -68.41 -14.1 62.76 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 120.647 1.567 . . . . 0.0 114.005 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.94 -14.14 59.18 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 121.003 -1.061 . . . . 0.0 113.656 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -95.54 -11.04 28.05 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.039 1.336 . . . . 0.0 114.234 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.04 -173.7 24.7 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.63 1.11 . . . . 0.0 114.97 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.42 133.44 24.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.829 3.686 . . . . 0.0 111.715 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.3 mt -119.31 125.73 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.4 1.48 . . . . 0.0 109.067 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.95 -35.26 18.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.352 1.461 . . . . 0.0 112.311 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -165.43 173.81 10.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.559 1.143 . . . . 0.0 113.214 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 46.3 t -151.55 147.35 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.641 2.376 . . . . 0.0 108.298 172.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 t -148.6 124.75 10.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.217 1.007 . . . . 0.0 112.034 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -89.78 146.56 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 110.269 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 99.4 t -86.35 122.94 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.674 0.79 . . . . 0.0 109.684 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -116.47 142.85 46.33 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.437 1.495 . . . . 0.0 111.855 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.03 141.62 58.69 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.683 . . . . 0.0 114.587 -169.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -75.13 -9.83 58.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 0.0 114.251 -172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -122.98 -26.9 4.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.377 1.071 . . . . 0.0 112.866 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 89.1 p -132.34 -3.59 3.43 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 64.08 8.3 3.92 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.243 1.817 . . . . 0.0 114.708 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -60.48 150.08 32.35 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.075 1.35 . . . . 0.0 110.88 170.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.1 t -64.69 134.35 54.04 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.112 -0.992 . . . . 0.0 110.633 170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -83.38 2.85 34.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.537 0.735 . . . . 0.0 112.838 172.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.51 20.86 57.74 Favored Glycine 0 N--CA 1.471 1.026 0 C-N-CA 124.544 1.068 . . . . 0.0 114.296 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -152.14 160.92 43.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.73 1.265 . . . . 0.0 113.487 177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.36 171.67 19.49 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.004 1.721 . . . . 0.0 112.293 -168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -130.27 134.66 47.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.567 1.547 . . . . 0.0 109.665 174.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.21 132.81 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.705 2.002 . . . . 0.0 108.581 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -119.18 108.61 14.88 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.623 1.169 . . . . 0.0 110.926 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -85.59 154.69 21.55 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.406 1.083 . . . . 0.0 110.872 174.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -71.63 -19.38 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -147.98 142.1 26.05 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.635 1.574 . . . . 0.0 111.78 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.93 -27.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.217 1.007 . . . . 0.0 113.002 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -71.75 -17.93 62.16 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -95.5 -30.78 13.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.916 1.287 . . . . 0.0 111.841 170.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.85 85.35 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.452 0.701 . . . . 0.0 112.46 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.2 -47.17 87.07 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.495 -0.753 . . . . 0.0 112.191 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -61.83 -50.34 72.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.427 1.091 . . . . 0.0 110.318 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.11 -49.71 73.09 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.756 0.822 . . . . 0.0 112.91 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -54.67 -54.1 46.17 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.443 1.097 . . . . 0.0 111.466 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -70.52 -27.75 64.41 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 -174.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -81.58 -40.24 23.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.496 0.718 . . . . 0.0 112.798 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.42 27.63 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -59.49 113.49 2.23 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.195 -0.941 . . . . 0.0 112.308 -174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.44 1.05 75.34 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.122 1.344 . . . . 0.0 115.746 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -63.49 177.34 0.69 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.303 1.551 . . . . 0.0 113.136 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.16 128.53 55.21 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.891 1.276 . . . . 0.0 110.196 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.7 tp -134.04 121.28 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.705 1.602 . . . . 0.0 109.456 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.4 t70 56.36 32.75 21.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.986 1.714 . . . . 0.0 112.389 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.92 -5.48 58.27 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.686 1.136 . . . . 0.0 114.316 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 13.4 mmt-85 -91.4 132.61 36.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.875 1.338 . . . . 0.0 110.035 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -95.16 105.48 17.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.792 0.806 . . . . 0.0 110.17 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -81.36 179.62 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.303 1.841 . . . . 0.0 114.48 -169.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -139.13 143.67 38.33 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.857 2.463 . . . . 0.0 108.375 169.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.4 t -141.3 131.67 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.938 1.295 . . . . 0.0 110.454 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -157.39 160.01 37.98 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.161 1.385 . . . . 0.0 111.645 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -61.55 146.63 48.11 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.291 1.037 . . . . 0.0 112.912 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 79.1 p -131.13 172.74 11.76 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.216 1.406 . . . . 0.0 111.528 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.5 pt -144.18 161.35 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.161 1.384 . . . . 0.0 111.838 -174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 88.5 m -113.92 138.9 49.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.957 1.703 . . . . 0.0 108.692 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.84 156.8 43.05 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.08 1.352 . . . . 0.0 112.071 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -157.94 137.46 8.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.739 1.616 . . . . 0.0 110.519 -174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.19 154.4 46.66 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.388 2.725 . . . . 0.0 111.259 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -145.59 151.05 37.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.029 1.332 . . . . 0.0 111.25 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.148 1.779 . . . . 0.0 112.26 -175.567 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 119.447 -0.64 . . . . 0.0 112.295 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -81.57 -8.2 12.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 124.157 3.238 . . . . 0.0 114.568 -174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -156.11 124.35 5.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.538 1.535 . . . . 0.0 109.508 -175.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.33 133.63 11.88 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.806 1.193 . . . . 0.0 112.078 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -165.46 168.72 16.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.675 1.59 . . . . 0.0 111.065 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -140.63 132.02 26.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.764 1.626 . . . . 0.0 110.873 -177.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.89 175.76 9.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.205 2.202 . . . . 0.0 110.608 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -158.85 123.97 2.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.142 0.977 . . . . 0.0 112.584 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -80.25 170.73 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.746 2.964 . . . . 0.0 111.843 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -155.44 138.33 10.54 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.206 1.803 . . . . 0.0 109.545 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.04 97.01 0.97 Allowed 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.757 2.305 . . . . 0.0 111.596 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -163.04 126.5 2.82 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.213 1.805 . . . . 0.0 110.923 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 75.4 m -75.21 -13.93 60.49 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 63.9 m -103.84 125.31 50.18 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.207 1.403 . . . . 0.0 110.985 -171.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.0 mt -123.68 143.08 50.48 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.643 1.577 . . . . 0.0 111.332 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.94 145.84 16.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.756 1.646 . . . . 0.0 110.448 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.87 121.95 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.966 1.707 . . . . 0.0 107.835 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -130.49 149.03 52.35 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.575 1.15 . . . . 0.0 111.484 -168.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 87.77 23.96 37.19 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.198 0.904 . . . . 0.0 113.505 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.4 mt -76.52 167.72 21.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.334 1.453 . . . . 0.0 112.523 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.3 t -87.56 161.89 17.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.659 0.784 . . . . 0.0 112.861 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.9 mt -71.28 -20.34 62.23 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.681 -0.637 . . . . 0.0 112.094 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.48 -3.75 49.4 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.776 1.63 . . . . 0.0 114.211 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 62.9 m -68.21 141.38 55.97 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 109.919 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 56.8 p -127.69 162.15 27.24 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.848 1.659 . . . . 0.0 110.688 175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -63.07 -20.88 65.76 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.737 -0.602 . . . . 0.0 112.574 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -65.92 -46.33 78.64 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -64.25 -46.29 84.41 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.388 0.675 . . . . 0.0 110.998 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.57 -48.48 81.48 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.345 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -58.81 -43.52 90.59 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.662 1.119 . . . . 0.0 112.018 173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.48 -37.04 86.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.009 0.822 . . . . 0.0 112.603 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.6 -36.0 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.919 0.888 . . . . 0.0 112.53 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -94.18 -20.28 20.0 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 85.0 p -69.79 -12.95 62.02 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.71 1.596 . . . . 0.0 114.204 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -64.19 -16.36 61.8 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.106 -0.997 . . . . 0.0 113.285 169.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -92.15 -9.31 42.89 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.129 1.372 . . . . 0.0 113.929 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 137.88 -168.98 24.35 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 124.982 1.277 . . . . 0.0 115.129 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -73.69 132.36 17.18 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.708 3.605 . . . . 0.0 112.181 -171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.2 mt -116.1 130.38 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.42 1.488 . . . . 0.0 109.591 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.86 -34.74 15.14 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.846 1.658 . . . . 0.0 112.918 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -166.19 163.12 17.88 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.765 1.626 . . . . 0.0 111.316 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -154.93 143.15 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 127.65 2.38 . . . . 0.0 108.531 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.4 p -152.44 120.76 6.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.934 0.894 . . . . 0.0 113.35 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.6 mt -90.29 145.83 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 O-C-N 120.714 -1.241 . . . . 0.0 110.282 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 68.1 t -91.19 126.94 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.079 0.952 . . . . 0.0 110.221 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -120.3 148.31 43.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.028 1.731 . . . . 0.0 111.52 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -67.12 141.61 57.37 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -169.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -65.77 -15.75 63.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.115 1.766 . . . . 0.0 114.382 -174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -133.11 -32.71 1.18 Allowed 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.852 1.206 . . . . 0.0 112.951 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 t -92.92 -20.53 20.54 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 63.02 1.59 0.89 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 127.079 2.152 . . . . 0.0 115.314 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -71.37 157.41 38.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.802 1.241 . . . . 0.0 110.188 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.0 t -63.27 140.02 58.83 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.22 -0.925 . . . . 0.0 111.478 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.62 1.88 47.41 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.787 0.835 . . . . 0.0 112.857 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.94 21.53 52.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.545 1.069 . . . . 0.0 114.444 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -153.61 163.8 39.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.605 1.203 . . . . 0.0 113.626 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.401 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -158.78 174.58 14.8 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.803 1.641 . . . . 0.0 112.617 -168.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.27 147.37 51.93 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.442 1.897 . . . . 0.0 110.139 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.11 133.54 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.283 1.833 . . . . 0.0 108.116 -174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -126.31 113.34 16.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.06 0.944 . . . . 0.0 110.833 -170.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -88.58 150.04 23.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.981 0.912 . . . . 0.0 111.739 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -75.47 -22.59 57.13 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.846 0.858 . . . . 0.0 112.261 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -137.84 138.7 39.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 111.479 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.3 p -70.04 -29.14 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -169.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -73.67 -31.95 63.72 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.42 -0.8 . . . . 0.0 112.047 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.43 -29.29 59.67 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.488 1.115 . . . . 0.0 111.623 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.61 80.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.638 0.775 . . . . 0.0 111.888 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -62.69 -43.0 99.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.429 0.692 . . . . 0.0 111.753 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -59.53 -55.06 39.37 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.417 1.087 . . . . 0.0 110.474 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.05 -48.77 73.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.729 0.812 . . . . 0.0 113.001 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.65 -49.66 74.38 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.477 0.711 . . . . 0.0 111.84 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.49 -26.35 60.86 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -84.59 -40.73 17.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.866 0.866 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.01 -27.14 35.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -60.06 114.56 2.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.217 -0.927 . . . . 0.0 112.235 -176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.94 2.49 69.09 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.154 1.359 . . . . 0.0 115.725 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -65.92 -170.67 0.08 Allowed 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 119.659 1.73 . . . . 0.0 113.233 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -130.28 135.73 48.41 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.912 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.4 tp -136.35 126.84 26.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.3 1.44 . . . . 0.0 109.905 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.1 t70 64.26 9.52 4.89 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.131 2.172 . . . . 0.0 113.611 -175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.86 4.74 64.98 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.336 1.446 . . . . 0.0 113.873 -171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -98.25 135.03 40.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.904 1.352 . . . . 0.0 110.35 174.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -77.84 137.02 38.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.707 0.803 . . . . 0.0 110.782 172.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 6.5 pt -120.59 175.56 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -145.19 130.53 18.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 128.691 2.796 . . . . 0.0 107.456 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -136.84 130.95 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.276 1.03 . . . . 0.0 110.52 -172.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.68 174.49 15.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.696 1.198 . . . . 0.0 111.854 -177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -74.99 155.21 37.6 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.446 1.098 . . . . 0.0 112.094 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.0 t -144.96 166.6 24.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.635 1.174 . . . . 0.0 112.121 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.2 pt -146.32 155.33 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.48 1.512 . . . . 0.0 111.999 -173.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.1 m -69.65 137.57 52.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.231 1.413 . . . . 0.0 110.075 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -78.75 37.75 0.3 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.348 1.459 . . . . 0.0 113.228 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.59 132.55 88.64 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.856 1.663 . . . . 0.0 111.532 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.21 147.39 29.52 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.423 2.749 . . . . 0.0 111.304 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -138.28 14.05 2.81 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.668 1.187 . . . . 0.0 113.289 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.483 1.217 0 C-N-CA 127.317 2.247 . . . . 0.0 110.173 -179.23 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 CA-C-O 118.237 -1.313 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.42 -19.73 65.53 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.029 3.152 . . . . 0.0 116.988 -172.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.2 mt -94.88 0.51 54.85 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.154 1.382 . . . . 0.0 113.094 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.8 135.79 9.07 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.103 1.811 . . . . 0.0 110.861 -169.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 m -81.4 -0.29 40.77 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -157.58 143.28 17.33 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.078 1.751 . . . . 0.0 110.525 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.99 157.33 37.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.256 1.822 . . . . 0.0 111.042 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -157.48 72.28 4.37 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.376 1.47 . . . . 0.0 111.022 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.57 153.63 60.1 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.63 2.887 . . . . 0.0 111.464 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -148.87 136.54 11.15 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.388 1.475 . . . . 0.0 110.357 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -66.19 102.35 0.56 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.794 2.33 . . . . 0.0 112.464 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -164.07 121.18 1.71 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.674 1.589 . . . . 0.0 110.749 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 69.7 m -66.79 -18.86 65.59 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.703 1.201 . . . . 0.0 114.004 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 59.5 m -99.98 126.54 46.18 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.404 1.482 . . . . 0.0 110.346 -172.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.1 mt -121.95 137.19 54.89 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.229 1.412 . . . . 0.0 110.596 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.06 146.45 18.21 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.174 1.369 . . . . 0.0 110.227 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.76 128.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 126.136 1.774 . . . . 0.0 107.689 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.78 151.41 50.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.426 1.09 . . . . 0.0 111.758 -167.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.22 47.81 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 124.022 0.82 . . . . 0.0 113.272 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.1 168.92 19.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.823 1.649 . . . . 0.0 112.614 -178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 t -93.96 159.65 15.08 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.198 0.999 . . . . 0.0 112.772 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -71.75 -19.89 61.97 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.513 -0.742 . . . . 0.0 111.308 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -84.91 -7.52 59.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.358 1.463 . . . . 0.0 114.272 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.8 m -72.44 139.54 47.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.003 . . . . 0.0 109.51 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -123.45 163.6 20.55 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.398 1.479 . . . . 0.0 110.433 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -60.58 -24.63 65.6 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 171.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -67.47 -39.95 85.3 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.206 0.912 . . . . 0.0 111.382 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -64.44 -49.76 70.2 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.372 0.669 . . . . 0.0 110.388 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.36 -47.44 85.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.717 -0.659 . . . . 0.0 111.721 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -54.75 -50.89 67.31 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.182 0.901 . . . . 0.0 111.201 172.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.31 -41.72 96.69 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 97.3 t -75.11 -37.01 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.872 0.869 . . . . 0.0 112.256 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -88.93 -18.34 27.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 34.1 t -63.67 -20.92 66.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.935 1.243 . . . . 0.0 113.681 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -63.68 -14.09 48.87 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.63 -1.294 . . . . 0.0 114.361 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -97.39 -12.13 23.13 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.71 -172.7 28.0 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 124.279 0.942 . . . . 0.0 115.089 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.51 135.63 20.34 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.587 3.525 . . . . 0.0 111.22 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.84 128.26 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.126 1.37 . . . . 0.0 109.397 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.63 -39.13 16.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.383 1.473 . . . . 0.0 112.313 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.88 169.37 14.94 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.215 1.406 . . . . 0.0 112.294 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 88.5 t -154.95 140.13 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.496 2.319 . . . . 0.0 108.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 69.3 m -148.18 125.07 11.27 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.649 1.18 . . . . 0.0 112.105 -177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 73.4 mt -85.17 149.8 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.111 -0.993 . . . . 0.0 110.09 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.46 128.22 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.142 0.977 . . . . 0.0 109.068 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -119.5 151.04 39.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.083 1.353 . . . . 0.0 112.872 -172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.16 158.89 15.82 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.342 1.857 . . . . 0.0 113.742 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.83 -13.68 57.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -137.97 -42.54 0.52 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 120.06 1.3 . . . . 0.0 113.334 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 93.4 p -91.79 -15.07 28.8 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.285 1.034 . . . . 0.0 113.436 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 62.59 15.62 8.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.928 2.091 . . . . 0.0 114.661 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -69.49 157.73 36.56 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.11 1.364 . . . . 0.0 110.53 169.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -62.18 140.04 58.45 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.322 -0.861 . . . . 0.0 111.075 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -77.57 -3.65 41.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.506 0.723 . . . . 0.0 112.748 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 92.0 18.53 43.12 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.186 1.374 . . . . 0.0 113.822 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -154.6 161.4 41.62 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.561 1.172 . . . . 0.0 113.567 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -158.28 174.07 15.71 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 111.945 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -133.39 143.76 49.13 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.607 1.563 . . . . 0.0 110.483 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.3 t -130.62 129.87 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 107.788 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.11 110.1 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.184 0.994 . . . . 0.0 110.986 -171.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -83.46 146.67 28.27 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.947 0.899 . . . . 0.0 111.504 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -79.27 -8.14 58.81 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.804 0.842 . . . . 0.0 112.493 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -129.64 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.184 1.794 . . . . 0.0 110.802 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -61.99 -26.94 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.393 1.077 . . . . 0.0 112.824 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.15 -27.39 18.56 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -76.46 -23.76 53.86 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.825 0.739 . . . . 0.0 112.473 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.64 -33.77 74.52 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.269 0.628 . . . . 0.0 112.29 170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -66.64 -46.04 77.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 0.0 111.436 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.39 -54.21 48.28 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.829 1.252 . . . . 0.0 110.05 173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.19 -49.49 69.23 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.515 0.726 . . . . 0.0 112.701 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -55.85 -55.09 36.62 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.65 0.78 . . . . 0.0 111.988 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -75.0 -21.51 59.09 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -86.41 -37.58 18.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.796 0.839 . . . . 0.0 113.028 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.9 -27.54 33.34 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.44 115.03 2.99 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.139 -0.976 . . . . 0.0 112.128 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.54 1.06 75.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.041 1.305 . . . . 0.0 115.667 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -65.36 178.94 0.83 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.577 1.688 . . . . 0.0 113.815 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -103.14 132.97 49.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.158 1.383 . . . . 0.0 111.127 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 tp -144.89 125.1 13.71 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.105 1.762 . . . . 0.0 108.607 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.8 t70 57.84 23.31 9.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.428 1.891 . . . . 0.0 113.346 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.8 -1.14 79.95 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.533 1.063 . . . . 0.0 114.113 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -82.12 171.5 14.27 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.198 1.399 . . . . 0.0 111.169 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -117.85 106.61 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.82 1.248 . . . . 0.0 109.7 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.5 pt -94.25 173.83 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.075 1.35 . . . . 0.0 113.494 -170.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -135.46 144.84 46.64 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.409 2.284 . . . . 0.0 108.315 169.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -138.65 129.41 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.129 1.372 . . . . 0.0 109.511 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -151.26 160.93 43.54 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.714 1.606 . . . . 0.0 111.529 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -69.02 141.43 54.85 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.792 0.837 . . . . 0.0 111.452 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.8 m -76.09 81.36 2.92 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.776 0.798 . . . . 0.0 111.25 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.7 pt -84.45 4.51 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.307 1.443 . . . . 0.0 112.92 173.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 23.4 p -82.94 1.77 37.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.249 2.62 . . . . 0.0 113.931 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.22 139.89 46.35 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.274 1.429 . . . . 0.0 112.173 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -62.3 151.09 83.05 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.034 0.934 . . . . 0.0 112.903 -174.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.18 156.34 55.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.241 2.627 . . . . 0.0 110.698 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -139.79 143.96 37.13 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.801 1.241 . . . . 0.0 110.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.126 1.77 . . . . 0.0 112.336 -174.608 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.74 -8.32 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.186 3.258 . . . . 0.0 114.469 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.0 tp -159.59 144.71 15.49 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.652 1.581 . . . . 0.0 110.187 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.59 51.9 3.43 Favored Glycine 0 N--CA 1.474 1.222 0 C-N-CA 125.529 1.538 . . . . 0.0 114.007 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.2 m 68.77 12.88 8.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.285 1.834 . . . . 0.0 114.711 172.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -73.04 123.31 23.29 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.255 1.022 . . . . 0.0 111.052 177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -166.98 45.81 0.06 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.329 2.252 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.59 160.24 25.71 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.681 1.192 . . . . 0.0 113.641 -165.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.24 -179.89 4.82 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.01 3.14 . . . . 0.0 111.329 169.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -55.98 120.88 37.01 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.394 1.478 . . . . 0.0 112.785 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.64 161.51 33.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.021 3.147 . . . . 0.0 112.634 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -156.43 58.64 0.56 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 40.2 m 73.5 5.82 5.0 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 126.825 2.05 . . . . 0.0 116.261 167.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.73 146.51 27.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.354 1.434 . . . . 0.0 114.636 -173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.2 mt -128.08 139.52 52.48 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.193 1.797 . . . . 0.0 110.704 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.0 144.01 16.87 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 166.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.27 126.87 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.023 1.729 . . . . 0.0 107.751 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -133.8 145.13 49.47 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 111.92 -168.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.23 36.73 Favored Glycine 0 N--CA 1.475 1.234 0 C-N-CA 124.624 1.106 . . . . 0.0 113.664 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.54 155.05 40.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.239 1.416 . . . . 0.0 112.795 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.3 t -71.11 147.22 48.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.807 0.843 . . . . 0.0 111.862 170.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.71 -13.48 62.14 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.65 -0.656 . . . . 0.0 112.755 173.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -90.71 0.35 57.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.149 1.38 . . . . 0.0 113.822 173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.9 m -67.84 145.23 54.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.522 1.129 . . . . 0.0 109.862 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.5 p -123.32 164.05 19.56 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.53 1.132 . . . . 0.0 110.626 171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.16 -23.91 67.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.305 0.642 . . . . 0.0 111.557 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.34 -40.59 62.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.302 1.441 . . . . 0.0 111.934 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -63.01 -45.58 91.68 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.403 -0.811 . . . . 0.0 110.753 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.0 mt -59.85 -44.69 93.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.56 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -54.52 -52.29 62.47 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.595 1.089 . . . . 0.0 111.331 169.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -65.83 -30.38 70.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.0 t -81.75 -34.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.066 0.848 . . . . 0.0 112.297 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -98.84 -14.62 19.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.9 p -70.09 -15.61 63.01 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.687 1.585 . . . . 0.0 114.322 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -62.62 -11.27 15.86 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -104.38 1.92 30.69 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.963 1.705 . . . . 0.0 113.925 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 130.37 -176.76 18.67 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.027 1.299 . . . . 0.0 115.29 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.86 134.07 44.87 Favored 'Trans proline' 0 C--N 1.352 0.731 1 C-N-CA 125.304 4.003 . . . . 0.0 112.402 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.8 mt -117.79 118.9 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.623 1.569 . . . . 0.0 108.617 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.13 -40.06 60.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.997 1.319 . . . . 0.0 111.97 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -161.22 165.83 28.72 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.897 1.279 . . . . 0.0 112.061 -172.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.5 t -150.92 137.54 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.689 1.996 . . . . 0.0 108.614 176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.9 m -135.93 111.88 9.55 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.419 1.087 . . . . 0.0 111.63 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.31 144.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.247 -0.908 . . . . 0.0 109.417 169.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.34 128.12 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.708 0.803 . . . . 0.0 109.257 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.69 148.19 43.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.241 1.416 . . . . 0.0 112.511 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.15 154.56 15.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.592 1.957 . . . . 0.0 114.406 -175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -56.3 -32.3 64.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.647 1.579 . . . . 0.0 114.379 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -148.47 -26.15 0.32 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -169.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 87.4 p -89.96 -15.37 32.13 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 119.531 1.06 . . . . 0.0 112.749 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 61.46 17.43 8.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.905 2.082 . . . . 0.0 114.318 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -71.52 155.9 40.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.455 1.502 . . . . 0.0 109.776 168.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.6 t -62.51 139.56 58.6 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.282 -0.887 . . . . 0.0 111.165 172.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -78.74 -1.63 35.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.565 0.746 . . . . 0.0 112.784 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.97 19.04 48.71 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.019 1.295 . . . . 0.0 113.731 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.58 160.29 41.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.585 1.192 . . . . 0.0 113.715 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.32 173.77 15.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.036 1.735 . . . . 0.0 112.123 -168.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -133.33 141.59 48.02 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.976 1.711 . . . . 0.0 110.408 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.49 129.42 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.397 1.879 . . . . 0.0 108.621 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -117.31 118.61 32.73 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.931 1.292 . . . . 0.0 110.911 -172.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -97.72 156.62 16.47 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.457 1.503 . . . . 0.0 111.423 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -72.01 -20.32 61.73 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -142.26 153.47 43.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.275 1.43 . . . . 0.0 111.666 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.54 -27.29 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.776 0.831 . . . . 0.0 112.583 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.7 -27.74 55.61 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -73.99 -36.55 64.54 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.493 0.717 . . . . 0.0 110.822 173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.77 93.89 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.343 0.657 . . . . 0.0 111.74 170.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.53 -46.22 87.03 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.187 -0.946 . . . . 0.0 111.906 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -58.22 -45.68 87.26 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.782 0.719 . . . . 0.0 111.935 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.88 -47.24 85.87 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.096 0.559 . . . . 0.0 112.493 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -64.16 -32.01 73.43 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.844 -1.16 . . . . 0.0 113.003 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -71.88 -19.54 61.93 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -116.63 -35.17 4.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.98 23.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.269 1.028 . . . . 0.0 113.7 -176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -66.11 114.9 5.59 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.983 -1.073 . . . . 0.0 111.79 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 91.75 3.18 68.76 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.077 1.322 . . . . 0.0 115.491 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.53 -169.54 0.08 Allowed 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 119.408 1.604 . . . . 0.0 113.372 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -130.19 135.11 47.8 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.811 1.644 . . . . 0.0 110.017 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 41.8 tp -134.32 126.56 29.95 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.411 1.484 . . . . 0.0 109.719 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.8 t70 57.35 32.27 21.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.247 1.819 . . . . 0.0 112.564 -175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.83 -0.73 70.61 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.421 1.01 . . . . 0.0 114.303 -176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.2 mmt-85 -96.85 130.56 44.11 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.76 1.28 . . . . 0.0 110.304 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -71.82 142.2 49.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.282 0.633 . . . . 0.0 110.63 170.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.0 pt -128.32 174.32 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.62 1.168 . . . . 0.0 113.918 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 42.1 ttp-105 -133.9 145.09 49.3 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.622 2.369 . . . . 0.0 108.625 169.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.79 128.88 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.229 1.412 . . . . 0.0 109.668 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -156.99 156.47 33.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.454 1.101 . . . . 0.0 112.219 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.14 125.25 23.92 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.893 0.877 . . . . 0.0 112.164 -174.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 24.4 p -89.33 58.96 4.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.484 1.114 . . . . 0.0 110.788 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.04 -14.97 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -169.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 29.8 m -81.01 139.12 35.95 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.351 1.861 . . . . 0.0 110.979 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -135.41 168.26 19.53 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.961 1.704 . . . . 0.0 111.201 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.91 140.94 68.14 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.957 1.303 . . . . 0.0 112.749 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.66 150.48 56.8 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.42 2.747 . . . . 0.0 111.29 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -134.36 15.23 3.77 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.139 1.376 . . . . 0.0 112.613 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.733 2.013 . . . . 0.0 112.287 -173.112 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.421 -0.655 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.08 156.74 51.56 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 124.104 3.202 . . . . 0.0 111.95 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.98 161.09 31.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.967 1.707 . . . . 0.0 111.679 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.38 14.64 78.19 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.232 0.92 . . . . 0.0 114.235 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.4 m -75.7 -1.33 24.3 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -138.51 155.4 48.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.217 1.807 . . . . 0.0 111.297 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.81 35.0 0.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.68 1.592 . . . . 0.0 111.541 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -160.09 153.16 18.22 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.708 1.603 . . . . 0.0 112.131 -169.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.67 163.11 36.53 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.481 2.787 . . . . 0.0 111.012 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -159.63 122.4 1.93 Allowed Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.562 1.545 . . . . 0.0 109.61 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.43 126.54 9.12 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.951 2.434 . . . . 0.0 111.583 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -152.53 90.39 1.49 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.722 1.609 . . . . 0.0 110.7 -174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 55.9 m -79.41 -14.57 58.85 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -171.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.89 146.57 43.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.475 1.11 . . . . 0.0 111.293 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.9 mt -119.09 135.44 54.64 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.332 1.853 . . . . 0.0 109.415 173.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.28 142.95 16.25 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.65 126.56 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.748 1.619 . . . . 0.0 107.642 -173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -132.76 150.77 52.12 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 111.419 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.94 50.07 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.859 0.743 . . . . 0.0 113.085 -176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.01 166.92 22.79 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.496 1.518 . . . . 0.0 112.69 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.8 t -87.64 158.8 18.77 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.657 0.783 . . . . 0.0 112.649 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.0 mt -71.78 -18.05 62.13 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.537 -0.727 . . . . 0.0 112.094 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -91.37 -3.73 56.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.844 1.658 . . . . 0.0 114.118 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 84.8 m -70.17 144.74 51.88 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.641 1.176 . . . . 0.0 110.239 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 35.2 p -132.67 167.8 19.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.85 1.66 . . . . 0.0 110.863 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -66.86 -8.17 27.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.14 0.976 . . . . 0.0 112.825 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 mtp-105 -96.0 -35.81 11.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.116 1.366 . . . . 0.0 111.539 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.51 -46.97 85.97 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.167 0.987 . . . . 0.0 110.959 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.4 mt -60.46 -44.42 95.9 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.738 0.815 . . . . 0.0 111.833 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -57.41 -47.57 81.4 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.386 0.994 . . . . 0.0 111.69 171.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.9 -36.49 83.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.128 0.876 . . . . 0.0 112.551 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.97 -37.58 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.073 0.949 . . . . 0.0 113.011 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.66 -18.84 17.09 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -173.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.4 t -70.64 -15.08 62.7 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.175 1.352 . . . . 0.0 113.303 -178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -62.81 -13.71 36.72 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 120.597 -1.314 . . . . 0.0 114.069 170.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -98.43 -16.53 19.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.23 -178.18 32.02 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.288 0.947 . . . . 0.0 114.971 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.53 134.95 25.35 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.604 3.536 . . . . 0.0 111.359 -175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.7 mt -119.24 129.13 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.477 1.511 . . . . 0.0 109.244 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.61 -27.48 14.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.159 1.383 . . . . 0.0 113.281 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -165.32 162.73 19.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.383 1.473 . . . . 0.0 111.635 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 89.9 t -153.9 139.56 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 127.268 2.227 . . . . 0.0 108.459 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.9 t -149.07 135.8 19.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.595 0.758 . . . . 0.0 112.03 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 82.7 mt -104.54 145.6 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.63 1.572 . . . . 0.0 109.28 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.16 129.47 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.745 0.818 . . . . 0.0 109.818 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -122.92 152.17 41.07 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.432 1.493 . . . . 0.0 112.905 -173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.24 138.9 57.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.758 1.623 . . . . 0.0 113.457 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.13 -13.76 60.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -118.5 -18.61 9.08 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.715 1.143 . . . . 0.0 113.431 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 96.9 p -139.36 -5.81 1.4 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 62.94 12.18 5.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.17 1.788 . . . . 0.0 114.902 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -67.52 150.58 48.66 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.689 1.196 . . . . 0.0 110.028 169.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.6 t -63.88 137.24 57.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.15 -0.969 . . . . 0.0 111.052 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -81.39 -3.18 52.04 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.367 0.667 . . . . 0.0 112.643 173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.99 20.78 48.71 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.992 1.282 . . . . 0.0 113.916 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.67 158.89 43.03 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.577 1.189 . . . . 0.0 113.517 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.93 176.6 11.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.074 1.75 . . . . 0.0 112.589 -167.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -135.69 145.29 46.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.015 1.726 . . . . 0.0 110.993 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.63 124.44 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.353 1.861 . . . . 0.0 109.113 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -106.25 119.34 38.99 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.214 1.406 . . . . 0.0 111.174 -174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -95.57 137.47 34.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.301 1.04 . . . . 0.0 111.009 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.16 -26.59 60.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.233 0.613 . . . . 0.0 111.713 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -106.13 115.01 29.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.222 1.409 . . . . 0.0 110.256 172.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.41 -24.14 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -77.17 -24.64 51.44 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.79 -20.47 24.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.138 0.975 . . . . 0.0 112.431 174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.44 -39.81 88.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.769 0.713 . . . . 0.0 111.549 169.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -63.94 -45.83 87.44 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.482 0.713 . . . . 0.0 111.953 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -61.21 -50.91 71.19 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.74 -49.93 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.144 0.978 . . . . 0.0 112.491 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -56.4 -49.54 74.19 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.939 0.896 . . . . 0.0 112.273 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.76 -27.91 62.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.26 -39.98 31.7 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.59 0.756 . . . . 0.0 112.528 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.25 -27.01 22.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -60.88 112.93 2.24 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.535 1.061 . . . . 0.0 112.228 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 94.93 -0.95 64.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.428 1.49 . . . . 0.0 115.879 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -65.38 -172.9 0.12 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.446 1.623 . . . . 0.0 113.744 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.72 133.28 53.24 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.546 1.539 . . . . 0.0 110.295 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.4 tp -130.08 127.13 39.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.828 1.651 . . . . 0.0 109.533 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t70 65.34 10.39 6.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.783 2.033 . . . . 0.0 113.805 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.24 5.12 65.88 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.245 1.402 . . . . 0.0 113.827 -171.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 11.7 mmp_? -100.43 133.24 45.14 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.986 1.314 . . . . 0.0 110.174 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -77.8 125.56 29.53 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.198 0.599 . . . . 0.0 110.444 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 8.3 pt -106.77 173.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.514 1.126 . . . . 0.0 113.568 -174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 85.3 mtt85 -140.5 149.05 42.0 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.416 2.286 . . . . 0.0 108.742 168.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.12 132.48 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.969 1.308 . . . . 0.0 110.126 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -157.15 162.76 39.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.77 1.228 . . . . 0.0 111.888 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.89 155.34 38.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.89 1.276 . . . . 0.0 114.132 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 37.1 t -146.78 143.16 28.44 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.896 1.678 . . . . 0.0 111.181 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.2 pt -134.86 -9.41 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.3 t -168.32 148.35 4.69 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.324 1.849 . . . . 0.0 110.827 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -104.33 4.05 33.16 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.695 1.598 . . . . 0.0 111.943 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -154.32 111.94 2.44 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.884 1.674 . . . . 0.0 110.972 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.31 158.02 52.38 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.0 2.467 . . . . 0.0 110.946 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -148.89 25.17 0.93 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.496 1.118 . . . . 0.0 111.905 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.253 1.259 0 C-N-CA 127.044 2.138 . . . . 0.0 112.997 -171.218 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 CA-C-O 119.519 -0.601 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.25 156.16 51.16 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.047 3.165 . . . . 0.0 111.707 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.3 mt -84.27 -11.15 56.94 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.962 0.905 . . . . 0.0 113.296 178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.71 150.7 21.29 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.351 1.453 . . . . 0.0 112.144 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.9 p -165.19 166.32 19.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.892 1.277 . . . . 0.0 112.182 -175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 -67.33 141.52 57.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.365 1.066 . . . . 0.0 111.656 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.65 174.96 9.98 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.926 1.69 . . . . 0.0 111.954 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 57.69 62.0 5.59 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 126.111 1.764 . . . . 0.0 112.875 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.39 179.81 5.81 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.03 3.153 . . . . 0.0 112.133 -178.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -132.57 76.59 71.4 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.694 1.598 . . . . 0.0 109.672 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -67.83 149.54 78.24 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.881 3.054 . . . . 0.0 115.939 -168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -169.57 170.09 8.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.756 2.422 . . . . 0.0 111.319 169.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.1 m -64.72 -16.89 63.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.52 133.49 51.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.025 0.93 . . . . 0.0 111.913 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 55.5 mt -108.92 140.73 42.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.328 1.451 . . . . 0.0 110.363 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.21 142.46 15.99 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 166.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.44 125.45 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.726 1.611 . . . . 0.0 107.727 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -131.69 158.57 40.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.868 1.267 . . . . 0.0 111.486 -168.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.12 27.5 62.01 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.414 0.531 . . . . 0.0 113.183 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.06 165.17 25.67 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.322 1.449 . . . . 0.0 112.408 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -74.51 141.44 44.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.064 0.546 . . . . 0.0 109.902 168.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.33 -6.82 42.85 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.363 -0.836 . . . . 0.0 113.139 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.51 1.88 44.36 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.255 1.822 . . . . 0.0 113.642 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.9 m -63.78 143.48 57.81 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.976 1.31 . . . . 0.0 110.099 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 34.8 p -116.73 160.82 20.2 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.141 1.376 . . . . 0.0 110.591 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.3 mp0 -58.65 -26.23 63.55 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -68.28 -41.42 81.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.993 0.917 . . . . 0.0 111.734 174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -62.05 -48.07 81.88 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.213 0.605 . . . . 0.0 110.369 174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 81.7 mt -57.9 -50.84 71.97 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 118.61 -0.71 . . . . 0.0 111.42 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -58.21 -39.62 79.49 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.699 1.136 . . . . 0.0 112.511 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -68.79 -39.46 80.13 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.986 0.812 . . . . 0.0 112.631 176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -76.75 -29.9 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 0.0 112.843 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -102.81 -20.42 14.32 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -72.65 -10.2 59.52 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.818 1.644 . . . . 0.0 114.306 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -61.31 -12.6 14.27 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.275 1.03 . . . . 0.0 113.691 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -105.95 2.9 27.87 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.355 1.862 . . . . 0.0 113.839 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 133.63 177.69 15.1 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.513 1.53 . . . . 0.0 115.098 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -55.62 136.18 72.9 Favored 'Trans proline' 0 C--N 1.353 0.806 1 C-N-CA 125.313 4.009 . . . . 0.0 113.542 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.15 125.57 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.415 1.486 . . . . 0.0 109.018 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.52 -33.24 21.83 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.723 1.609 . . . . 0.0 112.781 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -162.18 164.3 27.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.108 1.363 . . . . 0.0 112.086 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 40.4 t -154.17 142.08 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.133 2.173 . . . . 0.0 108.562 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -153.38 125.7 8.06 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.504 0.722 . . . . 0.0 112.619 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 88.1 mt -92.33 146.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.215 1.406 . . . . 0.0 110.124 174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 79.2 t -85.65 122.61 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.462 0.705 . . . . 0.0 109.551 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.26 148.55 41.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.599 1.56 . . . . 0.0 111.846 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.37 147.94 46.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.405 1.482 . . . . 0.0 114.06 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -78.11 -5.61 52.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.481 1.512 . . . . 0.0 114.336 -171.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -139.08 -39.5 0.48 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.571 1.078 . . . . 0.0 113.06 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.0 t -103.41 -7.03 21.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.372 1.069 . . . . 0.0 113.114 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 60.26 13.77 4.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.887 2.075 . . . . 0.0 116.068 174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.26 156.17 39.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 110.337 173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -63.48 142.72 58.29 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.119 -0.988 . . . . 0.0 111.141 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -93.57 3.74 55.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.269 1.028 . . . . 0.0 112.829 171.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.25 17.72 62.1 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 124.469 1.033 . . . . 0.0 114.781 174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -149.83 161.58 41.98 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.526 1.163 . . . . 0.0 113.293 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.44 173.71 15.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.826 1.65 . . . . 0.0 112.551 -167.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -134.22 141.55 47.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.898 1.679 . . . . 0.0 110.441 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 78.6 t -129.78 122.43 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.161 1.784 . . . . 0.0 108.646 -173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -107.77 102.61 11.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.908 1.283 . . . . 0.0 110.957 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -76.27 157.09 32.9 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.693 0.797 . . . . 0.0 111.152 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -74.64 -8.95 58.0 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -152.86 144.85 23.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.734 1.613 . . . . 0.0 111.207 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -62.35 -25.78 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.058 0.943 . . . . 0.0 111.913 169.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.89 -33.37 74.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -78.95 -35.16 43.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.28 0.632 . . . . 0.0 111.54 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.15 -37.04 86.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.54 0.736 . . . . 0.0 112.216 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -59.83 -49.43 77.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.511 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -59.26 -47.39 85.54 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.409 0.684 . . . . 0.0 111.619 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.32 86.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -61.51 -40.01 93.09 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.265 -0.897 . . . . 0.0 112.127 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -74.29 -13.19 60.73 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -113.27 -35.41 5.34 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -90.75 -21.18 21.69 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -63.52 114.25 3.8 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.717 1.144 . . . . 0.0 112.179 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.34 -1.1 69.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.373 1.463 . . . . 0.0 115.793 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -65.01 -171.84 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 119.581 1.691 . . . . 0.0 114.001 172.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -119.99 132.33 55.45 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.152 1.381 . . . . 0.0 110.803 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.2 tp -130.45 124.27 31.67 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.586 1.554 . . . . 0.0 109.183 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.1 t70 59.45 29.01 18.53 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.138 1.775 . . . . 0.0 113.392 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.99 87.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.005 1.288 . . . . 0.0 114.459 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -109.68 131.1 55.37 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.548 1.539 . . . . 0.0 110.704 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -80.15 111.69 16.75 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.171 0.989 . . . . 0.0 110.264 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.8 pt -86.58 178.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.926 1.29 . . . . 0.0 113.343 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -143.06 143.95 32.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.679 2.391 . . . . 0.0 108.039 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.0 t -139.65 132.63 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.8 1.24 . . . . 0.0 109.949 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -157.61 163.01 38.73 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.865 1.266 . . . . 0.0 111.634 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -60.1 140.48 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.614 0.766 . . . . 0.0 112.204 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.8 t -75.55 153.15 37.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -169.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 50.5 pt -85.61 3.83 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.264 1.826 . . . . 0.0 113.197 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 4.6 t -64.92 -12.49 49.9 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.971 1.708 . . . . 0.0 114.006 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -49.61 132.45 21.37 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.763 1.625 . . . . 0.0 113.057 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 36.2 ptt-85 -163.89 150.87 10.25 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.503 1.521 . . . . 0.0 112.061 -173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.52 162.29 40.31 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.529 2.819 . . . . 0.0 111.463 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -69.76 -33.76 72.87 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.586 0.754 . . . . 0.0 112.982 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.399 1.88 . . . . 0.0 110.772 -171.254 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.31 147.65 95.0 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.102 3.201 . . . . 0.0 112.669 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -153.92 108.31 3.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.265 1.026 . . . . 0.0 110.06 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.15 85.16 1.03 Allowed Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 111.62 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.3 p -78.49 5.82 9.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.342 1.857 . . . . 0.0 115.754 -170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -49.57 124.83 10.17 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.806 1.242 . . . . 0.0 112.015 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -138.18 131.88 31.04 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.647 1.579 . . . . 0.0 110.378 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -174.76 170.78 1.45 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 127.317 2.247 . . . . 0.0 109.771 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -56.11 123.95 15.08 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.121 2.547 . . . . 0.0 111.362 170.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -167.43 162.84 10.1 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 126.91 2.084 . . . . 0.0 110.081 -170.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.51 155.47 3.51 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.891 3.727 . . . . 0.0 116.174 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -108.85 140.27 42.53 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.678 1.991 . . . . 0.0 111.327 -170.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 60.5 m 71.45 -36.23 0.35 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 128.34 2.656 . . . . 0.0 115.377 171.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.3 t -98.78 125.87 44.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.67 1.188 . . . . 0.0 112.211 -177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.6 mt -114.64 131.03 56.86 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 125.556 1.542 . . . . 0.0 109.863 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.25 138.66 16.12 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.01 128.16 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.638 1.575 . . . . 0.0 107.998 -173.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -135.09 158.56 44.03 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.552 1.141 . . . . 0.0 111.423 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.89 29.81 50.09 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.622 0.629 . . . . 0.0 112.901 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.77 165.33 22.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.586 1.554 . . . . 0.0 112.321 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -82.36 154.83 25.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 112.094 173.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.97 -19.61 64.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.288 -0.883 . . . . 0.0 111.896 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -88.46 -5.36 58.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.436 1.494 . . . . 0.0 114.173 172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 88.1 m -70.8 133.0 46.16 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.287 0.949 . . . . 0.0 109.188 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.0 p -120.79 169.89 9.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.998 1.319 . . . . 0.0 110.654 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.32 -17.44 63.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.599 0.759 . . . . 0.0 112.037 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -70.48 -45.81 64.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.606 1.162 . . . . 0.0 110.656 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -67.04 -43.73 82.01 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.262 1.025 . . . . 0.0 110.6 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.35 -45.85 92.02 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.562 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.69 -45.46 89.42 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.342 0.974 . . . . 0.0 111.9 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.98 -38.54 91.44 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.252 0.933 . . . . 0.0 112.832 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.0 t -79.59 -35.75 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.734 1.214 . . . . 0.0 112.582 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -100.46 -20.97 15.52 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -175.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.5 t -73.29 -9.93 59.23 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.648 1.567 . . . . 0.0 113.473 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -64.64 -14.31 57.57 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.924 -1.11 . . . . 0.0 113.426 169.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -95.46 -6.62 40.32 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.449 1.5 . . . . 0.0 114.05 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.88 176.61 17.12 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.014 1.292 . . . . 0.0 114.537 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -59.95 137.6 77.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 125.186 3.924 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 43.3 mt -120.99 129.83 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.776 1.63 . . . . 0.0 109.277 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.25 -32.7 18.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.505 1.522 . . . . 0.0 112.728 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -166.7 166.22 16.03 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.421 1.488 . . . . 0.0 111.751 -177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -150.73 136.33 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.64 1.976 . . . . 0.0 108.544 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.7 m -132.99 112.78 12.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.534 1.134 . . . . 0.0 111.488 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.6 mt -79.71 145.92 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.382 -0.824 . . . . 0.0 109.802 169.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.9 t -95.41 133.13 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.272 1.029 . . . . 0.0 109.66 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.03 153.57 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.534 1.534 . . . . 0.0 112.309 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.05 141.91 57.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.445 1.098 . . . . 0.0 112.136 172.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -75.67 -15.32 60.33 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -124.89 -39.01 2.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.248 1.019 . . . . 0.0 112.707 -173.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 72.0 p -92.37 -13.85 29.55 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.468 1.031 . . . . 0.0 113.456 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 61.61 12.6 4.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.07 1.748 . . . . 0.0 114.101 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 -77.75 152.71 33.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.31 1.444 . . . . 0.0 110.704 173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.3 t -64.17 142.13 58.52 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.876 -0.515 . . . . 0.0 111.143 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -84.5 -2.68 57.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.608 0.763 . . . . 0.0 112.984 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.9 58.32 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.741 1.162 . . . . 0.0 113.887 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -151.72 162.39 41.09 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.386 1.088 . . . . 0.0 113.345 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.11 172.7 17.65 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.288 1.835 . . . . 0.0 112.307 -167.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.81 133.39 46.92 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.784 1.633 . . . . 0.0 109.921 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 79.9 t -117.89 128.78 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 126.453 1.901 . . . . 0.0 108.58 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.24 103.94 11.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.405 1.082 . . . . 0.0 111.222 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -76.01 151.57 37.15 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.708 0.803 . . . . 0.0 111.363 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -72.98 -18.99 61.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.383 0.673 . . . . 0.0 112.613 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -136.35 155.15 50.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.195 1.398 . . . . 0.0 111.873 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.94 -35.04 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.905 1.282 . . . . 0.0 113.67 -176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -81.5 -31.05 33.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.332 1.053 . . . . 0.0 113.433 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.43 -41.79 98.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.043 0.937 . . . . 0.0 111.3 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.84 99.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.197 0.599 . . . . 0.0 112.045 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -68.71 -36.23 78.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.263 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -68.64 -48.15 64.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.949 0.795 . . . . 0.0 111.43 169.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.43 -44.46 72.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.148 0.886 . . . . 0.0 112.94 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -57.75 -48.74 78.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.848 0.859 . . . . 0.0 111.618 174.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -66.82 -29.21 69.09 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -81.11 -37.24 29.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 113.134 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -102.2 -23.55 14.02 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -168.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.54 102.32 0.54 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.899 1.227 . . . . 0.0 113.231 -169.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.94 -3.71 30.3 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.528 1.537 . . . . 0.0 115.496 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.7 ptt? -65.05 -174.86 0.17 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.879 1.34 . . . . 0.0 114.127 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -121.24 126.33 49.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.228 1.411 . . . . 0.0 110.919 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 33.7 tp -127.62 123.64 36.12 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.467 1.907 . . . . 0.0 109.168 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 26.2 t70 57.54 32.7 22.22 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.898 1.679 . . . . 0.0 112.609 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.45 58.35 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.548 1.071 . . . . 0.0 114.24 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -95.62 130.9 42.34 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.994 1.318 . . . . 0.0 109.968 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -90.16 109.27 20.35 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.643 0.735 . . . . 0.0 110.235 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.6 pt -82.25 178.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.816 1.646 . . . . 0.0 113.945 -169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -139.4 143.49 37.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.88 2.472 . . . . 0.0 107.689 168.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.17 127.05 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.325 1.45 . . . . 0.0 109.061 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -158.14 159.48 36.23 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -68.01 139.43 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.971 1.308 . . . . 0.0 112.206 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 5.4 t -157.79 -173.72 4.51 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.0 pt -145.05 156.86 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 111.045 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.1 t -116.28 -15.73 10.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.138 1.375 . . . . 0.0 113.536 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -158.54 148.23 19.48 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.854 1.661 . . . . 0.0 111.08 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 26.9 tpt85 -156.02 109.11 2.11 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 125.232 1.413 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.03 140.23 86.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.463 2.775 . . . . 0.0 111.171 170.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -95.98 1.26 52.66 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.946 0.898 . . . . 0.0 113.307 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.873 2.069 . . . . 0.0 112.139 -177.751 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.83 153.02 58.76 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.105 3.203 . . . . 0.0 111.76 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 99.1 mt -144.39 158.37 43.78 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.049 1.739 . . . . 0.0 110.748 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.41 -10.38 85.63 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.28 0.943 . . . . 0.0 114.305 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.0 t -165.9 160.03 16.42 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.213 1.805 . . . . 0.0 111.424 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -90.11 0.57 57.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.138 1.375 . . . . 0.0 112.676 170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.0 -166.47 2.56 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.468 1.907 . . . . 0.0 111.088 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -139.87 69.99 36.33 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.305 1.042 . . . . 0.0 112.236 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.8 160.45 46.15 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.676 2.917 . . . . 0.0 110.787 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -65.68 116.77 34.96 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 123.984 0.914 . . . . 0.0 112.084 -177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.06 128.99 15.54 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.891 2.394 . . . . 0.0 110.315 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -161.17 172.1 17.32 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.984 1.314 . . . . 0.0 111.43 -173.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -69.06 -14.19 62.88 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 64.1 m -93.51 121.56 35.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.957 1.303 . . . . 0.0 111.148 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 62.6 mt -117.68 140.03 50.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.937 1.295 . . . . 0.0 111.032 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.27 142.97 16.46 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 166.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.8 132.64 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.376 1.471 . . . . 0.0 108.261 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -136.66 162.83 32.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.929 1.292 . . . . 0.0 111.296 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.1 26.96 69.44 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 123.517 0.579 . . . . 0.0 113.207 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.72 159.62 30.03 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 112.184 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.6 t -78.55 152.08 32.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.686 0.794 . . . . 0.0 111.808 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.45 -17.16 64.33 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -94.25 0.33 55.59 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 114.084 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.0 m -67.92 142.03 56.17 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 110.463 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 40.3 p -124.09 163.29 21.79 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.536 1.534 . . . . 0.0 110.455 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -63.17 -17.8 62.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 171.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -72.12 -43.68 64.35 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.137 -0.977 . . . . 0.0 110.862 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.49 -44.86 95.35 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.21 0.604 . . . . 0.0 110.712 174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 85.1 mt -60.3 -46.03 91.3 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.643 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -58.54 -42.93 88.95 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.945 1.248 . . . . 0.0 112.215 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -64.98 -36.5 84.59 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.743 1.156 . . . . 0.0 113.115 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.91 -29.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.347 1.059 . . . . 0.0 112.854 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.83 -21.68 12.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -73.49 -12.31 60.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.888 1.676 . . . . 0.0 113.066 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -64.22 -12.89 45.15 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 120.99 -1.069 . . . . 0.0 113.559 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.09 -5.21 37.92 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.212 1.405 . . . . 0.0 113.886 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.26 -177.24 20.48 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.283 1.42 . . . . 0.0 114.964 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.19 135.19 45.8 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 125.118 3.878 . . . . 0.0 112.385 -174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.0 mt -119.33 130.93 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.878 1.671 . . . . 0.0 109.227 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.65 -35.43 15.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.121 1.369 . . . . 0.0 112.754 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -167.11 162.25 15.2 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.009 1.723 . . . . 0.0 111.345 -176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.2 t -153.77 143.67 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 127.377 2.271 . . . . 0.0 108.548 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.4 t -153.49 124.89 7.56 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.293 0.637 . . . . 0.0 112.645 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 92.6 mt -88.73 147.23 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.105 1.362 . . . . 0.0 110.234 174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.61 130.69 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.994 0.917 . . . . 0.0 109.544 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -125.86 153.43 44.15 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.414 1.486 . . . . 0.0 112.564 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.2 132.66 51.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.482 1.513 . . . . 0.0 112.286 176.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -74.85 0.89 14.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -129.05 -50.31 1.21 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.502 1.121 . . . . 0.0 111.26 173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.5 m -86.74 -14.35 42.64 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? 62.28 12.73 5.4 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.332 1.853 . . . . 0.0 113.967 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.0 mtm105 -60.54 145.93 46.85 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.86 1.664 . . . . 0.0 110.911 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.9 t -66.52 140.04 57.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.711 -0.618 . . . . 0.0 110.395 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 37.5 mtp85 -86.94 -2.84 58.92 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.96 19.17 58.21 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.642 1.115 . . . . 0.0 114.115 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -152.15 160.86 43.31 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 1.156 . . . . 0.0 113.393 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.84 173.09 16.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.222 1.809 . . . . 0.0 112.505 -167.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.42 142.98 51.28 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.749 1.619 . . . . 0.0 109.986 174.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.47 128.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 126.205 1.802 . . . . 0.0 108.279 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -121.19 108.03 13.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.946 0.898 . . . . 0.0 111.459 -171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -80.15 155.88 27.24 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 0.0 111.422 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -74.15 -20.28 60.28 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -146.19 152.03 38.58 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.993 1.717 . . . . 0.0 111.262 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.95 -35.83 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.15 -27.37 65.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.122 0.873 . . . . 0.0 113.208 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -78.21 -29.51 48.4 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.019 . . . . 0.0 111.8 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -36.51 67.72 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.246 0.618 . . . . 0.0 111.8 169.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -62.82 -43.9 97.57 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.443 -0.786 . . . . 0.0 111.502 172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.17 -55.66 32.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.775 172.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.64 -47.63 76.32 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.53 -37.92 87.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.523 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -67.92 -48.31 66.32 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.945 0.793 . . . . 0.0 112.263 173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 16.3 mmp_? -77.12 -37.65 53.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -170.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.66 -19.44 19.0 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -64.63 112.61 3.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 120.012 1.278 . . . . 0.0 112.404 -173.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.31 70.79 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.402 1.477 . . . . 0.0 115.761 175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -66.03 -178.63 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.149 1.475 . . . . 0.0 113.837 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.18 130.78 50.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 111.75 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 35.7 tp -132.66 124.04 27.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.97 1.708 . . . . 0.0 108.916 168.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 24.7 t70 57.84 29.41 17.47 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.153 1.781 . . . . 0.0 113.466 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.35 11.53 81.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.333 0.968 . . . . 0.0 114.143 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -112.98 138.17 50.27 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 111.311 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 102.28 6.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.586 0.754 . . . . 0.0 109.478 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 178.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 0.0 112.889 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.03 146.11 29.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.844 1.658 . . . . 0.0 109.046 169.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -142.35 128.39 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.026 1.33 . . . . 0.0 109.652 -171.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -156.56 153.49 28.74 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -64.05 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.779 0.832 . . . . 0.0 111.596 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.1 t -152.16 -152.9 0.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.223 1.009 . . . . 0.0 111.108 -171.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -137.52 169.62 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.87 2.068 . . . . 0.0 110.893 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.7 t -68.01 141.54 56.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.479 0.711 . . . . 0.0 110.999 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -72.75 -13.38 61.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.251 1.02 . . . . 0.0 112.633 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -62.57 138.1 96.55 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.704 1.202 . . . . 0.0 111.557 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -58.63 171.13 2.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.064 3.176 . . . . 0.0 113.162 168.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -83.3 2.39 36.31 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.897 2.079 . . . . 0.0 113.505 -174.028 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.42 -7.65 12.76 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 124.057 3.171 . . . . 0.0 114.613 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.4 mt -137.82 129.6 28.45 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.589 1.556 . . . . 0.0 110.363 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.81 -11.83 39.24 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.796 1.189 . . . . 0.0 114.523 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.4 p -101.56 -8.99 21.39 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -165.32 147.17 7.63 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.571 1.548 . . . . 0.0 112.271 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.29 15.34 0.46 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.355 1.462 . . . . 0.0 113.798 -176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -63.74 121.43 70.74 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.185 0.994 . . . . 0.0 112.064 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.53 156.31 32.15 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.303 2.669 . . . . 0.0 111.864 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -156.41 127.26 3.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.39 1.476 . . . . 0.0 110.19 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.48 117.86 3.47 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.938 2.426 . . . . 0.0 111.004 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -160.41 121.81 3.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.076 1.35 . . . . 0.0 111.133 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.5 -0.03 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.456 1.502 . . . . 0.0 114.83 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.5 p -125.45 124.22 40.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.069 0.85 . . . . 0.0 112.959 -171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 52.4 mt -111.69 140.44 46.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.904 1.282 . . . . 0.0 110.694 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.74 143.89 16.85 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 167.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.62 120.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.053 1.741 . . . . 0.0 107.385 -174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.42 145.33 50.86 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.588 1.155 . . . . 0.0 111.668 -167.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 25.67 28.0 Favored Glycine 0 N--CA 1.474 1.175 0 C-N-CA 124.18 0.895 . . . . 0.0 113.572 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.49 170.06 17.22 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.893 1.677 . . . . 0.0 112.354 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.7 t -84.58 158.31 20.95 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.8 mt -68.41 -22.01 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.745 -0.597 . . . . 0.0 111.417 169.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -92.38 -4.14 54.25 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.022 1.729 . . . . 0.0 114.325 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 86.5 m -68.24 139.12 56.0 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.247 1.019 . . . . 0.0 109.51 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.9 p -124.8 164.4 20.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.316 1.446 . . . . 0.0 110.093 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -60.52 -19.3 56.66 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 174.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -70.21 -34.67 73.19 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.334 1.054 . . . . 0.0 111.753 173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -73.95 -46.25 45.27 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.439 0.696 . . . . 0.0 109.982 174.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.34 -49.53 77.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.471 -0.776 . . . . 0.0 111.521 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -62.16 -36.2 81.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.681 1.128 . . . . 0.0 112.282 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -69.36 -36.86 77.28 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.008 0.822 . . . . 0.0 112.876 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.0 t -81.79 -34.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.801 0.728 . . . . 0.0 112.344 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.67 -18.22 19.84 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 83.2 p -71.59 -12.49 61.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 120.763 1.619 . . . . 0.0 114.324 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -64.52 -14.3 56.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.015 -1.053 . . . . 0.0 113.331 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -94.29 -9.59 35.56 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.233 1.413 . . . . 0.0 114.028 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 143.0 -173.89 23.9 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.864 1.221 . . . . 0.0 115.195 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.76 133.79 22.64 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.576 3.517 . . . . 0.0 111.262 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 52.9 mt -114.88 130.9 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.129 1.372 . . . . 0.0 109.676 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -98.75 -27.24 14.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.841 1.656 . . . . 0.0 113.294 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -164.54 160.04 19.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.566 1.547 . . . . 0.0 111.494 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.3 t -154.87 137.93 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.398 2.279 . . . . 0.0 108.065 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.6 t -156.6 126.69 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.41 HG12 ' HB2' ' A' ' 162' ' ' ALA . 96.7 mt -92.93 145.44 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.512 1.525 . . . . 0.0 110.232 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 66.9 t -86.97 123.48 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.788 0.835 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -123.54 148.4 46.34 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.109 1.764 . . . . 0.0 111.538 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.54 134.25 52.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.452 1.101 . . . . 0.0 113.709 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -67.83 -13.25 61.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.906 1.282 . . . . 0.0 114.205 -175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -112.81 -53.17 2.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.474 1.109 . . . . 0.0 111.207 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.7 m -101.93 -3.98 26.92 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -167.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 63.5 6.51 2.57 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.69 1.996 . . . . 0.0 115.557 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -66.59 145.61 55.41 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.309 1.043 . . . . 0.0 110.793 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.8 t -67.71 139.86 56.73 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.886 -0.509 . . . . 0.0 110.771 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -90.37 2.21 55.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.723 0.809 . . . . 0.0 112.901 173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.42 22.99 59.4 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.299 0.952 . . . . 0.0 114.179 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -150.79 162.15 41.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.608 1.204 . . . . 0.0 113.379 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' A' ' 149' ' ' ILE . . . -157.79 174.56 15.12 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.915 1.686 . . . . 0.0 112.391 -167.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.86 145.15 48.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.762 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 59.5 t -133.15 129.6 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.501 1.92 . . . . 0.0 108.915 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -120.08 123.17 42.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.848 1.259 . . . . 0.0 111.022 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.62 145.38 25.8 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.843 0.857 . . . . 0.0 111.278 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -73.6 -13.82 61.08 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.898 0.879 . . . . 0.0 112.695 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -138.37 139.5 39.02 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.325 1.85 . . . . 0.0 110.087 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 5.8 p -65.77 -31.84 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -168.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.99 -22.92 41.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -75.08 -26.02 59.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.03 0.932 . . . . 0.0 111.698 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.75 -36.22 73.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.097 0.559 . . . . 0.0 111.439 168.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.09 -46.06 82.64 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.408 -0.808 . . . . 0.0 110.968 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -56.45 -53.09 61.55 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.846 1.258 . . . . 0.0 111.06 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.51 -46.24 80.66 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.424 -0.797 . . . . 0.0 113.086 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.77 -42.52 97.65 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.757 0.823 . . . . 0.0 111.967 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.22 -31.0 70.21 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -88.64 -41.1 12.84 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.66 -24.32 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -63.13 113.32 3.07 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.197 -0.939 . . . . 0.0 112.017 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 93.91 2.19 64.87 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.189 1.376 . . . . 0.0 115.673 177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -65.23 -174.73 0.18 Allowed 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 119.397 1.598 . . . . 0.0 113.328 169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -130.66 130.15 43.55 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.218 1.407 . . . . 0.0 109.956 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.42 126.59 26.29 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.052 1.741 . . . . 0.0 109.303 -176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.12 20.65 11.13 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 126.115 1.766 . . . . 0.0 112.626 -170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.28 84.09 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 121.101 -1.0 . . . . 0.0 113.682 -171.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -91.48 132.62 36.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.974 1.31 . . . . 0.0 109.748 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.06 116.51 27.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.603 0.761 . . . . 0.0 110.117 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 10.0 pt -101.11 176.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.776 1.23 . . . . 0.0 114.174 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -138.32 147.65 43.76 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.67 2.388 . . . . 0.0 108.585 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.1 t -141.13 131.18 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.085 1.354 . . . . 0.0 110.034 -175.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -157.81 158.64 35.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.612 1.165 . . . . 0.0 111.932 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -60.79 150.54 32.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.411 1.085 . . . . 0.0 111.939 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 91.9 p -142.42 -175.51 4.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.991 0.916 . . . . 0.0 113.136 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 pt -144.19 170.48 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.306 1.843 . . . . 0.0 111.082 -173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 6.7 t -147.38 179.66 7.49 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.96 1.704 . . . . 0.0 110.76 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -141.66 172.16 13.06 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.703 1.601 . . . . 0.0 113.577 -169.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -152.99 136.51 10.04 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.852 1.661 . . . . 0.0 110.597 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -62.88 141.87 86.2 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.652 2.901 . . . . 0.0 112.602 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -139.98 19.05 2.46 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.972 1.309 . . . . 0.0 112.747 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.253 1.265 0 C-N-CA 126.34 1.856 . . . . 0.0 110.907 -173.295 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 CA-C-O 119.49 -0.617 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.07 156.76 51.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.092 3.195 . . . . 0.0 111.812 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.5 tp -157.67 128.99 6.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.044 1.338 . . . . 0.0 110.538 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -91.4 172.67 36.45 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.26 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -161.75 151.98 17.18 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.142 1.377 . . . . 0.0 111.282 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -77.06 135.61 38.63 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.337 1.055 . . . . 0.0 111.417 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.46 132.92 15.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.446 1.498 . . . . 0.0 110.949 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -165.79 139.24 3.57 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.991 1.716 . . . . 0.0 110.151 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.08 82.49 2.34 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.464 2.776 . . . . 0.0 110.968 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -161.41 126.08 2.1 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.856 1.663 . . . . 0.0 110.34 -176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.29 135.35 18.44 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.029 2.486 . . . . 0.0 111.364 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -156.58 39.19 0.33 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.34 1.456 . . . . 0.0 110.509 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 20.1 m -77.75 -8.66 58.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.891 1.677 . . . . 0.0 115.273 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.7 t -93.32 134.28 35.69 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.452 1.101 . . . . 0.0 111.087 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.1 mt -118.55 142.79 47.26 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.017 1.727 . . . . 0.0 109.914 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 146.2 18.11 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 167.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -130.35 124.08 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.169 1.788 . . . . 0.0 107.368 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -130.44 143.74 50.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.322 1.049 . . . . 0.0 112.145 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 20.1 37.76 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.667 1.127 . . . . 0.0 113.933 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.44 172.03 7.82 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.582 1.553 . . . . 0.0 113.251 -175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.3 t -84.4 155.38 22.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.023 0.929 . . . . 0.0 112.288 175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.72 -20.35 65.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.63 -0.669 . . . . 0.0 112.123 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -94.86 -1.76 52.08 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.713 1.605 . . . . 0.0 114.211 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 92.1 m -65.56 136.83 56.87 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.215 1.006 . . . . 0.0 109.759 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.2 p -123.45 166.14 15.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.512 1.525 . . . . 0.0 110.474 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -59.24 -25.62 64.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.545 0.738 . . . . 0.0 111.847 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -62.99 -44.99 94.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.707 1.203 . . . . 0.0 111.02 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.41 -47.99 71.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.092 0.957 . . . . 0.0 110.325 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.23 -46.67 88.98 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.799 -0.62 . . . . 0.0 111.412 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -55.9 -50.76 69.79 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.166 0.894 . . . . 0.0 111.432 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.08 -36.2 83.57 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 93.2 t -79.17 -36.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.798 0.839 . . . . 0.0 112.216 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -96.07 -15.64 22.08 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 93.6 p -69.41 -16.33 63.48 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.716 1.598 . . . . 0.0 114.184 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -63.71 -13.85 46.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.45 -8.24 35.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.385 1.474 . . . . 0.0 113.868 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 139.66 -179.05 19.21 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.99 1.281 . . . . 0.0 115.067 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.25 134.84 50.89 Favored 'Trans proline' 0 C--N 1.352 0.744 1 C-N-CA 125.34 4.026 . . . . 0.0 112.486 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 76.1 mt -118.78 131.32 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.095 1.758 . . . . 0.0 109.193 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.34 -28.69 13.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.895 1.678 . . . . 0.0 113.482 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -164.29 159.74 20.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.482 1.513 . . . . 0.0 111.668 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 77.5 t -153.39 139.5 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.334 2.254 . . . . 0.0 108.643 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.1 t -151.45 146.69 26.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.813 0.845 . . . . 0.0 112.042 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 87.0 mt -117.32 142.91 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.937 1.695 . . . . 0.0 108.773 -177.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.75 125.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.494 0.717 . . . . 0.0 110.182 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -122.65 145.86 47.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.812 1.645 . . . . 0.0 111.407 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.67 134.88 57.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.533 1.133 . . . . 0.0 112.398 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -80.05 -0.22 34.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -119.27 -55.41 2.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 110.412 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 30.7 m -97.24 -6.24 35.03 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 -169.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 67.08 2.36 2.71 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.906 2.082 . . . . 0.0 115.833 170.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -68.86 152.19 45.61 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.737 1.215 . . . . 0.0 110.906 172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 43.8 t -64.71 139.2 58.74 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.512 -0.743 . . . . 0.0 111.206 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -87.3 2.25 50.79 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.916 0.887 . . . . 0.0 112.821 172.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.78 19.89 57.06 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 124.611 1.101 . . . . 0.0 114.663 173.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -150.46 161.43 42.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.946 1.373 . . . . 0.0 113.63 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.28 172.63 18.28 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.939 1.696 . . . . 0.0 112.534 -167.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.27 143.94 42.46 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.648 1.579 . . . . 0.0 110.796 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.42 125.26 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 108.794 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -110.09 114.76 28.52 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.137 1.375 . . . . 0.0 110.767 -175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -84.19 157.59 21.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.94 0.896 . . . . 0.0 111.478 175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.41 -22.53 61.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -141.54 148.1 38.82 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.272 1.429 . . . . 0.0 111.257 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.3 p -62.76 -27.56 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.519 0.728 . . . . 0.0 112.482 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.4 -22.81 60.14 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -82.34 -34.28 28.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.925 0.89 . . . . 0.0 111.289 171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.31 89.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.594 0.758 . . . . 0.0 112.347 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -60.98 -45.44 94.77 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.368 -0.832 . . . . 0.0 112.038 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -60.9 -54.28 47.02 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.438 1.095 . . . . 0.0 110.323 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.18 -47.78 74.73 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -56.9 -51.63 68.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.981 0.913 . . . . 0.0 111.503 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -71.46 -26.08 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -83.04 -41.4 18.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.685 0.794 . . . . 0.0 112.912 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.95 -25.53 24.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -61.74 112.13 2.14 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.298 0.954 . . . . 0.0 112.29 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 98.82 -2.34 58.41 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.338 1.447 . . . . 0.0 115.539 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -63.58 -175.5 0.13 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 119.267 1.533 . . . . 0.0 113.921 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -127.48 137.39 52.66 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.065 1.746 . . . . 0.0 109.837 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 39.2 tp -135.65 126.94 28.33 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.517 1.527 . . . . 0.0 109.541 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.21 24.72 14.8 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.976 1.71 . . . . 0.0 113.26 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.82 -0.46 89.15 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.046 1.308 . . . . 0.0 114.193 -176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -101.26 126.31 47.99 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.668 1.587 . . . . 0.0 110.072 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -73.85 139.06 44.81 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.531 0.733 . . . . 0.0 110.688 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.0 pt -126.88 175.33 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.555 1.142 . . . . 0.0 113.736 -171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -140.77 156.27 46.21 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.877 2.071 . . . . 0.0 109.786 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.73 133.49 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.497 1.519 . . . . 0.0 110.237 -171.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -157.61 161.75 38.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.009 1.324 . . . . 0.0 111.65 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -63.82 151.24 42.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.421 1.089 . . . . 0.0 112.954 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 8.4 t -153.27 -168.14 2.92 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.428 1.491 . . . . 0.0 111.469 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.7 pt -144.72 168.27 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.886 2.075 . . . . 0.0 111.257 -174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 9.6 t -61.96 144.87 54.43 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.411 1.084 . . . . 0.0 110.618 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -80.63 -3.76 51.68 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -156.89 95.32 2.21 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 126.053 1.741 . . . . 0.0 110.153 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -61.8 156.67 47.09 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.921 3.081 . . . . 0.0 112.298 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -145.86 152.04 38.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.432 1.493 . . . . 0.0 110.808 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.866 2.066 . . . . 0.0 110.25 179.364 . . . . . . . . 0 0 . 1 stop_ save_